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ABSTRACT 
The University of Manchester 
Guilan Kong 
PhD in Business Administration 
Thesis title: “An online belief rule-based group clinical decision support system” 
April 2011 
 
Around ten percent of patients admitted to National Health Service (NHS) hospitals 
have experienced a patient safety incident, and an important reason for the high rate of 
patient safety incidents is medical errors. Research shows that appropriate increase in 
the use of clinical decision support systems (CDSSs) could help to reduce medical 
errors and result in substantial improvement in patient safety. However several 
barriers continue to impede the effective implementation of CDSSs in clinical settings, 
among which representation of and reasoning about medical knowledge particularly 
under uncertainty are areas that require refined methodologies and techniques. 
Particularly, the knowledge base in a CDSS needs to be updated automatically based 
on accumulated clinical cases to provide evidence-based clinical decision support. 
In the research, we employed the recently developed belief Rule-base Inference 
Methodology using the Evidential Reasoning approach (RIMER) for design and 
development of an online belief rule-based group CDSS prototype. In the system, 
belief rule base (BRB) was used to model uncertain clinical domain knowledge, the 
evidential reasoning (ER) approach was employed to build inference engine, a BRB 
training module was developed for learning the BRB through accumulated clinical 
cases, and an online discussion forum together with an ER-based group preferences 
aggregation tool were developed for providing online clinical group decision support.  
We used a set of simulated patients in cardiac chest pain provided by our research 
collaborators in Manchester Royal Infirmary to validate the developed online belief 
rule-based CDSS prototype. The results show that the prototype can provide reliable 
diagnosis recommendations and the diagnostic performance of the system can be 
improved significantly after training BRB using accumulated clinical cases. 
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Chapter 1 
Introduction 
 
1.1. Background 
Patient safety incidents or adverse events, which are unintended or unexpected 
incidents that could have or did lead to harm for one or more patients receiving 
National Health Service (NHS)-funded health care, represent a serious public health 
problem and pose a threat to patient safety (Thomas and Brennan, 2001). Research 
shows that around 10% of patients admitted to NHS hospitals have experienced a 
patient safety incident, and that up to half of these incidents could have been 
prevented (Department of Health, 2004). Patient safety incidents cause great harm to 
not only patients and their families, but also involved clinicians and host hospitals. 
For example, it is estimated that patient safety incidents cost NHS £2 billion a year in 
addition to hospital stays, without taking account of human or wider economic costs 
(Department of Health, 2004).  
In clinical governance (Department of Health, 1998), which is a framework through 
which NHS organizations are accountable for continuously improving the quality of 
their services and safeguarding high standards of care by creating an environment 
favourable for the excellence in clinical care to flourish, the reduction of medical 
errors and the improvement of patient safety have become major priorities since 2000 
(Department of Health Expert Group, 2000). 
Research shows that an important reason for high rate of patient safety incidents is 
medical errors that are mostly caused by human factors (Reason, 2001). Take 
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Emergency Department (ED) for example, causes of medical errors that can happen in 
ED include clinicians’ inexperience or lack of training, interrupted clinical 
management of patients due to clinicians’ shift schedule, clinicians’ languished 
vigilance and alertness of patients’ abnormalities, and clinicians’ stress which may be 
caused by patients’ various conditions or the working environment in ED (Driscoll et 
al., 2001). In clinical governance, a very important action is to examine the potential 
of information technology (IT) to reduce the risks to patients and improve the quality 
of health care (Department of Health, 2001).  
Appropriate increase in the use of IT in health care has proved to help bring 
substantial improvement in patient safety (Bates et al., 2001). Particularly the 
introduction of clinical decision support, and appropriate communications between 
clinical decision support system (CDSS) and the deployed computerised clinical 
systems have simplified the health care process and substantially facilitated clinical 
practice and reduced medical errors (Sim et al., 2001, Kawamoto et al., 2005). There 
are numerous examples of CDSSs in health care which, have successfully improved 
the quality of health care (de Dombal et al., 1972, Jonsbu et al., 1993, Lin et al., 2006).  
Significant research progresses, both theoretical and practical, have been achieved 
since the idea of computer-based CDSSs emerged. Nonetheless few CDSSs in the 
literature have been widely applied in practice. The causes for the low popularity of 
CDSSs include, among others, uncertainties in clinical signs, clinical symptoms and 
clinical domain knowledge, the complexity of involved inference mechanism, 
difficulties with domain selection and knowledge base construction and maintenance, 
and problems with system validation and evaluation (Miller and Geissbuhler, 1999). 
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A recent survey conducted by Sittig and colleagues (2008) identifies several top 
challenges in clinical decision support, among which ‘prioritised and filtered 
recommendations to the user’ is the one for researchers in decision science area to 
overcome. This challenge is closely related to inference methodologies used in 
CDSSs. It requires that the inference mechanism in a CDSS should have the 
capability of handling different clinical uncertainties and generating possible 
recommendations with corresponding priorities attached to them and can filter 
irrational recommendations. 
Another challenge in CDSSs identified by researchers is to provide ‘evidence-
adaptive’ CDSSs to better facilitate evidence-based medicine (Sim et al., 2001). A 
CDSS is evidence-based rather than evidence-adaptive if its clinical knowledge base 
is derived from scientific evidence, but no mechanisms are in place to incorporate 
new clinical evidence. On the contrary, a CDSS is evidence-adaptive if its knowledge 
base is based on current evidence and its recommendations are routinely updated to 
incorporate new clinical evidence (Sim et al., 2001). As a result, an evidence-adaptive 
CDSS requires its knowledge base to be adaptive to up-to-date clinical evidence 
which usually can be obtained from clinical literature and clinical practice. However it 
is difficult for a CDSS to keep up with clinical literature since the contents of clinical 
literature are textual and thus not machine-interpretable by present-day CDSSs. 
Nonetheless, it is not insurmountable for a CDSS to adapt itself to accumulated 
clinical cases in local clinical practice. The knowledge base, which is usually derived 
from the best clinical literature or expert domain knowledge, can be updated 
automatically and routinely based on evidence accumulated in clinical practice in an 
evidence-adaptive CDSS. This requires that the knowledge representation scheme 
employed in the evidence-adaptive CDSS should have a corresponding mechanism 
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which can help the clinical rules embedded in the knowledge base to learn from 
accumulated clinical cases routinely. 
In short, CDSSs is promising in helping facilitate evidence-based medicine and 
reducing patient safety incidents. But there are some challenges in CDSSs research 
area that need to be tackled, and these challenges are closely related to knowledge 
representation scheme and inference methodology. Therefore representation of and 
reasoning with uncertain medical knowledge are areas that require refined 
methodologies and techniques (Musen et al., 2006, Lin et al., 2006). Moreover, 
although some researchers have proposed the idea of developing a CDSS which can 
provide group decision support (Hatcher, 1990, Rao et al., 1996), few CDSSs in the 
literature have the capability of providing group clinical decision support. 
1.2. Research Questions 
To surmount the challenges in CDSSs research as identified from the literature, a 
recently developed new Rule-base Inference Methodology using the Evidential 
Reasoning approach (RIMER) (Yang et al., 2006) is employed for developing a 
CDSS in the research. In the CDSS, belief rule base (BRB) is employed to model 
specific clinical domain knowledge such as clinical rules for risk assessment of 
cardiac chest pain (CCP); the evidential reasoning (ER) approach is used as a 
mechanism to do clinical inference and group clinical decisions aggregation; and an 
optimization model is used to train or fine-tune BRB through clinical cases 
accumulated in clinical practice.  The research is aimed at answering three main 
questions:  
(1) Is it feasible to employ RIMER for developing a CDSS?  
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(1-1) What are the system features of the existing CDSSs? 
A very important motivation of the research is the lack of a CDSS in the literature 
which can firstly, handle uncertainties properly in both clinical signs and symptoms 
and clinical domain knowledge; secondly, provide group or collaborative clinical 
decision support; and thirdly, have learning capability to automatically update the 
knowledge base so that the system can be adaptive to clinical practice. To bridge the 
gap identified in CDSSs literature, ‘what are the system features of the existing 
CDSSs’ is the first and most important question we need to answer in the research. 
System features include domain knowledge representation schemes, clinical inference 
mechanism, and group clinical decision supporting capability implemented in one 
CDSS. 
(1-2) Is it feasible to employ BRB to model clinical domain knowledge for 
developing a CDSS?  
In the research, we proposed to apply the RIMER methodology for developing a 
CDSS. It is original to use BRB to model domain knowledge in clinical areas, 
although BRB has been successfully employed in modelling domain knowledge in 
areas such as pipeline leak detection (Xu et al., 2007). The feasibility of employing 
BRB to model clinical domain knowledge should be studied prior to the design and 
development of a belief rule-based CDSS. 
(1-3) Is it reliable to apply the ER approach to build inference engine in the 
belief rule-based CDSS?  
The ER approach has been successfully applied in inference with the BRB model 
(Yang et al., 2006, Xu et al., 2007). However, it is novel to use the ER approach to do 
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clinical diagnosis or inference. The reliability of using ER to do clinical inference in a 
belief rule-based CDSS should be investigated in the research.  
(2) How to facilitate online group clinical decision making and arrive at a group 
combined clinical recommendation in a belief rule-based CDSS?  
Groups are often perceived as better equipped than individuals to make difficult 
decisions (Rangel, 2009). In CDSSs research, the idea of providing group or 
collaborative decision support for doctors in practice is not new, but few CDSSs in 
the literature have the capability of supporting group clinical decision making. In the 
research, we should try to investigate how to facilitate online group clinical decision 
making and arrive at a group combined clinical recommendation in a belief rule-based 
CDSS. 
(3) How to train belief rule-based CDSS and make its knowledge base to be 
adaptive to clinical practice?  
It is essential for an evidence-adaptive CDSS to have intelligent learning ability so 
that its knowledge base can be adaptive to clinical practice. In the RIMER 
methodology, some optimization models can be built to train BRB in belief rule-based 
systems (Yang et al., 2007). ‘How to train belief rule-based CDSS and make its 
knowledge base to be adaptive to clinical practice’ is a necessary research question we 
need to investigate in the research.  
1.3. Research Objectives  
Based on the research questions above, the measurable objectives of the research are 
as follows.  
(1) To investigate the existent CDSSs, and to identify system features of the 
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existing CDSSs. 
(2) To acquire target clinical domain knowledge.  
Although clinical domain knowledge can be found in medical textbooks, medical 
journals, clinical practice guidelines, and so on, it is impossible for a non-medicine 
relevant researcher to fully acquire or understand the knowledge all by himself or 
herself. Thus it is crucial to acquire and elicit domain knowledge from proper expert 
clinicians and get in-depth understanding of the domain knowledge through field 
study.   
(3) To investigate the feasibility of employing BRB to model clinical domain 
knowledge and using the ER approach to do clinical inference in a CDSS. 
Concerns would inevitably arise over whether it is feasible to use BRB for modelling 
clinical domain knowledge and use the ER approach to build inference engine in a 
CDSS, since employing the RIMER methodology for developing a CDSS is relatively 
novel. The knowledge modelling methodology most commonly used in the existent 
CDSSs since the early CDSS MYCIN is traditional ‘IF-THEN’ rules because of their 
naturalness and transparency (Spooner, 1999, Spooner, 2007). In the feasibility 
investigation of this research, inference with BRB using the ER approach is compared 
to traditional ‘IF-THEN’ rule-based inference by examining real or simulated cases in 
selected clinical area.  
(4) To design and develop an online belief rule-based group CDSS prototype.  
A belief rule-based CDSS should be designed and developed after the preliminary 
feasibility study for the target clinical areas. In system design, the system architecture 
can be designed as a web-based three-layer architecture, where system users from the 
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client layer can access the CDSS through internet, and core system components reside 
in the server layer, and most of data used in the system can be stored in the back-end 
data layer. Knowledge base should be constructed using the BRB model, while the 
kernel algorithm of inference engine and group decision supporting module should be 
the ER approach, and the knowledge training module can train BRB via learning from 
accumulated clinical cases. 
In system development, Microsoft .NET technology is considered.  
(5) To validate the online intelligent CDSS prototype using clinical cases in 
target clinical areas. 
Ideally, after system design and development, the CDSS prototype should be 
validated by real patients’ data collected in clinical practice. If the real data of patients 
can not be obtained, simulated patients’ data can be used for the purpose. A necessary 
requirement for the simulated data is that it should be close to real patients’ data.    
1.4. Research Approach  
A research methodology consists of the combination of the process, methods, and 
tools which are used in conducting research in a research domain (Nunamaker and 
Chen, 1990). A research domain is the subject matter under study in a research project. 
This research focuses on design, development and validation of an online belief rule-
based CDSS prototype. A multi-methodology approach (Nunamaker and Chen, 1990) 
is employed in the study in that one methodology only is far from sufficient for the 
current complex research. 
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Firstly, modelling (Turban and Aronson, 2001) is a key method used in the research. 
Similar to general DSS, a CDSS should include several models which represent 
different parts of the clinical decision making problem, and these models are 
knowledge-based model, inference model, and knowledge base optimization model.  
Secondly, field study is employed for study of clinical work flow in NHS hospitals 
and domain knowledge acquisition in knowledge modelling. By doing field study, 
manual methods including interviewing and observing (Turban and Aronson, 2001) 
are conducted in the research for knowledge elicitation. 
Thirdly, a system development methodology - prototyping (Turban and Aronson, 
2001) is used for CDSS prototype development,  
Fourthly, statistical techniques including the receiver operating characteristics (ROC) 
curve analysis (Metz, 1978) and comparison of the area under the ROC curve (AUC) 
(Vergara et al., 2008) are used for analyzing the prototype’s diagnostic performance 
in validating the CDSS prototype. Brief introduction to the statistical analysis used in 
the research will be discussed in Chapter 6. 
To sum up, four main research methods including modelling, prototyping, field study, 
and statistical analysis are used complementarily in the research. Detailed description 
of the research methods used can be found in Chapter 3.  
1.5. Significance 
The following research gaps regarding CDSSs have been identified by reviewing the 
related literature. 
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(1) There is a gap in knowledge modelling methodologies used in existent CDSSs 
(Lin et al., 2006, Musen et al., 2006).  
It is observed that not only clinical signs and clinical symptoms, but also clinical 
domain knowledge described by individuals is inherent with uncertainties in nature 
(Szolovits, 1995). To handle clinical uncertainties, various domain knowledge 
modelling methodologies such as artificial neural networks (ANNs), Bayesian belief 
networks (BBNs), cases have been applied in existent CDSSs. However, the existent 
knowledge modelling methodologies have their own inherent drawbacks in 
representing uncertainties in a transparent and easily understandable way (Lin et al., 
2006, Musen et al., 2006).. 
(2) There is insufficient capability of handling uncertainties in inference 
mechanisms used in existent CDSSs (Lin et al., 2006, Musen et al., 2006).  
Inference mechanisms used in CDSSs are closely related to their corresponding 
knowledge representation schemes. Through decades of development, researchers 
have proposed various reasoning methods for handling uncertainties in clinical 
decision making. Those methods include combining fuzzy logic or certainty factors or 
Bayesian probabilities with traditional ‘IF-THEN’ rules, ANNs, etc. However, most 
inference mechanisms used in the existent CDSSs can not handle clinical uncertainties 
in a satisfactory way. For example, reasoning in ANN-based CDSS is hard for system 
users to understand, and the knowledge base is restricted to its learnt zones. Another 
example is Bayesian rule-based reasoning, which takes advantages of conditional 
independence, but all conditional probabilities for modelling domain knowledge in a 
Bayesian rule-based CDSS are hard to acquire or estimate. Therefore an inference 
mechanism which can well handle clinical uncertainties and process clinical inference 
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in a transparent way is needed in CDSSs research area (Lin et al., 2006, Musen et al., 
2006). 
(3) There is insufficient intellectual capability of updating knowledge base in the 
existent CDSSs to make them to be adaptive to clinical practice to support 
evidence-based medicine (Sim et al., 2001).  
In the literature, some non-knowledge-based CDSSs have learning ability to 
automatically update their knowledge bases. For example, an ANN-based CDSS can 
train all parameters of its network using a large historical dataset before the system 
can be put into real use. However, non-knowledge-based CDSSs have drawbacks in 
clinical reasoning because their knowledge base is restricted to the training data. 
Knowledge learning functionality is rarely considered in system design and 
development in knowledge-based CDSSs, which acquire domain knowledge manually 
to construct knowledge bases. Therefore the intelligence of automatically updating 
knowledge base according to daily clinical practice in existent CDSSs is not sufficient 
(Sim et al., 2001). 
(4) There is a lack of a CDSS which can provide group clinical decision support 
together with individual clinical decision support (Rao et al., 1994, Rao et al., 
1996).  
Although the idea of embedding group decision making with individual CDSSs has 
been proposed by researchers (Hatcher, 1990, Hatcher, 1994, Rao et al., 1994), few 
CDSSs in the literature have the capability of providing group or collaborative clinical 
decision support. 
The research is, therefore, of significance as it addresses the above gaps effectively. 
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1.6. Contribution 
In trying to fill the research gaps outlined above, the current research contributes to 
both CDSS research and practical domain application. Major contributions of the 
research are listed as follows: 
(1) From a CDSS research perspective: 
z The research develops a new CDSS framework which integrates knowledge-
based CDSS with automatic knowledge learning functionality and online 
group decision supporting functionality. 
z The research proposes and uses relational database to uniquely store and 
manage BRB model, and this makes physical knowledge base construction 
flexible and portable, and it makes it possible to share the knowledge between 
different clinical systems free of technology barriers thanks to mature 
relational database technologies.  
(2) From a practical domain application perspective: 
z The research develops a target clinical domain BRB for modelling domain 
specific knowledge under uncertainty. The BRB can be used not only for 
generating automatic diagnosis recommendations but also for clinicians’ future 
domain knowledge reference in practice. 
z  The research develops an ER based inference engine to do inference with 
input uncertain clinical data and back-end uncertain domain knowledge in the 
BRB. The inference engine does inference with different clinical uncertainties 
in a rational way, and can generate prioritised and informative diagnosis 
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recommendations. 
z The research develops an ER based group clinical decision support module. 
The module provides not only a group diagnosis preferences aggregation 
mechanism but also a discussion forum for a group of consultants to hold 
online meetings and discussions or consultations. 
z The research develops a BRB training module that can help to update the 
embedded clinical rules automatically and routinely and help to keep the 
knowledge base to be adaptive to clinical practice. 
z The research implements guideline-based user interfaces which not only 
facilitates clinicians complying with the practice guidelines, but also makes the 
integration of CDSS into clinical work flow easily implemented. 
1.7. Outline of Contents of the Thesis 
The thesis comprises 7 chapters as shown in Figure 1-1. 
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Figure 1-1: Structure of the Thesis 
Chapter 1 presents an overview of the research. 
Chapter 2 reviews the state of the art of CDSSs. 
Chapter 3 discusses methodologies employed in the research and the research design.  
Chapter 4 presents a preliminary feasibility study of employing RIMER for 
development of a CDSS, in which a comparison between a traditional rule-based 
system and a belief rule-based system in drawing clinical conclusions is conducted. 
Chapter 5 describes the design and development of an online intelligent group CDSS 
prototype which provides individual clinical decision support, group consultation 
Research questions & objectives
(Chapter 1) 
Literature review 
(Chapter 2) 
Research methodology & design 
(Chapter 3) 
Design & development of an online belief rule-based group CDSS prototype
(Chapter 5) 
Validation of the online intelligent CDSS prototype 
(Chapter 6) 
Conclusions & future research
(Chapter 7) 
A preliminary feasibility study 
(Chapter 4) 
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support, and automatic knowledge updating based on daily clinical cases accumulated 
in clinical practice. 
Chapter 6 discusses the validation of the developed prototype system using simulated 
clinical cases in target clinical areas.  
Chapter 7 summarises the whole thesis and discusses possible future research.
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Chapter 2  
Literature Review 
 
2.1. Introduction 
CDSSs are computer systems designed to impact clinical decision making about 
individual patients at the point of time that these decisions are made (Berner and La 
Lande, 2007). With the increased focus on the prevention of medical errors, CDSSs 
have been proposed as a key element of systems’ approaches to improve patient safety 
(Bates et al., 1998, Kohn et al., 2000). If designed, developed, and implemented 
properly, CDSSs have potential to improve the quality of health care service and 
change the way medicine has been practiced (Sim et al., 2001, Kawamoto et al., 2005). 
From early generation of CDSSs such as AAPhelp - the Leeds abdominal pain 
diagnosis system (de Dombal et al., 1972), MYCIN (Shortliffe, 1976), and Quick 
Medical Reference (QMR) (Miller and Masarie, 1989), to the evolution of modern 
clinical decision support tools such as EON (Tu and Musen, 1999), PROforma (Fox et 
al., 1998), and GLIF (Peleg et al., 2000) based on evidence-based clinical guidelines, 
CDSSs have a history of almost 40 years. Significant research progresses, both 
theoretical and practical, have been made since the idea of computer-based CDSSs 
emerged. However, CDSSs are not yet common in patient care settings, and several 
challenges such as representation of and reasoning about medical knowledge under 
uncertainty, and integration of CDSSs into clinical workflow continue to impede the 
effective implementation of CDSSs in clinical settings (Musen et al., 2006). 
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This chapter provides a review of the literature which is essential in order to ascertain 
the research work that has been carried out in CDSSs and reveal the topics in which 
further research can be fruitfully made to advance both the literature and the practice 
of CDSSs. The chapter is organised as follows. Section 2.2 outlines typical definitions 
of CDSSs. Section 2.3 presents a review of state-of-the-art of CDSSs, where Section 
2.3.1 provides a discussion of different types of CDSSs, Section 2.3.2 discusses 
sources of different types of clinical uncertainties, Section 2.3.3 and Section 2.3.4 
present a review of knowledge-based and non-knowledge-based CDSSs respectively, 
group CDSSs are discussed in Section 2.3.5, and review of CDSSs validation study is 
presented in Section 2.3.6. Finally, Section 2.4 concludes the review and identifies the 
research gaps that this research aims to bridge. 
2.2. Definition of CDSSs 
There are different types of computerised systems in health care that can provide 
potential clinical decision support. While traditional CDSSs are defined as systems 
providing intelligent and automatic diagnostic inference or reasoning to generate 
patient specific assessment or recommendations to aid clinicians, some medical 
systems having no reasoning capability can also provide clinical decision support. For 
example, BestBETs (http://www.bestbets.org/) is a web-based medical system 
developed and maintained in Manchester Royal Infirmary (MRI) to provide evidence-
based clinical decision support, and the web-based system has a large volume of best 
evidence topics provided by clinicians all over the world, but the system possesses no 
reasoning capability. This review is based on CDSSs that have intelligent diagnosis or 
assessment capability. Typical definitions of CDSSs in the literature are given below.  
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Musen (1997) defines a CDSS as any piece of software that takes information about a 
clinical situation as inputs and that produces inferences as outputs that can assist 
practitioners in their decision making and that would be judged as intelligent by the 
program’s users.  
Miller and Geissbuhler (1999) defines a CDSS providing diagnostic decision support 
as a computer-based algorithm that assists a clinician with one or more component 
steps of the diagnostic process.  
Sim et al. (2001) defines CDSSs as ‘software that is designed to be a direct aid to 
clinical decision-making, in which the characteristics of an individual patient are 
matched to a computerised clinical knowledge base and patient specific assessments 
or recommendations are then presented to the clinician or the patient for a decision’. 
All above cited definitions of CDSSs given by masters in CDSSs research specify 
three similar key elements of a CDSS, namely (a) information about a clinical 
situation or an individual patient that acts as the system’s inputs, (b) an intelligent 
diagnosis or assessment mechanism which may contain one or more components, and 
(c) patient specific assessments or recommendations that are the system’s outputs.  
2.3. State-of-the-Art of CDSSs 
2.3.1. Types of CDSSs 
CDSSs can be classified into different types according to different criterion. 
Berlin and his colleagues (2006) propose to classify CDSSs according to their 
technical, workflow, and contextual characteristics.  
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z Based on internet technology, CDSSs can be classified as stand-alone and web-
based systems.   
If we classify CDSSs based on their technical characteristics, e.g. internet technology, 
some early CDSSs such as AAPhelp - Leeds abdominal pain diagnosis system (de 
Dombal et al., 1972) and MYCIN (Shortliffe, 1976) are stand-alone systems, some 
recently developed CDSSs such as (Huang and Chen, 2007, Fearn et al., 2007) are 
web-based or online systems.  
z Based on the working environment, CDSSs can be classified as ED CDSS, ICU 
CDSS, laboratory CDSS, and bed-ward CDSS, etc.  
If we classify CDSSs based on the roles that they play in the process of clinical work 
flow or their clinical working environment, some CDSSs target ED (Roukema et al., 
2008, Graham et al., 2008), some CDSSs target intensive care unit (ICU) (Gago et al., 
2007, Mack et al., 2009, Kumar et al., 2009), some CDSSs target laboratories (Grams, 
1993), some CDSSs target bed-ward (Thilo et al., 2009), and some target medicine 
prescription (Lin et al., 2009).  
z Based on target clinical domain, CDSS can be classified as in different clinical 
areas. 
If we classify CDSSs based on different clinical domains that they have impact on, 
some CDSSs are for cancer pain management (Thilo et al., 2009), some CDSSs are 
for acute abdominal pain (de Dombal et al., 1972), some CDSSs are for gynecological 
diseases (Mangalampalli et al., 2006), and some CDSSs are for heart disease (Yan et 
al., 2006), and so on. 
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Metzger and her colleagues (2002) describe CDSS using different dimensions. 
According to their research, CDSS differ among themselves in the timing at which 
they provide support (before, during, or after the clinical decision is made) and how 
active or passive the support is, i.e. whether the CDSS actively provides alerts or 
passively responds to physician input or patient-specific information. 
More generally, researchers classify CDSSs based on the way their knowledge bases 
are constructed. Some are knowledge-based CDSSs in which domain knowledge is 
acquired from domain experts or medical literature, and the others are non-
knowledge-based CDSSs which learn domain knowledge through large historical data 
(Berner and La Lande, 2007, Spooner, 2007).  
z Knowledge-based CDSSs 
Before elaborating on the framework of knowledge-based CDSSs, here we provide a 
brief discussion of general knowledge-based decision support systems (DSSs) first. 
Klein and Methlie (1995) defined that a knowledge-based system is a computer 
program that employs knowledge and reasoning to solve problems, and an expert 
system (ES) is such a knowledge-based system, where knowledge and inference 
procedures are modelled after human experts. For a traditional DSS, its aim is to 
provide information in a given application domain by means of analytical decision 
models in order to support a decision maker in making decisions. The framework of 
knowledge-based DSSs is resulting from integrating DSSs technologies and ESs 
technologies. It is based on the paradigm of decision support, but also enables us to 
incorporate specialized knowledge and expertise into the system, and it can take 
advantages of numeric computations in traditional DSSs and reasoning functions in 
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ESs, and the system architecture consists of components from DSSs and ESs (Klein 
and Methlie, 1995).  
In CDSSs research area, many of today’s knowledge-based CDSSs arose out of 
earlier ESs research. What we usually mean by a CDSS is a program that supports a 
reasoning task carried out behind the scenes and based on clinical data. For example, 
a program that accepts clinical information about a patient with some clinical signs 
and symptoms and generates a list of possible diagnoses is what we usually recognize 
as a diagnostic decision support system which is a particular type of CDSS. The intent 
of these CDSSs is no longer to simulate an expert’s decision making, but to assist a 
clinician in his or her own decision making. The system was expected to provide 
information for the user, rather than to come up with “the answer” as was the goal of 
earlier ESs. The knowledge-based systems cannot simply “learn” how to do the 
reasoning task from modelling human experts, and the human expert must put the 
knowledge into the system explicitly and directly (Berner and La Lande, 2007, 
Spooner, 2007).  
Based on the idea of knowledge-based CDSSs as proposed in the literature, a general 
model of knowledge-based CDSSs in the literature can be depicted as in Figure 2-1. 
We adopt the general knowledge-based CDSS model in our review. 
 
Figure 2-1: A General Model of Knowledge-Based CDSSs (Spooner, 2007) 
CDSS
Input  Output
User Interfaces 
Inference Engine Knowledge Base 
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From the general system structure as depicted in Figure 2-1, there are generally three 
essential system components in a knowledge-based CDSS. The first component is a 
knowledge base which includes clinical domain knowledge that is often, but not 
always, represented in the form of traditional ‘IF-THEN’ rules. The second one is an 
inference engine which contains algorithms or formulas for combining or matching 
clinical rules in the knowledge base to input clinical data. The third part is a user 
interface which is a communication mechanism between the system users and the 
system allowing the system users to input the data of patients into the system and get 
the automatically generated recommendations from the system to help to make final 
clinical decision.  
z Non-knowledge-based CDSSs 
Unlike knowledge-based CDSSs that get clinical domain knowledge from expert 
clinicians or medical literature, non-knowledge-based CDSSs use a form of artificial 
intelligence called machine learning that allows the system to learn from past 
experience and/or to recognise patterns in clinical data (Marakas, 2003).  
CDSSs are classified as knowledge-based systems and non-knowledge-based systems 
in the following review. Sources of different types of uncertainties in medical decision 
making are reviewed first, since uncertainties in both clinical domain knowledge and 
clinical situation are inevitable, and CDSSs are entangled with uncertainties since the 
very early CDSSs such as MYCIN. 
2.3.2. Sources of Uncertainties in Medical Decision Making 
Uncertainty exists in almost every stage of a clinical decision making process 
(Szolovits, 1995). Uncertainties may arise from the following circumstances.  
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z Patients can not describe exactly what has happened to them or how they feel.  
z Doctors and nurses can not tell exactly what they observe.  
z Laboratories report results may be with some degrees of error.  
z Physiologists do not precisely understand how the human body works.  
z Medical researchers can not precisely characterise how diseases alter the normal 
functioning of the body.  
z Pharmacologists do not fully understand the mechanisms accounting for the 
effectiveness of drugs.  
z No one can precisely determine one's prognosis.  
The above sources of uncertainties in both medical domain knowledge and clinical 
symptoms during the process of medical decision making can be summarised as in 
Table 2-1, where all roles involved in medical decision making are listed, and the 
resultant uncertainties in medical domain knowledge or clinical symptoms related to 
each role along with their causes are described as well.  
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Table 2-1: Sources of Uncertainties in Medical Decision Making (Szolovits, 1995) 
Roles Involved in
Medical Decision
Making 
Causes of Uncertainties Resultant 
Uncertainties 
Patients Can not describe exactly what has happened 
to them or how they feel. 
Uncertainties in 
clinical symptoms 
Doctors Can not tell exactly what they observe and 
may produce laboratory results with some 
degrees of error. 
Uncertainties in 
clinical symptoms 
Nurses Can not tell exactly what they observe. Uncertainties in 
clinical symptoms 
Physiologists Do not precisely understand how the 
human body works. 
Uncertainties in 
medical domain 
knowledge 
Medical Researchers Can not precisely characterise how diseases 
alter the normal functioning of the body. 
Uncertainties in 
medical domain 
knowledge 
Pharmacologists Do not fully understand the mechanisms 
accounting for the effectiveness of drugs. 
Uncertainties in 
medical domain 
knowledge 
As shown in Table 2-1, all those listed roles including patients, doctors, nurses, 
physiologists, medical researchers, and pharmacologists can have uncertain judgments 
or observations. In consequence, uncertainties in medical domain knowledge, clinical 
symptoms’ description, and phased diagnosis judgments provided by clinicians are 
indeed unavoidable. 
2.3.3. Knowledge-Based CDSSs 
In the general structure of knowledge-based CDSSs as shown in Figure 2-1, core 
components of knowledge-based CDSSs include user interfaces, knowledge base, 
inference engine, decision models, and database. The user interfaces are used for 
acquiring system’s inputs and displaying system’s outputs. The knowledge base is a 
structured collection of expert medical knowledge used by the system. The inference 
engine is a set of computerised algorithms used to match clinical inputs with 
knowledge base to generate clinical recommendations. The decision models are to 
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provide decision support for clinicians. The database is for storing system inputs and 
outputs.  
In a review study of what makes a CDSS successful in improving clinical practice 
(Kawamoto et al., 2005), researchers found that a knowledge-based CDSS is as 
effective as its underlying knowledge base only. In fact, the effectiveness of the 
knowledge base is dependent on its knowledge representation scheme. Moreover, the 
inference method used in the inference engine is also closely related to the 
representation schemes used in a CDSS. The following subsections will shift to 
review of the knowledge representation schemes and inference mechanisms used in 
existent knowledge-based CDSSs.  
2.3.3.1. Knowledge Representation Schemes  
The goal of knowledge representation is to provide intelligent systems with 
information about a specific domain in a form that can be processed efficiently, and 
basically, knowledge representation schemes can be classified into four categories: 
logic, procedural, graph/network, and structured (Carter, 1999). This section reviews 
knowledge representation schemes according to these four categories. 
z Logic 
Firstly, logic seems to be the most common representation format used by researchers 
in the field of general artificial intelligence in the literature. In general, medical 
knowledge can be divided into two types, namely declarative knowledge and 
procedural knowledge. Declarative knowledge includes propositions and sentences. 
Propositions are statements about the world that are either ‘true’ or ‘false’. These 
statements may be connected by Boolean operators such as ‘and’, ‘or’, and ‘and not’ 
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to form sentences. Procedural knowledge provides more explicit information about 
what action can be taken or what conclusion can be drawn from declarative 
knowledge. For example, “‘ElectroCardioGram (ECG) shows ≥2mm ST elevation in 
two contiguous chest leads’ or ‘ECG shows ≥1mm ST elevation in two contiguous 
limb leads’” is declarative knowledge, and “IF ‘ECG shows ≥1mm ST elevation in 
two contiguous limb leads’, THEN ‘treat the patient as with ST-Segment Elevation 
Myocardial Infarction (STEMI)’” is procedural knowledge. The logic-based 
representations are declarative in nature, in that they consist of ‘true’ or ‘false’ 
statements and all questions are resolved through standard logic inference mechanism 
which is simply a ‘look up’ of known facts (Carter, 1999). 
z Procedural knowledge representation 
Secondly, procedural knowledge representation, on the other hand, is not simply a 
‘look up’ of known facts. It offers a ‘process’ to aid diagnostic and therapeutic 
decision-making (Carter, 1999). Procedural knowledge in medicine is usually 
provided in the form of rules in existent CDSSs. Many implemented CDSSs, from the 
very early CDSSs such as MYCIN, PUFF (Aikins et al., 1983), and IMM/Serve 
(Miller et al., 1996), to recently developed CDSSs such as Unified Medical Language 
System (UMLS)-based CDSS (Achour et al., 2001), and Chinese medical diagnostic 
system (Huang and Chen, 2007) are all rule-based. Actually, rules have been the 
dominant knowledge representation scheme for medical expert systems since the days 
of MYCIN (Carter, 1999). 
In practice, because of the existence of uncertainty in clinical domain knowledge, 
clinical signs and symptoms as discussed in Section 2.3.2, some CDSSs embed fuzzy 
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logic, certainty factors or probabilities into traditional ‘IF-THEN’ rules to represent 
knowledge with uncertainties. 
Fuzzy logic has been widely applied in CDSSs (Shiomi et al., 1995, Suryanarayanan 
et al., 1995, Palma et al., 2006). Certainty factors together with rules are employed in 
chest pain diagnosis support system (Hudson and Cohen, 1987, Hudson and Cohen, 
1988, Hudson and Cohen, 2002), and Bayes’ rule are used in Lliad (Warner, 1989). 
However, it is hard to get Bayes’ probabilities (Spooner, 1999, Spooner, 2007). 
z Network-based knowledge representation 
Thirdly, in terms of the network-based knowledge representation schemes used in 
knowledge-based CDSSs, Bayesian belief network (BBN) is a commonly used 
representation scheme, many CDSSs in the literature such as  (Burnside et al., 2006, 
Nicholson et al., 2008) are based on BBN. A Bayesian network is a way to put Bayes’ 
rule to work by laying out graphically which events influence the likelihood of 
occurrence of other events. In CDSS design, the choice of adopting a Bayesian 
network as representation scheme allows one to explicitly take advantage of 
conditional independencies from the modelling viewpoint, and to rely on several 
powerful algorithms for probabilistic inference. But it is really very difficult for 
researchers to derive all necessary parameter values or probabilities among the 
network (Stefania Montani, 2006). Decision trees are another network-based 
knowledge representation schemes used in knowledge-based CDSSs, and they are 
frequently used in guideline-based CDSSs such as EsPeR system (Colombet et al., 
2005) and breast cancer treatment CDSS (Skevofilakas et al., 2005). The advantage of 
decision trees is that they are simple to understand and interpret, and it is possible that 
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uncertainties can be incorporated into the decision trees. But it is always hard for 
CDSSs developers to extract an exact decision tree from domain experts.  
z Structural representation 
Fourthly, structural representations emphasise the ‘packaging’ of knowledge into well 
defined pieces with higher levels of organizations (Carter, 1999, Carter, 2007). 
‘Frame’ was the first widely accepted structural knowledge representation format 
created in 1970s (Minsky and Haugeland, 1975), and it is an application of the object-
oriented approach to knowledge-based systems, and a frame is a data structure 
containing typical knowledge about a concept or object. Some CDSSs such as earlier 
CENTAUR (Aikins, 1980) and Arden Syntax (Clayton et al., 1989, Starren et al., 
1994), and GASTON (de Clercq et al., 2001) and GLARE  (Terenziani et al., 2003) 
all use frame as one of their representation formats. Since each frame has its own 
name and a set of attributes or slots which contain values; for instance, the frame for 
patient might contain an age slot, sex slot, smoking status slot, etc. frames can be used 
to construct semantic network model. An important part of every frame is the pointer 
to a more general frame. The slots are filled with fillers which can be either atomic 
values or names of other frames. The slots of the generic frames can have procedures 
attached to them. The reasoning in frame-based system starts by identifying of a given 
object as an instance of a generic frame. After that all slot fillers which have not been 
set explicitly but can be inherited, are inherited. Where available, the procedures for 
frame can be invoked. Disadvantages of a frame-based system include: it can not 
process objects which characteristics are not known in advance; it can not process non 
typical situations; the procedural knowledge is not represented by a frame but by the 
procedures attached to frames (Grigorova and Nikolov, 2007). 
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In recent CDSS studies, Data-Base Management Systems (DBMS) offer another 
structured format for knowledge representation, and there are two types of databases 
which are frequently found in clinical settings—relational and object-oriented (Carter, 
2007). Relational DBMS uses a relational record to store and manage data, and each 
record has a number of fields. Records are then collected together into tables, while 
each row in the table represents a unique rerecord and each column represents a 
feature of the record. However, a column in   the   relational   DBMS can not hold 
more complex data structures, for example, another record, or a list of numbers. 
Differing from relational database object-oriented DBMS incorporates object-oriented 
technology into DBMS, where the data is seen as an object, and it permits greater 
expressiveness by permitting the storage of data types that can not be handled by 
relational DBMS (Pinciroli et al., 1992). Therefore some CDSSs use object-oriented 
DBMS to store complex medical datasets which are limited by data types in relational 
databases. A major drawback of DBMS is that although its Structured Query 
Language (SQL) can manipulate ‘query’, ‘add’, ‘update’ and ‘delete’ to its stored 
objects, it lacks a specific knowledge inference mechanism to reason and draw logic 
conclusions from the data (Carter, 2007). 
As discussed above, most knowledge representation schemes have their own 
advantages and drawbacks. Especially in dealing with uncertainties, knowledge 
representation schemes in existent CDSSs lack a mechanism that can 
comprehensively incorporate or represent different clinical uncertainties in a 
satisfactory way.  
The choice of an appropriate knowledge representation scheme in the construction of 
a knowledge base depends on the domain knowledge it represents and the inference 
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mechanism it uses. Inference mechanisms used in existent CDSSs are reviewed as 
follows. 
2.3.3.2. Inference Mechanisms 
An inference mechanism used in a CDSS is closely related to the corresponding 
knowledge representation scheme employed in the system. From the literature, 
inference mechanisms commonly used in knowledge-based CDSSs include rule-based, 
Bayesian based, and frame-based. 
In rule-based CDSSs, a set of ‘IF-THEN’ rules are processed. The forward and 
backward chaining can be used to conclude a diagnosis and provide diagnostic 
explanations for clinical users (Shortliffe and Perreault, 1990). Take forward chaining 
for example, forward chaining is a top-down method taking facts as they become 
available and attempts to draw conclusions from satisfied conditions in rules. The 
process of inference using forward chaining involves assigning values to attributes, 
evaluating conditions, and checking to see if all of the conditions in a rule are satisfied 
so as to fire satisfied rules. If fuzzy logic is incorporated in rule-based systems for 
handling uncertainties, compositional rule of inference (Zadeh, 1973) is commonly 
used for fuzzy rule-based inference. If certainty factor as used in MYCIN (Shortliffe, 
1976) is incorporated in rules for representing uncertainties, a threshold value need to 
be set for assessing whether a rule in the rule chain is fired or not. 
Bayesian systems predict the posterior probability of diagnoses based on the prior 
disease probabilities, and the sensitivity and specificity of confirmed clinical signs 
and symptoms (Warner, 1979). BBNs are often created as reformulations of 
traditional Bayesian representations and can provide many of the same browsing and 
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explanation capabilities of traditional systems (Li et al., 1994). Although Bayesian 
rules are preferred by researchers in statistics, it is very hard to derive all necessary 
probabilities and sensitivity and specificity of clinical signs and symptoms in target 
clinical area.  
As to reasoning in frame-based systems, it can not process objects which 
characteristics are not known in advance. Since most medical knowledge is ill-
structured and involves uncertainties, it is difficult to use frames to make clinical 
inference under uncertainties in CDSSs (Grigorova and Nikolov, 2007).  
It is important to note that medical experts will turn to concrete examples to express 
their knowledge when medical knowledge is difficult to be modelled in the format of 
logical representation. In such situation, the case-based reasoning (CBR) approach 
(Althoff et al., 1998, Kumar et al., 2009) is used in CDSSs. The advantage of CBR is 
that concrete similar empirical clinical cases are more convincing than some other 
implicit medical knowledge. The disadvantages of CBR include that it is difficult to 
measure the similarity between cases, especially under different types and degrees of 
uncertainties, the retrieval process is hard to be accurate and efficient, and the input 
scheme required by the CDSS based on CBR may not be easily accepted by clinicians. 
An important aspect of inference engines implemented in CDSSs is their 
independence from their knowledge base. Since CDSSs take a great deal of time to 
design and develop, reusability has been a focus of research (Tu et al., 1995). 
2.3.3.3. Challenges of Knowledge-Based CDSSs 
As reviewed from the literature, clinical uncertainties are inevitable not only in the 
process of shaping domain knowledge in one formal format but also in each clinical 
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role’s clinical judgments or observations. Thus one important aspect of knowledge 
representation scheme and inference mechanism is their capability of representing and 
reasoning under clinical uncertainties.  
For knowledge-based CDSSs, dominant knowledge representation schemes used in 
the literature that can somehow represent uncertainties include fuzzy rules, traditional 
Bayesian rules, and BBN. Traditional ‘IF-THEN’ rules can be used together with 
some certainty factors or fuzzy logic to represent uncertain clinical rules in target 
clinical domain. Both traditional Bayesian rules and BBN use conditional 
probabilities to represent clinical uncertainties to some degree. 
However, there are drawbacks in reasoning with rules together with certainty factors, 
or fuzzy logic, or Bayesian probabilities. Firstly, in rule-based CDSSs that 
incorporates certainty factor model, the certainty factor in the conclusion of one rule 
is based on the assumption that the premise is known with a certainty factor of 1, and 
uncertainties are propagated through the rules of an inference chain. However, it is 
unlikely that a premise is always perfectly known, and the premise of one rule can be 
uncertain due to uncertain facts. Usually, in the system, a threshold value for premise 
certainty factors is defined to prevent rules with too low premise certainty factors 
from firing. For example, the premise threshold certainty factor is set to be 0.2 in 
MYCIN, and the system will stop triggering one rule if calculated certainty factor of 
its premise is 0.2 or less. This causes more or less information loss in the inference 
process. Moreover, Clancy and Cooper (1984) observed that perturbations in certainty 
factors led to an incorrect diagnosis in certain cases, and this observation suggests that 
the certainty factor model may be inadequate for diagnostic systems (Heckerman and 
Shortliffe, 1992). Secondly, in a fuzzy rule-based system, essential inference steps 
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include: fuzzification and fuzzy rule inferencing, where fuzzification is for 
interpreting a crisp numerical input as a fuzzy set with the membership function and 
fuzzy rule inferencing is the process of reasoning with fuzzy rules. In cases when 
linguistic result expressed by inferred fuzzy set contains required information, there is 
no need for any defuzzification. In other cases, when a crisp value is needed for the 
output variable, defuzzification is required. However, fuzzy rule inference is 
controversial partly because of its fuzzification and defuzzification processes. Thirdly, 
for Bayesian rule-based CDSSs, it seems that uncertainties in both clinical domain 
knowledge and clinical signs and symptoms can be considered in both knowledge 
representation and inference processes, but since this kind of CDSSs take advantages 
of conditional probability and all necessary probabilities in the Bayesian rules or BBN 
are difficult to derive, it is difficult for CDSSs researchers to elicit domain knowledge 
from domain experts and to develop such CDSSs. 
To conclude, although some existent knowledge-based CDSSs such as early MYCIN 
have taken clinical uncertainties into consideration in system implementation, 
methods used in existent CDSSs have their limitations in knowledge representation or 
knowledge inference under uncertainties. For example, it is hard for experts to 
estimate all parameters in Bayesian model based systems, and certainty factor model 
may be inadequate for diagnostic systems in other clinical areas where the system 
performance is sensitive to perturbations in certainty factors. Therefore, representation 
of and reasoning about medical knowledge particularly under uncertainties are areas 
that require refined methodologies and techniques (Lin et al., 2006, Musen et al., 
2006).  
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2.3.4. Non-Knowledge-Based CDSSs 
2.3.4.1. Machine Learning Technologies 
In non-knowledge-based CDSSs, clinical domain knowledge is not extracted from 
domain expert clinicians or medical literature, instead, it is automatically learned from 
past experience or past clinical data by the system through some machine learning 
technologies. Commonly used machine learning technologies used in non-knowledge-
based CDSSs include artificial neural networks (ANNs) used by Mangalampalli et al. 
(2006), Yan et al. (2006), and Tan et al. (2008); genetic algorithms (GAs) used by 
Grzymala-Busse and Woolery (1994) and Levin (1995); and decision tree learning 
used by Gerald et al. (2002). 
z ANNs 
ANNs are frequently used by researchers as inference mechanism in CDSSs because 
developers are not required to understand the relationship between input clinical data 
and output clinical diagnosis recommendations during the development of this kind of 
systems. ANNs are a black box technique that models relationships by learning from 
historical data, while developers of CDSSs based on Bayesian networks need to have 
sufficient domain knowledge including related probabilities. Li et al. (2000) compare 
ANNs with other mathematical models for building a traumatic brain injury medical 
decision support system in their study, and the results suggest that ANNs may be a 
better solution for complex, non-linear CDSS than conventional statistical techniques. 
The major advantage of ANNs is that they have the ability to learn from the observed 
data. The disadvantage is that they are unable to provide reliable and logical 
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representation of knowledge beyond their learnt zones, and the rules that the network 
uses do not follow a particular logic and are not explicitly understandable. 
z Genetic algorithms (GAs) 
GAs provide an approach to learning that is based on simulated evolution (Mitchell, 
1997). The problem addressed by GAs is to search a space of candidate hypotheses to 
identify the best hypothesis. Here hypotheses are often described by bit strings whose 
interpretation depends on the application. Instead of searching from general-to-
specific or simple-to-complex hypotheses, GAs generate successor hypotheses by 
repeatedly mutating and recombining parts of the best currently known hypotheses, 
and the search for an appropriate hypothesis begins with a collection of initial 
hypotheses. At each step, a collection of hypotheses is updated by replacing some 
fraction by offspring of the fittest current hypotheses. In GAs the ‘fittest hypothesis’ 
is defined as the one that optimizes a predefined numerical measure for the problem at 
hand. For example, if the learning task is to approximate an unknown function based 
on a set of training examples with inputs and outputs, the hypothesis fitness can be 
defined as the accuracy of the hypothesis over this training data. GAs have an 
advantage that by iteratively extracting the best solutions, an optimal solution which 
fits best can be reached, but how to define the fitness is a challenge in GA based 
CDSSs (Spooner, 1999, Spooner, 2007). 
z Decision tree learning 
In knowledge-based CDSSs, decision trees are used to represent domain knowledge if 
they can be explicitly acquired from domain experts. While in non-knowledge-based 
CDSSs, decision tree learning is used as a method to automatically acquire knowledge 
from previous concrete cases that were already solved by domain experts (Hardin and 
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Chhieng, 2007, Sam et al., 2008). In the process of learning a decision tree from 
sample data, there is no need to make prior assumptions of data, and decision trees are 
easily understandable. However, decision tree learning algorithms are unstable since 
they can produce drastically different hypothesis from training examples that differ 
just slightly, and there are limitations about the number and data type of output 
variable (Mitchell, 1997).  
2.3.4.2. Challenges of Non-Knowledge-Based CDSSs 
On the one hand, as domain knowledge is learned from clinical data for non-
knowledge-based CDSSs, system users do not really know what happens in the 
learning process and how the system handle those uncertainties in the learnt clinical 
data, and it is this black-box learning process that hinders the use of non-knowledge-
based CDSSs. Take ANN-based CDSSs as an example, because clinicians can not 
really understand the knowledge represented in ANNs, most clinicians would refuse 
this type of CDSSs in clinical practice (Spooner, 2007). 
On the other hand, in contrast to knowledge-based CDSSs, non-knowledge-based 
CDSSs have an advantage of providing knowledge learning capabilities. This 
advantage helps this type of CDSSs to be adapted to past clinical experience or 
clinical data, while being adaptive to clinical practice is an important characteristic of 
CDSSs to support evidence-based medicine (Sim et al., 2001).    
To conclude, non-knowledge-based CDSSs have learning capabilities which help this 
type of systems being adaptive to clinical practice, but their knowledge learnt from 
past clinical experience or data are not easily understandable. This more or less 
hinders clinicians using the systems. A potential research direction is to combine an 
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easily understandable knowledge representation scheme with the learning capabilities 
as used in non-knowledge-based CDSSs so that a knowledge-based CDSS can also 
own learning capability and can be adaptive to clinical practice to provide evidence-
based clinical decision support. 
2.3.5. Group CDSSs  
Group or collaborative clinical decision making is another important research area of 
CDSSs, and in the early 1990s, Hatcher (1990, Hatcher, 1994) did research on the 
uniqueness of group CDSSs and proposed to use analytic hierarchy process (AHP) to 
arrive at a clinical decision consensus in group CDSSs. In the mean time, Rao and his 
colleagues (Rao et al., 1994, Rao and Suresh, 1995) found that although group 
decision making is wide spread in medicine, limitations in technology and other 
factors limited the growth of group CDSSs for medical decision making (MDM). Rao 
et al. (1996) did an analysis on the classification of MDM from a group CDSS 
perspective, and then Rao and Turoff (2000) proposed and developed a hypermedia-
based group CDSS to support collaborative MDM. MEDICALWARETM (Rao and 
Turoff, 2000), which is integrated with the group CDSS, is designed to provide 
problem-solving support, access to clinical algorithms and procedures, expert 
inference support and several MDM support tools with hypermedia functionality. In 
the integrated group CDSS, Delphi method (Linstone and Turoff, 1975) was used for 
supporting group decision making and achieving a group consensus. 
However in the literature, there are currently not many publications on group CDSSs 
yet apart from the above mentioned studies. But group or collaborative clinical 
decision making is becoming popular in today’s health care (Rao et al., 1996, 
Christensen and Larson, 1993, Rangel, 2009).    
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2.3.6. Validation of CDSSs 
Validation is a crucial component in the development of any CDSS (Berner, 1999). In 
the literature, appropriate validation design is considered as an important perspective 
in formal validation of CDSSs (Miller, 1996). Keith and Greene (1994) studied 
validation of CDSSs from the following perspectives: (1) validation of the expert 
knowledge; (2) validation of the integrated system; (3) external validation of the 
system; (4) in-house online trial; (5) multicenter randomised trial in validation of their 
system. Thomas et al. (1999) used case scenarios to validate their guideline-based 
CDSS. Becker and colleagues (1997) validated their CDSS by validating not only the 
knowledge base, but also the inference mechanism. 
As discussed in the literature, a sound CDSS validation study contains the following 
fundamental components: enough clinical cases for validation; an appropriate 
validation design; knowledge base validation; and inference engine validation. 
2.4. A New Belief Rule-base Inference Methodology Using the 
Evidential Reasoning Approach 
Above review helps to give audience a rough holistic picture of existent CDSSs, and 
through the review we know that representation of and reasoning about medical 
knowledge particularly under uncertainties are areas that require refined 
methodologies and techniques. Motivated by this, we looked into the possibility of 
using a recently developed new belief Rule-base Inference Methodology using the 
Evidential Reasoning approach (RIMER) (Yang et al., 2006) to implement a CDSS 
that can represent uncertain clinical domain knowledge and provide informative 
clinical diagnosis recommendations.  
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Next we provide a brief discussion of RIMER and its advantages compared to other 
knowledge representation and reasoning methods used in existent CDSSs. 
2.4.1. What is RIMER? 
RIMER contains three main parts, one part is a model for representing uncertain 
knowledge, one part is the method to do inference with knowledge and observed facts, 
and one more part is an optimization model for fine-tuning knowledge model. In 
RIMER, the belief rule base (BRB) is used for modelling target clinical domain 
knowledge and the evidential reasoning (ER) approach is used to do clinical inference, 
and a BRB optimization model is designed and used to train the belief rule-based 
CDSS. BRB is extended from traditional rule base by adding a belief structure to it, in 
which knowledge representation parameters including rule weights, antecedent 
attribute weights and belief degrees in consequents are considered. The ER approach 
(Yang and Sen, 1994, Yang and Singh, 1994, Yang and Xu, 2002) was originally 
proposed to deal with multiple attribute decision analysis (MADA) problem having 
both qualitative and quantitative attributes under uncertainty. In the situation of 
reasoning with BRB, ER is employed to combine all belief rules triggered by 
observed facts in the inference process, where the uncertainties in both observed facts 
and belief rules can be rationally preserved and their effects can be represented in the 
final reasoning results. 
Details of BRB, inference with BRB using the ER approach, and the BRB 
optimization model can be found in Section 3.2 of Chapter 3.      
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2.4.2. Advantages of RIMER  
Compared with alternative knowledge representation and reasoning methods used in 
existent CDSSs, advantages of using BRB for uncertain domain knowledge modelling 
and using the ER approach for reasoning with uncertain knowledge are discussed as 
follows. 
2.4.2.1. Advantages of Modelling Clinical Domain Knowledge 
with BRB 
When choosing a modelling methodology to model domain knowledge, several 
factors including naturalness, uniformity, and understandability; degree to which 
knowledge is explicit (declarative); modularity and flexibility of the knowledge base; 
efficiency of knowledge retrieval; and capability of uncertainty representation should 
be taken into account (Turban and Aronson, 2001). For a knowledge-based CDSS, 
transparency and explanation ability of the system affect user acceptance. The more 
transparent the system is, the easier will it be for users to accept it (Tsymbal et al., 
2009). 
Compared to alternative methodologies used to model clinical domain knowledge in 
existent CDSSs, BRB has following advantages: 
z Transparent representation of domain knowledge 
Not like ANNs representing domain knowledge in black boxes, belief rules can 
represent domain knowledge in a transparent way. Take a belief rule ‘IF there is new 
left bundle branch block (LBBB) with possibility of 80%, AND the history and 
examination are strongly suggestive of STEMI, THEN the patient is diagnosed as 
 60
with STEMI with 90% belief degree’ for example, the relationship between the 
antecedent ‘new LBBB with possibility of 80%, AND the history and examination are 
strongly suggestive of STEMI’ and the consequent ‘diagnosed as with STEMI’ is 
transparent. While in ANNs, there is no transparent knowledge about the conclusion 
‘diagnosed as with STEMI’. A non-expert has no idea about what happens between 
the input and output, and even those parameters used in ANNs need to be pre-trained 
by historical data. 
z Naturalness of representation  
Same as traditional rules, belief rules is a very natural knowledge representation 
method with a high level of comprehensibility, and they look like a natural language 
expression. For example, even a non-expert in clinical area who has no knowledge of 
‘LBBB’ and ‘STEMI’ can understand the logic behind the example belief rule 
discussed above. 
z Handling different types of uncertainties in clinical decision making  
BRB provides a flexible framework to capture different types of uncertainties in 
clinical signs, symptoms and clinical domain knowledge. Take the belief rule 
discussed above for example, it represents the uncertainties in domain knowledge for 
diagnosing one patient as with ‘STEMI’ when a clinician can not be 100% sure of the 
patient’s Electrocardiograph (ECG) signs and the patient’s history and examination. 
At the same time, the rule captures uncertainties in clinical symptoms such as ‘new 
LBBB with possibility of 80%’ and ‘the history and examination are strongly 
suggestive of STEMI’. 
z Provision of explanations  
 61
Given that explanations in CDSSs are necessary, BRB has the ability to provide 
explanations for the derived conclusions in a straightforward manner. If a patient is 
diagnosed as with ‘STEMI’ to a belief degree of 0.9 by a belief rule-based CDSS, the 
system can provide an explanation of the diagnosis recommendation by presenting 
users the inputs about the patient’s clinical signs and symptoms and all activated 
clinical rules in the inference process, which are very straightforward. 
2.4.2.2. Advantages of Using the ER Approach for Clinical 
Inference 
As to clinical inference, the ER approach has many advantages compared to 
alternative reasoning methods used in existent CDSSs. 
z Preserving uncertainties in the inference process  
The ER approach initially aims to provide assessment to MADA problems which 
have both quantitative and qualitative attributes with uncertainties. In the application 
of reasoning with clinical BRB model, it is used to combine all belief rules triggered 
by input facts with different belief degrees. Uncertainties in the inference process may 
be caused either by uncertain domain knowledge or uncertain clinical data. Firstly, 
uncertainties in domain knowledge such as incompleteness, and nonlinear causal 
relationships can be represented in belief rules by belief degrees. Secondly, an input 
with uncertainties to an antecedent clinical symptom can be transformed into a belief 
distribution on all referential values of the antecedent with different matching degrees, 
and the distribution describes the degree of each antecedent being activated. 
Subsequently, inference using the ER approach takes into consideration of both the 
rule activation weight and belief degrees in possible consequents, and thus both 
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uncertainties in domain knowledge and input data can be rationally preserved and 
their affects can be represented in the final reasoned results.  
z Providing informative and prioritised clinical recommendations 
The ER approach can generate a distributed consequent associated with belief degrees 
after aggregating all activated rules in the inference process, and the inferred results 
with belief degrees attached to possible consequents can provide an informative 
clinical recommendation compared to those recommendations with single result. For 
example, if a patient is diagnosed as with {(STEMI, 0.9878), (LBBB without STEMI, 
0.0122), (neither STEMI nor LBBB, 0)} after matching the patient’s clinical data with 
clinical rules in the BRB by the ER approach, we can see that all possible consequents 
including ‘STEMI’, ‘LBBB without STEMI’, and ‘neither STEMI nor LBBB’ have 
been associated with belief degrees in the inferred result, and the belief degrees 
demonstrate different confidence in corresponding consequents, and such a type of 
recommendation is more informative than inferred result with only one consequent 
without belief degree such as {STEMI} or {LBBB without STEMI} or {neither 
STEMI nor LBBB}. 
z Ranking the severity of patients’ illness 
ER-based inferred results can provide a severity ranking of patients’ illness, based on 
the concept of utility and utility interval as proposed by Yang and Xu (2002) for the 
combined assessment result generated by the ER approach. Let us examine the same 
example again which is discussed above. Similar to the concept of expected utility 
value, in the context of clinical diagnosis, we can use a severity score ranged from 0 
to 1 to represent the seriousness of patient illness, where 1 represents that the patient 
is in a most serious status and 0 represents that the patient has no clinical risk at all. 
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For example, we can assign a severity score of 1 to patients with ‘STEMI’, a severity 
score of 0.5 to patients with ‘LBBB without STEMI’, and a severity score of 0.25 to 
patients with ‘neither STEMI nor LBBB’, where ‘STEMI’ is severer than ‘LBBB 
without STEMI’ and ‘LBBB without STEMI ’is severer than‘ neither STEMI nor 
LBBB’. Thus we can get an overall severity score for a patient with distributed 
diagnosis recommendation, and the overall severity score is calculated by the 
following equation: (overall severity score) = (severity score of ‘STEMI’) * (belief 
degree in ‘STEMI’) + (severity score of ‘LBBB without STEMI’) * (belief degree in 
‘LBBB without STEMI’) + (severity score of ‘neither STEMI nor LBBB’) * (belief 
degree in ‘neither STEMI nor LBBB’). As to the patient with the distributed diagnosis 
result {(STEMI, 0.9878), (LBBB without STEMI, 0.0122), (neither STEMI nor 
LBBB, 0)} as discussed above, the overall severity score of the patient can be 
calculated by (1*0.9878+0.5*0.0122+0.25*0) = 0.9939. It is this overall severity 
score that can be used as a measure to rank the severity of patients’ illness.  
z Learning capability 
Most existent knowledge-based CDSSs such as traditional ‘IF-THEN’ rule-based 
systems and frame-based systems lack knowledge learning capability. While domain 
knowledge used in existent non-knowledge-based CDSSs such as ANN-based 
systems can only be learned from historical clinical data.  
In belief rule-based CDSSs, domain knowledge can be explicitly modelled using BRB. 
However, it is difficult to accurately determine the parameters of a BRB entirely 
subjectively, and a change in rule weight or attribute weight may lead to changes in 
the performance of a BRB. As such, the ER algorithm used for inference with BRB 
model can be used to form optimization models to train BRB using accumulated past 
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clinical data. Therefore, inference with BRB model using the ER approach can 
possess system features of both knowledge-based and non-knowledge-based systems. 
However, RIMER has its limitations. For example, just like knowledge representation 
schemes used in existent knowledge-based CDSSs such as traditional rule-based 
systems, it is hard to extract belief rules from experts. Though knowledge 
representation parameters of BRB models can be fine-tuned by historical data, the 
accuracy of the initial BRB in a belief rule-based CDSS is very important to the 
system performance.  
2.5. Conclusions   
After a critical review of the literature on CDSSs, a conclusion can be drawn that a 
number of CDSSs have been developed in the past 40 years, many of which show 
potential for making significant impacts on patient care. However, after decades of the 
development of these programs, no CDSS is widely used by clinicians (Carter, 1999, 
Carter, 2007). 
Miller and Geissbuhler (1999) identified that there are a number of problems that have 
limited the ultimate success of CDSSs, and these include difficulties with domain 
selection and knowledge base construction and maintenance, problems with the 
diagnostic algorithms and user interfaces, and problems with system validation or 
evaluation. 
In more recent studies, Kawamoto et al. (2005) identified four features of CDSSs as 
independent predictors of a good CDSS:  
(1) Automatic provision of decision support as part of clinical work flow. 
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(2) Provision of recommendations rather than just assessments. 
(3) Provision of decision support at the time and location of decision making. 
(4) Computer based decision support. 
To achieve those four features as identified by Kawamoto and his colleagues, a CDSS 
should have (a) a friendly user interface that help the clinicians easily play their roles 
in part of the clinical work flow; (b) a knowledge base which contains comprehensive 
clinical domain knowledge including uncertainties; (c) an intelligent diagnostic 
inference mechanism that can handle medical uncertainties; (d) linkage to the whole 
clinical work flow; and (e) reliable, informative and prioritised clinical decision 
recommendations. These requirements are consistent with Miller and Geissbuhler’s 
findings about what accounts for the lack of CDSS application in clinical practice. 
The problem of developing an adequate database which can store both patients’ 
clinical data and declarative and procedural knowledge may not be difficult to 
overcome with the rapid development of networking and database technologies. 
However, representation of and reasoning about clinical domain knowledge under 
uncertainty, and keeping the knowledge base be adaptive to clinical practice are still 
the main challenges in CDSSs.  
Based on the review results, the following four issues are identified as research gaps 
in CDSSs literature. 
(1) Current CDSSs need a more informative knowledge representation scheme 
which can represent uncertain clinical domain knowledge comprehensively and 
accurately (Musen et al., 2006, Lin et al., 2006). 
(2) Current CDSSs need a refined inference mechanism which can reason with 
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information which has different uncertainties (Musen et al., 2006, Lin et al., 
2006). 
(3) Current CDSSs need an intelligent learning capability to automatically update 
reasoning rules by learning from past experience or clinical data to make the 
system be adaptive to clinical practice (Sim et al., 2001); 
(4) Few CDSSs in the literature support both individual and group clinical decision 
making although group MDM attracted attention for CDSSs researchers (Hatcher, 
1990, Hatcher, 1994, Rao et al., 1994, Rao et al., 1996, Rao and Turoff, 2000). 
There is a need for a CDSS that can also support group or collaborative clinical 
decision making. 
To address the gaps as described above, the recently developed RIMER was 
investigated and employed in this research for clinical knowledge representation and 
inference under uncertainties (Kong et al., 2008a, Kong et al., 2008b, Kong et al., 
2009). In RIMER, a rule base is designed with belief degrees embedded in all possible 
consequents of a rule. Such a rule base is capable of capturing vagueness, 
incompleteness, and nonlinear causal relationships, while traditional ‘IF-THEN’ rules 
can be represented as a special case. Inference in such a rule base is implemented 
using the ER approach. 
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Chapter 3 
Research Methodology and Design 
 
3.1. Introduction 
Research is defined as a systematic investigation to establish facts or principles or 
collect information on a subject (Collins English Electronic Dictionary, 2008). Usually, 
a study is conducted in sequential research process stages from deciding research topic, 
defining research objectives, and choosing appropriate research methodologies to 
collecting data, analyzing data, developing conclusions, and finalizing findings. 
Choosing appropriate research methodologies and making a good research design 
before conducting core research is important for a study to produce fruitful research 
results. This chapter discusses the research methodologies and research design of the 
study. A multi-methodology approach (Nunamaker and Chen, 1990) is employed in 
the study to investigate how to design, develop, and validate a belief rule-based CDSS 
that can provide online, intelligent, group and informative clinical decision support 
under uncertainties. In the research, modelling and prototyping are main research 
methods for design and development of the target CDSS. Field study is used to acquire 
more specific clinical domain knowledge and to get better understanding of clinical 
work flow. Statistical techniques are used to analyze the generated results in validating 
the developed prototype system. 
This chapter is organised as follows. The modelling methodology is discussed in 
Section 3.2, where three models used in the research for design and development of an 
intelligent evidence-based CDSS are discussed together with their advantages 
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compared to available alternative models used in existent CDSSs. The system 
development methodology-prototyping (Turban and Aronson, 2001) and its advantages 
compared to other system development methodology are presented in Section 3.3. 
Field study and statistical techniques are discussed in Section 3.4 and Section 3.5 
respectively. A research design is also discussed in Section 3.6. Finally, the chapter is 
summarised in Section 3.7. 
3.2. Modelling 
CDSSs are large systems consisting of interrelated components working together in a 
coordinated manner. Generally, a knowledge-based CDSS should consist of five 
essential components if we use a Data-Base Management System (DBMS) to store 
both inputs and outputs of the system, as shown by the general system structure in 
Figure 2-1 of Chapter 2. The first component is user interfaces, which facilitate 
communication between system users and the systems. The second one is a knowledge 
base, which contains the clinical rules necessary for the completion of its task. The 
third one is a database, in which data and conclusions can be stored. The fourth 
component is an inference engine, which matches clinical rules to input data to derive 
its conclusions. The fifth one is decision models employed in the system to provide 
different types of decision support. Considering machine learning through past clinical 
experience and group clinical decision support, we can integrate a machine learning 
functionality and an online group decision supporting functionality into the 
knowledge-based CDSS. The system should then contain two more components - 
knowledge training module and group decision supporting module. 
It is found from the literature, as discussed in Chapter 2, that a good CDSS should 
follow the three principles. Firstly, building appropriate knowledge base and inference 
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engine to provide intelligent and accurate clinical decision support under uncertainties 
is important for a CDSS to be successful in practice. Secondly, providing online group 
clinical decision support is necessary for a CDSS to meet the needs of inevitable group 
clinical decision making in clinical practice. Thirdly, building a knowledge training or 
learning module to automatically update knowledge base according to accumulated 
clinical practice is necessary for a CDSS to support today’s evidence-based medicine. 
Different reasoning methods one could use in arriving at a diagnosis in the literature 
could be using rules, statistics, neural networks, comparison with past cases and so on. 
The knowledge representation scheme and the knowledge training model chosen are 
closely related to the reasoning method. The group decision achieving methods used in 
existent group CDSSs include Delphi method (Rao and Turoff, 2000) and AHP 
(Hatcher, 1994). 
In the research, a new belief rule-based inference methodology called RIMER (Yang et 
al., 2006) is investigated and employed for the design and development of an online 
intelligent group CDSS, and the target CDSS can help bridge the research gaps as 
identified in Chapter 2. 
In the clinical BRB model, domain knowledge is represented by a new knowledge 
representation scheme, i.e. belief rules. They are different from conventional rules in 
that they are designed with belief degrees embedded in all possible consequents of a 
rule, and other knowledge representation parameters such as the weights of rules and 
antecedent attributes are also considered in this scheme. Such a BRB is capable of 
capturing the vagueness, incompleteness, and nonlinear causal relationships in 
knowledge (Yang et al., 2006). 
 70
In a belief rule-based system, an input to an antecedent attribute is transformed into a 
belief distribution on referential values of the attribute, and subsequently inference 
with the BRB is implemented using the ER approach. As a result of the ER-based 
aggregation of all activated rules in the BRB, all possible consequents in the inferred 
result are associated with belief degrees. 
The ER approach, which is used for aggregating all activated belief rules in RIMER 
methodology, is also employed to aggregate all group clinicians’ diagnosis preferences 
in the system thanks to its advantages of combining both quantitative and qualitative 
judgments under various uncertainties.  
As for knowledge training in a belief rule-based system, several online and offline 
BRB training models have been proposed by researchers (Zhou et al., 2009, Zhou et al., 
2010, Yang et al., 2007). Some models target both BRB structure and knowledge 
representation parameters training (Zhou et al., 2010), while some other models target 
only knowledge representation parameters training (Yang et al., 2007, Zhou et al., 
2009). Based on previous research on BRB training in the literature, an optimization 
model for training the belief rule-based CDSS was implemented in the research.  
The following subsections briefly introduce BRB, ER, and the optimization model 
used for BRB training.. 
3.2.1. BRB 
BRB is extended from traditional rule base by adding a belief structure, in which 
knowledge representation parameters including rule weights, antecedent attribute 
weights and belief degrees in consequents are considered. 
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Conventionally, in a rule base, the kth rule in an ‘IF-THEN’ format can be described as 
:kR  If 
k
T
kk
k
AAA ∧∧∧ L21 , then kD       (3-1) 
where ( )kki TiA ,,1 K=  is a referential value of the ith antecedent attribute in the kth 
rule, and kT  is the number of the antecedent attributes used in the kth rule. Dk is the 
consequent of the kth rule. 
If rule weights, antecedent attribute weights, and belief degrees associated with all 
possible consequents are taken into account, rule described in (3-1) can be extended to 
a packet rule using a belief structure, which is referred to as a belief rule and can be 
described as :kR  
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(3-2) 
where ( )LkNiik ,,1;,,1 LL ==β  is the belief degree originally given by experts to 
which iD  is believed to be the consequent if in the kth belief rule the input satisfies the 
packet antecedents ( )kTkkk kAAAA ,,, 21 K= , the attribute weight 
( )LkTi kki ,,1; , ,1 KK ==δ  represents the relative importance of the ith antecedent 
attribute in the kth rule, and the rule weight kθ  represents the relative importance of the 
kth rule in the rule base. L  is the number of all belief rules in the rule base. kT  is the 
number of all antecedent attributes used in the kth belief rule. N is the number of all 
possible consequents in the rule base. 
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BRB is a collection of belief rules as described by (3-2). Inference with BRB is 
implemented using the ER approach, and knowledge representation parameters 
including rule weights ( )Lkk ,,1 K=θ , antecedent attribute weights 
( )LkTi kki ,,1; , ,1 KK ==δ  and consequent belief degrees { }( )Niik ,,1 K∈β  can be 
learned from past experience or data.  
3.2.2. The ER Approach 
The ER approach (Yang and Sen, 1994, Yang and Singh, 1994, Yang and Xu, 2002) 
originally aims to deal with multiple attribute decision analysis (MADA) problem 
having both qualitative and quantitative attributes under uncertainty. The kernel of the 
ER approach is an ER algorithm which is developed for aggregating multiple attributes 
based on a belief decision matrix and the evidence combination rule of the Dempster-
Shafer (D-S) theory (Shafer, 1976). Different from traditional MADA approaches that 
describe a MADA problem using a decision matrix, the ER approach uses the belief 
decision matrix, in which each attribute of an alternative is described by a distribution 
assessment using a belief structure. How to use the ER approach to do inference with 
BRB and how to use the ER approach to aggregate group preferences are briefly 
discussed as follows.  
3.2.2.1. Inference with BRB Using the ER Approach 
Assume a BRB has L belief rules { }LRRR ,,, 21 L , and the kth rule can be described as 
kR : If U  is 
kA , then D  is with belief degree kβ , where  U  represents the 
antecedent attribute vector, kA  represents the packet antecedents in kth rule, D  
represents the consequent vector ( )NDDD ,,, 21 L  of the rule base, and kβ  represents 
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the vector of belief degrees ( )Nkkk βββ ,,, 21 L  in the rule base. N is the number of 
consequents in the BRB and { }Lk ,,1 L∈ . In inference with the BRB using the ER 
approach, a belief rule expression matrix can be described as Table 3-1. 
Table 3-1: A Belief Rule Expression Matrix for the BRB (Yang et al., 2006) 
Input  
Output ( )11 ωA ( )22 ωA  K  ( )kkA ω  K  ( )LLA ω  
1D  11β  12β   K  k1β   K  L1β  
2D  21β  22β   K  k2β   K  L2β  
M  M  M  K  M  K  M  
iD  1iβ  2iβ   K  ikβ   K  iLβ  
M  M  M  K  M  K  M  
ND  1Nβ  2Nβ   K  Nkβ   K  NLβ  
In the belief rule expression matrix, Di { }( )Ni  , ,1 K∈  is the consequent vector D  which 
represents possible consequent in the rule base, and ikβ { } { }( )LkNi  ,   , KK ,1,,1 ∈∈  
represents belief degree associated to the ith consequent in the kth belief rule in the 
BRB. kω  is the activation weight of the kth rule, which measures the degree to which 
the kth rule is weighted and activated in the inference process.  
The ER algorithm has recursive and analytical formats (Wang et al., 2006), the 
following brief discussion of inference with BRB is based on the recursive ER 
algorithm as introduced in the original paper for proposing RIMER (Yang et al., 2006), 
and the inference process can be described by the following five steps.  
z Step 1: Transform input clinical data to a distribution on referential values of 
relevant antecedent symptoms using belief degrees. 
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Given an input U = (Ui, i=1, …, T) together with its corresponding belief degree 
),,1,( Tii L== εε , where T is the total number of antecedent attributes in the rule 
base, Ui (i=1, …, T) is the input value of the ith antecedent attribute, and 
),,1( Tii L=ε  represents the degree of belief assigned to the input value Ui of the ith 
antecedent attribute, which reflects the uncertainty of the input data. How should the 
BRB be used to infer and generate output? Before an inference process starts, all input 
data need to be transformed to a distribution on referential values of each antecedent 
attribute using belief degrees and this transformation process can be implemented by 
the rule or utility-based equivalence transformation techniques (Yang, 2001). For 
example, the input value Ui for the ith antecedent attribute along with its belief degree 
iε  can be transformed as 
( ) ( ){ } TiJjAUS iijijii ,,1,,,1;,, KK === αε      (3-3) 
where ijA  is the jth referential value of the ith antecedent attribute, ijα  the degree to 
which the input Ui with belief degree iε  belongs to the referential value ijA  with 
0≥ijα  and ( )TiiJj ij ,,2,111 K=≤∑ = α , and Ji is the number of all referential values of 
the ith antecedent attribute. 
z Step 2: Calculate the activation weight of each rule in the BRB. 
After the input transformation, the activation weight ( )Lkk  , ,1 K=ω  which measures 
the degree to which the packet antecedent Ak in the kth rule is activated, can be 
calculated with  
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= ( 10 ≤≤ kiδ ) is transformed from antecedent weight 
( )LkTi kki ,,1; , ,1 KK ==δ  representing the relative importance of the ith antecedent 
attribute in the kth rule. ),,1( Lkk L=θ  is the relative weight of the kth rule. 
( )kki Ti  , ,1 K=α  is the individual matching degree to which the input Ui (i=1,…,Tk) 
belongs to ),,1;,,1( LkTiA k
k
i LL ==  that is the referential value of the ith 
antecedent attribute used in the kth rule, and it is generated from the input 
transformation as described by equation (3-3), with 0≥kiα  and 11 ≤∑ =kTi kiα . 
( ) kikT
i
k
ik
δ
αα ∏
=
=
1
 ( )Lk  , K,1=  is called the combined matching degree to which the 
input vector U matches the packet antecedent kA  in the kth rule. Tk is the total number 
of antecedents in the kth belief rule. L is the total number of all belief rules in the BRB. 
It can be easily found from equation (3-4) that in the calculation of the combined 
matching degree ( )Lkk  , ,1 K=α  of input to packet antecedent, all individual 
matching degrees ( )LkTi kki ,,1; , ,1 LK ==α  and all antecedent weights 
( )LkTi kki ,,1; , ,1 KK ==δ  have been taken into account, and then the calculation of 
the activation weight ),,1( Lkk L=ω  takes into consideration both rule weights 
),,1( Lkk L=θ  and the calculated combined matching degrees of input to packet 
antecedent. This means that all knowledge representation parameters play their roles 
in calculating a rule’s activation weight. 
 76
z Step 3: Update belief degrees to possible consequents in the BRB based on 
the input information. 
As for the belief degree ikβ  ( 10 1 ≤≤∑ =Ni ikβ ; i=1,…, N; k=1,…, L) which is originally 
given by experts when a BRB having a collection of rules as described by equation (3-
2) is established, if 1
1
=∑ =Ni ikβ , the kth belief rule is said to be complete; otherwise, it 
is incomplete. If 0
1
=∑ =Ni ikβ , it means the output of the kth belief rule is completely 
unknown. In such situation, the incompleteness of the consequent in a rule is caused by 
a lack of domain knowledge or expert experience, and the inferred result from this 
incomplete rule should be incomplete according to the properties of the ER approach 
(Yang and Xu, 2002). In other situation, when the input data is incomplete, for 
example, the sum of matching degrees of an input to all referential values of an 
antecedent attribute is smaller than 1, the inferred result from this incomplete input 
data should be incomplete as well (Yang et al., 2006).  For instance, if the input for the 
antecedent attributes of a rule is completely unknown, a completely unknown 
consequent will be generated. If the input of antecedent attributes is partially known, 
the inferred result will also be partially known or incomplete. In the inference process, 
the incompleteness in input data should be taken into consideration, because an 
incomplete input for an antecedent attribute will cause an incomplete output after 
inference with the rule where the attribute plays its antecedent role. Considering the 
incompleteness of input data, belief degrees in consequents of a rule need to be 
updated based on the real input. More specifically, the original belief degree 
( )∑ = ≤≤≤ Ni ikikik β1 1;10  ββ  given to the ith possible consequent ( )NiDi ,...,1=  in the 
kth rule which is extracted from experts should be updated on the basis of the actual 
input information in the inference process by  
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where ikβ  is the belief degree in consequent iD  when the kth rule is activated by the 
actual input and it is determined by original belief degree ikβ  together with the 
incompleteness of real input data, in which     
( ) ( ) ,
.otherwise 0,
. , 1, definingin  used is attribute antecedent   theif,1
,
th
⎭⎬
⎫
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⎧ == kk TtRtkt K  τ  
and tjα is the degree to which the input Uk belongs to the referential value 
),,1;,,1( tktj JjTtA LL == with 0≥tjα  and ( )tJj tj Jjt ,,111 L=≤∑ = α . The 
transformation from input Uk to tjA  is described as equation (3-3), where tjA  is the jth 
referential value of the tth antecedent attribute, and Rk is the kth rule in the BRB. N is 
the number of consequents in the kth rule. Tk is the number of all antecedents in the 
kth rule, and Jt is the number of referential values of the tth antecedent attribute in the 
kth rule. 
z Step 4: Aggregate all activated rules using the ER approach to generate a 
combined belief degrees in possible consequents. 
Once the activation weight of each rule and belief degrees in the possible consequents 
of each rule in a BRB have been determined by the input clinical data, the ER 
algorithm (Yang and Xu, 2002) can be applied directly to aggregate all activated rules 
in a BRB to generate the combined degrees of belief in the consequents of a BRB as 
follows 
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( ) ( ){ }NjDUO jj ,,1,, K== β        (3-6) 
This equation reads as that given an input to a belief rule-based system in the vector 
form of { }TiUU i  , ,1 , K== , the outcome is consequent jD  with a belief degree of 
( )Njj  , ,1 K=β . 
z Step 5 (optional): If necessary, calculate expected severity and severity 
interval of different diagnostic consequents to rank the severity of patients’ illness 
caused by the same disease.  
For example, if the severity score of  ‘H’ clinical risk is set to be 1, ‘M’ clinical risk set 
to be 0.5, and ‘L’ clinical risk set to be 0, a patient’s overall severity score would be 
0.8 if he/she is assessed as ‘H’ clinical risk with 60% probability and ‘M’ clinical risk 
with 40% probability. The details of the concept and calculation of the expected utility 
and utility interval of the ER approach can be found in Yang and Xu (2002). 
For better understanding, a flowchart illustrated by Figure 3-1 can be used to describe 
the whole inference process using the ER approach in a belief rule-based CDSS. 
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Figure 3-1: Inference with BRB Using the ER Approach in Recursive Format 
Yes
Start
Read clinical rules and knowledge
representation parameters extracted
from domain experts 
Read input clinical data
Transform input information to a distribution
on referential values of relevant antecedent
symptoms as described by equation (3-3) 
Calculate the activation weight of each 
rule in the BRB using equation (3-4) 
Aggregate all activated rules using
the ER algorithm 
Is there any need of
a severity score? 
End
Calculate expected severity and severity 
interval of diagnostic consequents 
Update original belief degrees to
possible consequents in the BRB
using equation (3-5) 
No
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3.2.2.2. Group Preferences Aggregation Using the ER 
Approach 
Assume there are H consultants ( { }( )HhCh  , ,1 K∈ ) participating in a group consultation 
for one patient, and there are R possible diagnosis results ( { }( )RrDr  , ,1 K∈ ) about the 
patient. When we use the ER approach for group reference aggregation, the group 
decision making problem can be expressed in matrix format as follows: 
[ ]     ,
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where hC  denotes the hth consultant, rD denotes the rth possible diagnosis result about 
the patient, { } { }( )HhRrrh  , ,1 , , ,1 KK ∈∈β  represents belief degree provided by the 
hth group consultant hC  to the rth diagnosis result rD  about the patient, and 
{ }( )Hhh ,,1 L∈ω  is the weight assigned to hC   representing the importance of the hth 
group consultant in the group preference aggregation process. The detailed steps of 
using the ER approach to aggregate group consultant preferences can be described as 
follows. 
z Step 1: Invite a group of clinicians to participate a group consultation for 
one patient. 
Assume we have a patient, who is with CCP, and the clinician on duty is not sure about 
what should be taken in the next step based on current status of the patient, then we 
need to carry out a group consultation for assessing clinical risk of the patient. If there 
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are H experts in CCP field who are available for the group consultation, the clinician 
on duty can act as a group facilitator role for the group consultation and invite these H 
experts to participate it. 
z Step 2: Acquire group consultant diagnosis preferences expressed as a 
distributed assessment of possible diagnoses. 
If possible diagnosis results for one patient is { }( )RrDr  , ,1 K∈  and there are H 
consultants are in the group consultation, the group facilitator can request the hth 
consultant input his/her risk assessment as ( ) ( ) ( ){ }RhRhh D, , DD βββ ,, ,, 2211 K . Take 
above mentioned patient with CCP for example, possible risk status of the patient may 
include: ‘very high’ (D1), ‘high’ (D2), ‘low’ (D3), and ‘no’ (D4), and group facilitator 
can request the hth participated clinician express his/her risk assessment as {( Dh, h1β  ), 
(Dh, h2β ), (Dh, h3β ), (Dh, h4β )}, for example, {(‘very high’, 0.8), (‘high’, 0.2), (‘low’, 
0), (‘no’, 0)}. 
z Step 3: Assign weight to each group consultant based on his/her expertise 
and reputation. 
The weight { }( )Hhh ,,1 L∈ω  of each participated clinician represents the importance 
of each individual clinician based on his/her expertise or reputation in the group 
consultation. Using the ER approach to aggregate all group preferences can take into 
consideration of the importance of each group member. For example, there are two 
experts in CCP who are invited to participate a group consultation, one is an 
experienced clinician and is in a senior position while the other is less experienced and 
in a junior position, the group facilitator may assign a weight of 1 to the former and a 
weight of 0.7 to the latter in the group consultation. 
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z Step 4: Aggregate all group consultant diagnosis preferences using the ER 
approach to generate a combined belief degrees in possible diagnoses. 
As soon as we get all the parameters such as weight { }( )Hhh ,,1 L∈ω  of individual 
consultant and the distributed diagnosis preference ( ) ( ) ( ){ }RhRhh D, , DD βββ ,, ,, 2211 K  
provided by each consultant, we can use the analytic ER algorithm to aggregate the 
group diagnosis preference and get a combined belief degrees in all possible diagnoses. 
The analytic ER algorithm is as follows. 
( ) ( )[ ]
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= = == =∑ ∏ ∑∏ ∑ −×−−−+= Rr Hh Rr rhhHh Rr rhhrhh R βωβωβωµ  
where ( )Rrr ,,1 L=β  is the final belief degree attached to the rth possible diagnosis 
rD  after combining all group consultant diagnosis preferences in the group 
consultation, ( )HhRrrh ,,1;,,1 LL ==β  is the belief degree assigned to the rth 
possible diagnosis rD  by the hth consultant, and hω  is the weight of  hth group 
consultant.  
In the existent group CDSSs, methods used to achieve a group consensus in the group 
decision making situation include Delphi method and AHP. The Delphi method seeks 
to achieve a consensus among group members through a series of questionnaires 
which requires several rounds for group members to fill in the questionnaires, yet it is 
actually time consuming and needs carefully designed questionnaires to acquire 
participants’ opinions in each round (Linstone and Turoff, 1975). If we use AHP in 
the group decision making context, just as using AHP for supporting individual 
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decision making, we need to acquire comparison information with regard to each pair 
of objects be determined. Traditionally, there are two approaches that can be used to 
get the comparison information as to each pair of objects. Firstly, the entire group 
provides a single numeric value for each pair of objects, for example, object “i” 
compared to object “j”, and we can take the group provided comparison information 
as a “consensus” of each pair objects. Secondly, we can request each group member 
provide a numeric value that reflected her/his view of the relative importance of 
object “i” compared to object “j”, and then we use geometric mean of all group 
member input numeric values to get a “consensus” of comparison information of each 
pair of objects. After we get comparison information for each pair of objects, we can 
use AHP method to aggregate the comparison information and get a final preference 
order of the objects. However, using AHP in group decision making context to 
achieve an aggregated preference order of objects has its limitations.  The first option 
of acquiring a group consensus on comparison information as to each pair of objects  
suffers from the negative effects of status influence (or power differential problem) 
which could prevent the realization of real consensus, and a major disadvantage of the 
second option is that wide disparities in the comparison information could result in 
the computed ‘consensus’ matrix being an inaccurate representation of the given 
situation at human level (Bryson, 1996).  
Compared to the above mentioned group decision support methods in the existent 
group CDSSs, using ER in group clinical decision making context to achieve a group 
consensus has the following advantages. Firstly, rather than seeking individual group 
member’s diagnosis preference through several rounds of questionnaires as in Delphi 
method, using the ER approach for group preference aggregation only needs each 
individual group member’s belief degrees on all possible diagnosis results for one 
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patient. It helps speed up the group decision making process. Secondly, uncertainties 
in the judgement of all possible diagnosis alternatives can be reflected by the 
distributed assessment, where the individual group member can provide both 
complete and incomplete judgements. Note here complete judgement means belief 
degrees of all possible alternatives add up to 1, while incomplete judgement means 
the sum of belief degrees of all possible alternatives is smaller than 1. Thirdly, 
influence of different individual group member on the final group consensus is 
reflected by weight assigned to individuals in the preferences aggregation process. 
Fourthly, based on the utility and utility interval of the group aggregated judgement 
for a patient, the severity of the patient’s illness can be calculated. 
3.2.3. An Optimization Model for BRB Training 
As described in Section 3.2.1, the initial belief rules and knowledge representation 
parameters including rule weights, attribute weights and consequent belief degrees are 
originally given by domain experts or randomly generated, and they can not be 100% 
accurate. To make the BRB to represent clinical domain knowledge more accurately, 
we need to train or fine-tune the BRB using historical data.  
Generally, machine learning comes in two categories: supervised learning and 
unsupervised learning (Hardin and Chhieng, 2007) as shown in Figure 3-2. In 
supervised learning the goal of learning is to adjust the knowledge representation 
model through minimizing the discrepancy between the system results and observed 
results of the training sample as shown in Figure 3-2 (A). As for unsupervised 
learning, we know nothing about the knowledge representation model ahead and just 
let the system learn meaningful structure from a set of historical data as shown in 
Figure 3-2 (B). 
 85
 
Figure 3-2 (A): Supervised Learning; (B): Unsupervised Learning. (Hardin and 
Chhieng, 2007) 
In terms of BRB training, several online and offline models have been proposed in the 
literature, where online training models target real-time BRB training by newly input 
data and offline training models target BRB training by accumulated historical data. 
All these BRB training methods fall into supervised learning category which requires 
an initial BRB acquired from domain experts and uses a historical clinical dataset 
with real clinical outcome to train the BRB.  
In the research, target domain BRB is originally constructed based on expert 
clinicians’ experience and knowledge and those clinical rules have been verified by 
clinical research. Although domain knowledge in medicine keeps changing, it changes 
at a comparatively low speed, and we do not have to update the domain BRB hourly 
or daily. Thus, we choose the offline BRB training methods to train the developed 
belief rule-based CDSS prototype by available accumulated clinical data. 
As for the offline BRB training methods, Yang et al. (2007) proposed several optimal 
learning models for training BRB.  Depending on the type of input and output of 
sample data, the optimal learning model can be constructed in different ways (Yang et 
Simulated Results 
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Observed Results 
Data Real System
Learning System
Data Learning System
(A) 
(B) 
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al., 2007). For example, if the output of the training sample is of numerical type, a 
single objective nonlinear optimization model can be constructed by minimizing the 
total mean squared error between the simulated output and the observed output of the 
sample data. 
The following is a brief discussion of the BRB training model. The training 
parameters of the optimization training model may consist of different sets of 
knowledge representation parameters including rule weights, attribute weights and 
belief degrees. If necessary, utilities or scores associated with different consequents 
can be used for training as well. The objective of the optimization model is to 
minimise the discrepancy between system generated diagnosis results and the 
observed clinical status of the real or simulated patients, and the discrepancy is 
calculated by total mean squared error between system and observed results. The 
constraints of the optimization model are constructed based on the characteristics of 
those knowledge representation parameters and the utility values. Details of the 
optimization model are as follows. 
The aim of BRB training is to find a set of parameters 
( )( )NjNiLkjkik ,,1;,,1;,,1,, LLL ===βδθ  of a BRB that can help the BRB to 
represent domain specific knowledge correctly. The training process is implemented 
through minimizing the discrepancy between the system generated results and 
observed results of the training sample. Assume there are M cases in the training 
sample, and the input-output pairs of those M cases are ( )( )Mmyx mm ,,1ˆ,ˆ L= . The 
process of learning from these M datasets can be depicted in Figure 3-3, where the 
system generated output ( )my  is produced by the system via the inference engine. The 
real output ( )myˆ  is observed by experts or acquired by instruments, and ( )Pξ  
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represents the difference between the real output and the system generated output. The 
objective function of the BRB optimization model is to minimise ( )Pξ , and the 
constraint function can be defined based on the conditions that the training parameters 
must satisfy. As a result of the training process, there will be a new set of ( )jkik βδθ ,,  
for the BRB.  
 
Figure 3-3: Training Process 
Regarding the objective function of the training model, we used the total mean 
squared error ( ) ( )2
1
ˆ1 ∑ = −Mm mm yyM to represent ( )Pξ . As an explicit ER aggregation 
function is required in BRB training, the analytical ER algorithm (Wang et al., 2006) 
was used to construct the objective function in the training model. When the 
analytical ER algorithm is applied to inference with BRB, final belief degrees 
( )Njj ,,1 L=β  attached to all possible consequents ( )NjD j ,,1 L=  are inferred 
using the following equation: 
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where ( )LkNjjk ,,1;,,1 LL ==β  is the original belief degree assigned to the jth 
consequent in the kth belief rule, 
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the kth rule’s activation weight which is calculated using equation (3-4). Here the 
diagnosis result generated by ER based inference engine for a patient is a set of belief 
degrees attached to all possible consequents as ( )( )NjD jj ,,1, L=β  other than a 
single numerical output. We need to transform the inferred result of the mth case to a 
single numerical value ( )my  based on the concept of utility and utility interval 
proposed by Yang and Xu (2002), and  the transformation is implemented using 
( ) ( )MmDy jNj jm ,,11 L== ∑ = βµ , where ( )( )MmNjmj ,,1;,,1 LL ==β  is 
generated by the inference engine, and ( )( )NjD j ,,1 L=µ  is the utility value or score 
we set for the jth consequent jD . As for the constraints’ setting for the BRB training 
model, it depends on specific domain knowledge and domain experts’ judgements. 
3.3. Prototyping  
Once the methodology of RIMER has proven feasible to model the clinical domain 
knowledge and to do clinical inference in target clinical areas, a computerised CDSS 
prototype can be developed to test whether such a CDSS is really reliable and useful 
in a real clinical decision making scenario. Prototyping is employed as the system 
development methodology in the research. 
3.3.1. Brief Introduction to Prototyping 
Prototyping is an adaptation of the traditional system development life cycle (SDLC). 
A traditional SDLC starts from some kind of need and results in a completed system, 
and it consists of four fundamental phases-planning, analysis, design, and 
implementation which lead to a deployed system (Turban and Aronson, 2001). In a 
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traditional SDLC, an ideal progression is to follow each phase in order, yet it is 
possible to return to any phase from any other. While in prototyping methodology, a 
system is developed sequentially in modules, and it is deployed to users and gains 
feedback from users for further refinement when each module is completed, so that a 
prototype system can be quickly developed and demonstrated to users. Figure 3-4 
shows a typical prototyping development process. 
 
Figure 3-4: Prototyping Development Process (Turban and Aronson, 2001) 
Following the development process as shown in Figure 3-4, the analysis, design, and 
prototype implementation phases are iteratively performed until a small prototype is 
sufficiently developed.  
3.3.2. Alternative System Development Methodologies 
Planning
Analysis
Design
Implementation
Implementation 
Need 
Prototype 
System 
Prototype Not OK
Prototype OK 
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There are several alternative system development methodologies which include the 
traditional SDLC, parallel development which resembles the SDLC, and phased 
development. 
In parallel development, the design and implementation phases are split into multiple 
sub-ones after the analysis phase, and each of the sub-ones involves development of a 
separate subsystem. All the sub-ones come together in a single implementation phase, 
in which a system integrator puts the subsystems together in a cohesive system. 
In the phased development methodology, a system is developed sequentially by a 
series of versions. Each version has more functionality than its previous version, and 
they evolve into a final system. 
3.3.3. Advantages of Prototyping  
Compared to alternative development methodologies, prototyping has the following 
advantages in developing a CDSS: 
z Users are involved in every phase and iteration.  
Unlike in the traditional SDLC, users only play roles in the planning phase when 
system developers seek information from them. The iterative nature of prototyping 
allows users to be involved in system design and development, which is important for 
a CDSS. Getting system users involved in system design and development process 
enables us to learn from them gradually about the ill-structured clinical domain 
knowledge and system users’ real requirements of a CDSS in clinical practice.  
z Prototype can be developed quickly.  
Unlike a traditional SDLC, prototyping essentially bypasses the formal steps of 
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requirements acquisition and analysis, since prototyping attempts to clarify users’ 
needs by actively involving them in a fast-feedback development process, and this 
helps a prototype system to be developed quickly in the prototyping system 
development methodology.   
In the research, we need to design and develop a CDSS first and then use clinical 
cases to test whether the developed CDSS is really reliable and useful. Due to limited 
time and human resources, alternative system development methodologies discussed 
above are not suitable, and prototyping methodology is the appropriate method to 
develop a CDSS prototype for the study.     
3.4. Field Study 
In the research, practice guidelines in target areas are important resources for 
knowledge elicitation in construction of knowledge base. But the domain knowledge 
in target clinical areas keeps changing, and all the practice guidelines that we obtained 
at the beginning of the study can be outdated soon. In such situation, we need to hold 
regular interviews and meetings with expert clinicians for acquiring advanced clinical 
domain knowledge. Moreover, field study is necessary for us to investigate the daily 
clinical work flow in NHS hospitals and to acquire real user requirements for a CDSS 
in clinical practice. 
3.5. Statistical Techniques 
After system design and development, real or simulated clinical cases are used to 
validate the developed prototype system. For example, for inference engine validation, 
real or simulated patients’ data can be used as inputs to the prototype system, and then 
the automatic diagnostic recommendations generated by the prototype system can be 
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used to compare with real clinicians’ conclusions, and finally a conclusion about the 
prototype system’s reliability can be drawn based on the diagnostic performance 
provided by the system.  
Statistical techniques are used to analyze the diagnosis results generated in the 
prototype validation process. The receiver operating characteristics (ROC) curve 
(Metz, 1978, Park et al., 2004) is employed to analyze the diagnostic performance of 
the different diagnosis tests taken in the validation, and the area under the ROC curve 
(AUC) (DeLong et al., 1988, Mei-Ling Ting and Bernard, 2001) is used to compare 
diagnostic performance of the different diagnosis tests. Brief introduction of the 
statistical techniques used in the research can be found in Chapter 6. .  
3.6. Research Design 
Once research questions and objectives of a study are formulated concretely, a 
researcher develops a research design as a strategic plan to conduct the study. 
Research design is a format for detailed steps in a study to tackle previously identified 
research questions and to achieve already set research objectives. 
The research design comprises data collection, prototype CDSS design, development 
and validation. The research is conducted based on a multiple-methodologies research 
approach. The research consists of five research stages, the details of which are 
outlined in Table 3-2. 
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Table 3-2: Research Design 
Stages Actions Objectives Questions to Answer Research Methodologies 
Stage 1 1. Literature review 
2. Theoretical investigation   
1. To identify research gaps 
2. To formulate research questions 
Research question (1-1) Literature review 
Stage 2 A feasibility study 
Ö Domain knowledge acquisition 
Ö Compare a traditional rule-based 
CDSS with a belief rule-based 
CDSS 
1. To acquire target clinical domain 
knowledge 
2. To analyze the feasibility of 
applying RIMER for 
development of a CDSS 
Research questions (1-2)& 
(1-3)     
1. Literature review 
2. Field study 
3. Modelling 
Stage 3 1. Design of a belief rule-based 
online intelligent group CDSS 
2. Development of the belief rule-
based online intelligent group 
CDSS prototype 
To design and develop an online 
belief rule-based group CDSS with 
learning capability 
Research questions (1-2) & 
(1-3) & 
Research questions (2) & (3)  
1. Modelling 
2. Prototyping 
Stage 4 Validation of the developed CDSS 
prototype  
Ö Domain knowledge acquisition & 
Data simulation 
Ö Validation of inference engine: 
compare system’s diagnostic 
performance with one doctor’s 
Ö Validation of training module: 
compare the system’s diagnostic 
performance before and after 
BRB training 
To test the reliability of the prototype Research question (1-2) &  
(1-3)& 
Research questions (3)    
 
1. Field study 
2. Statistical analysis 
Stage 5 1. Finalizing main results  
2. Presenting the prototype 
system and system manual 
1. To draw conclusions about 
the feasibility of employing RIMER 
for developing a CDSS 
2. To present the final prototype 
system and the user manual 
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(1) Identifying Research Problem  
At research stage 1, a research topic on CDSSs is chosen, and information with 
respect to the topic and its problems is initially extracted from the literature. Existing 
CDSSs are reviewed for its further requirements and research questions are 
formulated based on the identified research gaps. The potential of employing 
advanced methods and technologies in decision making areas such as RIMER to 
address the research problems is investigated. The research during this stage includes 
the following activities: 
z Review and analyze existent CDSSs; 
z Provide a key feature analysis in uncertainty handling for the existent CDSSs; 
i. Identify challenges of knowledge representation schemes and inference 
mechanisms in existent knowledge-based CDSSs; 
ii. Identify challenges of knowledge learning and representation mechanisms in 
existent non-knowledge-based CDSSs; 
iii. Identify challenges of group decision support in existent CDSSs; 
iv. Explore the possibility and creativeness of using advanced methods and 
technologies from decision making area to design and develop an intelligent 
group CDSS that can handle different uncertainties well; 
v. Formulate research questions; 
z Set detailed measurable research objectives for the research. 
(2) A Preliminary Feasibility Study 
At research stage 2, a clinical domain is chosen as a target clinical area for a 
preliminary feasibility study, and specific domain knowledge need to be extracted 
from domain medical literature or/and acquired from expert clinicians through field 
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study. Subsequently, the feasibility of using RIMER for the design and development 
of a belief rule-based CDSS is investigated. The research at this stage includes the 
following activities: 
z Acquire target clinical domain knowledge through literature review and field 
study; 
z Construct BRB models based on the domain knowledge; 
z Construct an inference model using the ER approach; 
z Compare the belief rule-based system with traditional rule-based system in 
drawing clinical conclusions about simulated cases in target clinical areas. 
(3) Design and Development of a Belief Rule-based Online Intelligent Group 
CDSS Prototype 
At research stage 3, we design and develop a belief rule-based online intelligent group 
CDSS. The system design and development need to consider the details of system 
architecture, back-end database, user interfaces, knowledge base, inference 
mechanism, group decision supporting module, and training module. The basic 
prototyping system development process as shown in Figure 3-4 is applied in the 
prototype development. The research at this stage includes the following activities: 
z Identify the prototype’s characteristics in varying aspects: web-based architecture, 
programming languages, software environment, and key components or 
functionalities of the system; 
z Design and develop the back-end database schema to store clinical data and  to 
physically construct BRB models; 
z Design and develop web-based user interfaces based on the clinical work flow 
depicted in target clinical practice guidelines; 
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z Design and develop ER-based inference engine; 
z Design and develop ER-based group decision supporting module; 
z Design and develop a BRB training module; 
z Integrate all key components together and present the online belief rule-based 
group CDSS prototype to target system users; 
z Improve the prototype based on users’ feedback.  
(4) Validation of the Online Intelligent CDSS prototype 
At research stage 4, clinical data in target clinical areas is used for validating the 
developed online intelligent CDSS prototype. In the validation, two core components: 
inference engine and training module are validated respectively. The activities at this 
stage include: 
z Acquire target clinical domain knowledge through field study; 
z Collect second-hand real patients’ data or invite expert clinicians to simulate 
clinical data; 
z Test the system’s diagnostic performance using the acquired dataset; 
z Split the dataset into training and test sets based on some criteria; 
z Train BRB model in the system using the training dataset; 
z Test the trained system using the test dataset; 
z Analyze the system’s diagnostic performance before and after BRB training. 
(5) Present the Final Prototype CDSS and User Manual 
This final research stage summarises the results, draws conclusion about the 
feasibility and viability of applying RIMER in development of a CDSS and presents 
the final prototype system and system manual. 
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3.7. Summary 
As identified in Literature Review chapter, representing and reasoning with clinical 
domain knowledge under uncertainties are areas that require refined technologies, and 
there are strong needs for a CDSS to provide group clinical decision support and 
automatic knowledge base updating in addition to individual clinical decision support. 
Thus we propose to employ RIMER methodology to implement a belief rule-based 
CDSS, while group clinical decision support and automatic clinical knowledge base 
updating are also taken into account. In this chapter, the main models we used for 
domain knowledge representation, clinical inference, and clinical knowledge base 
training are briefly discussed first, and followed by a brief description of the system 
development method - prototyping, and then we provide a brief discussion on field 
study which we used for domain knowledge acquisition and clinical practice 
observation, and the statistical method – ROC analysis which we employed to analyse 
the system validation results, and finally, a concrete research design is provided based 
on proposed methods. The advantages of using BRB for modelling or representing 
domain knowledge, using ER for individual clinical diagnosis and group clinical 
preferences aggregation, and using an offline BRB training model for automatic 
knowledge base updating include: (1) BRB can help transparently represent domain 
knowledge under uncertainties in an natural ‘IF-THEN’ rule format with a belief 
structure, which can be provided as explanation if required; (2) inference with BRB 
using ER can help preserve uncertainties rationally in the inference process and 
represent their effects in the finally conclusion, while aggregating group preferences 
using ER can help speed up the group decision making process compared to Delphi 
method. In the following chapter, we will provide a preliminary study on feasibility of 
employing RIMER for implementation of a CDSS. 
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Chapter 4  
A Preliminary Feasibility Study 
 
4.1. Introduction 
Prior to the design and development of an online intelligent CDSS based on the newly 
developed belief rule-base inference methodology-RIMER, a preliminary study on 
feasibility of employing RIMER for developing a CDSS was conducted. 
This chapter discusses a detailed investigation for the feasibility of using RIMER in 
developing a CDSS. In the feasibility study, clinical risk assessment of acute upper 
Gastrointestinal (GI) bleed was chosen as target clinical area, and a patient with acute 
upper GI bleed was simulated by an expert clinician in MRI for the investigation. In 
the study, knowledge-based systems including traditional rule-based system and belief 
rule-base system are constructed for investigation. 
In a traditional rule-based CDSS, forward chaining or backward chaining is used as 
the inference method, while in a belief rule-based CDSS, the evidential reasoning (ER) 
approach is employed as the inference method. Equipped by an intelligent decision 
system (IDS) (Xu and Yang, 2005), which is a Windows-based multiple criteria 
assessment system that implements the ER approach, we obtained a diagnostic 
recommendation through inference with the belief rule base (BRB) using ER in a 
belief rule-based CDSS. Through comparison of diagnosis recommendation generated 
by belief rule-based system and traditional rule-based system, we find that the 
diagnosis recommendation generated by a belief rule-based CDSS is more 
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informative than the diagnosis conclusion drawn from a traditional rule-based system 
when there is uncertainty in clinical data.  
The chapter is organised as follows. Section 4.2 discusses target clinical domain 
knowledge acquisition for the feasibility study. Section 4.3 presents the domain 
knowledge modelling, where the modelling of the domain knowledge using traditional 
‘IF-THEN’ rule base and BRB are discussed in Section 4.3.1 and Section 4.3.2, 
respectively. A description of a simulated patient in target clinical area will follow in 
Section 4.4. Inference with the constructed knowledge base and the clinical data is 
discussed in Section 4.5, where inference with the traditional rule base using forward 
chaining method is discussed in Section 4.5.1, and inference with the BRB using the 
ER approach is discussed in Section 4.5.2. Then conclusions about the feasibility of 
using RIMER for developing a CDSS are provided in Section 4.6, where the 
advantages of a belief rule-based system compared with a traditional rule-based 
system is discussed as well. Finally, Section 4.7 summarises the chapter. 
4.2. Domain Knowledge Acquisition 
Knowledge acquisition is a very important starting procedure for the construction of 
knowledge bases in CDSSs. The first step of knowledge acquisition is to select the 
target clinical area and select expert clinicians to gain domain specific knowledge, and 
then transfer the domain knowledge into computer interpretable knowledge based on 
the designed knowledge representation scheme. 
Target clinical domain selection and domain specific knowledge elicitation for the 
feasibility study are described as follows in Section 4.2.1 and Section 4.2.2 
respectively. 
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4.2.1. Clinical Domain Selection 
Upper GI bleeding is a significant and potentially life-threatening worldwide problem. 
Despite advances in diagnosis and treatment, mortality and morbidity have remained 
constant (Marc et al., 2000). In the UK, acute upper GI bleed is a common medical 
emergency with an incidence of approximately 100 per 100,000 adults per year and a 
mortality among unselected cases of 14% (Rockall et al., 1995). 
Patients with upper GI bleeding vary in severity from those with exsanguinating 
haemorrhage from oesophageal varices to those with simple streaking due to Mallory-
Weiss tear caused by retching after too much alcohol the night before. Thus to provide 
proper management of patient with acute upper GI bleed, it is important for ED 
doctors to make evidence-based decisions about the clinical risks involved to ensure 
that appropriate, timely treatment is provided and that investigation is carried out in 
an appropriate time-frame. Patients at high risk should be resuscitated and undergo 
emergency endoscopy immediately. Patients at moderate risk should have Intravenous 
(IV) access established, have their blood grouped and serum saved and should have 
endoscopy performed rapidly (Central Manchester and Manchester Children's 
University Hospitals NHS Trust, 2003b). 
Motivated by the above facts, we chose clinical risk assessment of acute upper GI 
bleed as target clinical domain for investigation in the feasibility study. 
4.2.2. Target Domain Knowledge Elicitation 
Generally, for acquiring medical domain specific knowledge, many computerised 
knowledge acquisition tools have been developed by CDSSs researchers. Among 
them, some tools such as a Unified Medical Language System (UMLS)-based 
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knowledge acquisition tool developed by Achour et al. (2001) is designed for 
acquiring domain specific medical rules, and other tools such as a guideline 
acquisition module in a guideline-based CDSS developed by Terenziani et al. (2001) 
is designed specially for the acquisition of clinical guidelines which can be used as the 
best and standardised clinical procedures.  
During this study we have expert clinicians in MRI as research collaborators who 
have already published a clinical practice guideline for diagnosis of acute upper GI 
bleed in ED. Therefore we do not have to use any computerised knowledge 
acquisition tool which require our research collaborator to input their domain 
knowledge as clinical rules or clinical guideline. Instead, we elicited rules for 
assessing clinical risk of acute upper GI bleed first from the published practice 
guideline, and then we invited our collaborators in MRI to verify those clinical rules 
before applying them to construct knowledge base for target CDSS. 
The clinical decision support guideline (CDSG) 2003-05 for acute upper GI bleed 
(Central Manchester and Manchester Children's University Hospitals NHS Trust, 
2003b), which we used for eliciting clinical rules for risk assessment of upper GI 
bleed, was developed by clinicians in MRI, and were originally published on central 
Manchester and Manchester children's university hospitals NHS trust intranet in 2003. 
Their content was reviewed by Clinical Effectiveness Committee of the British 
Association for Emergency Medicine in 2005. As presented in the practice guideline, 
rules for assessing clinical risk of acute upper GI bleed are as follows in Table 4-1, 
where SBP stands for ‘systolic blood pressure’, and NSAIs represents ‘non-steroidal 
anti-inflammatory drugs’.  
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Table 4-1: Rules for Clinical Risk Assessment of Upper GI Bleed 
Clinical Risk Clinical signs and symptoms, laboratory 
tests, and medical history High
(H) 
Moderate  
(M) 
Low 
(L) 
Known or suspected oesophageal varices √   
Pulse > 130 bpm √   
SBP < 90 mm Hg √   
Postural SBP drop > 20 mm Hg √   
On NSAIs or anticoagulants  √  
Major co-morbidity (eg cardiac or renal  √  
Stigmata of liver disease  √  
Witnessed acute fresh red blood in vomit  √  
Over 75 years old  √  
Urea > 8  √  
None of the above   √ 
Apart from acquiring domain knowledge from the CDSG as mentioned above, we did 
field study in MRI to observe one expert clinician’s clinical practice and held regular 
meegtings and discussions with expert clinicians to get correct and deep 
understanding of these clincial rules.  
Tradtitional rule base and BRB are constructed, in the following section for 
developing a CDSS, based on the clinical rules as described in Table 4-1. 
4.3. Domain Knowledge Modelling 
4.3.1. Modelling with Traditional ‘IF-THEN’ Rule Base 
Traditional ‘IF-THEN’ rule base is the dominant knowledge modelling methodology 
in CDSSs (Carter, 1999). If we use traditional rules to represent the rules for assessing 
clinical risk of upper GI bleed as described in Table 4-1, the rule base as shown in 
Table 4-2 can be constructed. 
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Table 4-2: Traditional Rule Base for Risk Assessment of Acute Upper GI Bleed 
Number Antecedent Consequent
1 (F1 is Y) R is H 
2 (F2 is Y) R is H 
3 (F3 is Y) R is H 
4 (F4 is Y) R is H 
5 (F1 is N ^ F2 is N ^ F3 is N ^ F4is N ^ F5 is Y) R is M 
6 (F1 is N ^ F2 is N ^ F3 is N ^ F4 is N ^ F6 is Y) R is M 
7 (F1 is N ^ F2is N ^ F3 is N ^ F4 is N ^ F7 is Y) R is M 
8 (F1 is N ^ F2 is N ^ F3 is N ^ F4 is N ^ F8 is Y) R is M 
9 (F1 is N ^ F2 is N ^ F3 is N ^ F4 is N ^ F9 is Y) R is M 
10 (F1 is N ^ F2 is N ^ F3 is N ^ F4 is N ^ F10 is Y) R is M 
11 (F1 is N ^ F2 is N ^ F3 is N ^ F4 is N ^ F5 is N ^ F6 
is N ^ F7 is N ^ F8 is N ^ F9 is N ^ F10 is N)  
R is L 
In above table, Y stands for ‘yes’, N stands for ‘no’, ‘^’ is a logical connective to 
represent the ‘AND’ relationship, and the meaning of other symbols are as follows.  
R represents ‘the clinical risk of acute upper GI bleed’. 
F1 represents ‘known or suspected oesophageal varices’. 
F2 represents ‘pulse > 130 bpm’. 
F3 represents ‘SBP < 90 mm Hg’.  
F4 represents ‘postural SBP drop > 20 mm Hg’.  
F5 represents ‘on NSAIs or anticoagulants’.  
F6 represents ‘major co-morbidity (eg cardiac or renal impaiment)’.  
F7 represents ‘stigmata of liver disease’.  
F8 represents ‘witnessed acute fresh red blood in vomit’.  
F9 represents ‘over 75 years old’.  
F10 represents ‘urea > 8’. 
Note that the same set of symbols will be used in the following sections to describe 
BRB which is constructed by extending the traditional rule base using the belief 
structure. 
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4.3.2. Modelling with BRB 
In the traditional rule base as described in Table 4-2, there is no uncertainty in the 
rules’ antecedent or consequent. However, there are indeed at least three 
circumstances in which uncertainties may arise. Firstly in a real clinical environment, 
conditions in a rule may not always be met with 100% accuracy by patients’ clinical 
data because there are uncertainties in doctors’ subjective judgements about one 
patient’s specific clinical symptoms. Secondly, diagnosis conclusions drawn from 
different clinicians about one patient may not be the same due to the fact that different 
clinician in the same clinical area may own different domain knowledge and different 
practice experiences. Finally even two patients are diagnosed as having the same 
disease, the severity of the two patients may be different, and accordingly, the two 
patients may need to be treated in a different time order. To deal with the uncertainties, 
belief rules may provide an alternative solution to accommodate different types of 
uncertainties in representing both clinical data and clinical domain knowledge. 
If those traditional rules described in Table 4-2 are extended using the belief structure 
for more precisely imitating human reasoning knowledge in rule-based CDSSs, the 
corresponding BRB representing clinical rules for risk assessment of upper GI bleed 
can be described as in Table 4-3. For details of the belief structure in BRB, readers 
can refer to Section 3.2.1 in Chapter 3. 
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Table 4-3: BRB for Clinical Risk Assessment of Acute Upper GI Bleed 
Number W Antecedent Consequent
1 1 (F1 is Y) R is {(H, 1)}
2 1 (F2  is Y) R is {(H, 1)}
3 1 (F3  is Y) R is {(H, 1)}
4 1 (F4  is Y) R is {(H, 1)}
5 1 (F1 is N ^ F2 is N ^ F3 is N ^ F4 is N ^ F5 is Y) R is {(M, 1)}
6 1 (F1 is N ^ F2 is N ^ F3 is N ^ F4 is N ^ F6 is Y) R is {(M, 1)}
7 1 (F1 is N ^ F2 is N ^ F3 is N ^ F4 is N ^ F7 is Y) R is {(M, 1)}
8 1 (F1 is N ^ F2 is N ^ F3 is N ^ F4 is N ^ F8 is Y) R is {(M, 1)}
9 1 (F1 is N ^ F2 is N ^ F3 is N ^ F4 is N ^ F9 is Y) R is {(M, 1)}
10 1 (F1 is N ^ F2 is N ^ F3 is N ^ F4 is N ^ F10 is Y) R is {(M, 1)}
11 1 (F1 is N ^ F2 is N ^ F3 is N ^ F4 is N ^ F5 is N ^ F6 is N  
^ F7 is N ^ F8 is N ^ F9 is N ^ F10 is N) 
R is {(L, 1)}
In the BRB as shown in Table 4-3, the weight of each rule (represented by W in the 
second column) and the weight of each antecedent attribute are assumed to be 1, 
which means all rules possess the same importance and all antecedent attribute play 
similar roles in assessing one patient’s clinical risk. Besides, each rule has a 
consequent only with a belief degree of exactly one, which means if one patient’s 
clinical data meets one rule’s antecedent condition, the patient will be 100% with a 
clinical risk at the level as the rule’s consequent describes.  
Although based on experts’ experience, we have not obtained rules like ‘IF (F1 is 80% 
Y) THEN R is {(H, 0.8)’, which can explicitly represent uncertainties in clinical 
domain knowledge and clinical data. The rules as described in Table 4-3, which 
represent certain clinical rules in assessing risk of upper GI bleed, are special cases of 
belief rules, and they can be used to inference with uncertain clinical data.   
4.4. Description of Clinical Data 
Due to the strict data protection regulations in the UK, we used simulated patient data 
to demonstrate the risk assessment process in both the traditional rule-based and belief 
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rule-based CDSSs. The made-up patient’s data have been verified by an expert 
clinician. 
The detailed information about a simulated patient with acute upper GI bleed is given 
in Table 4-4, where only ‘esophageal varices’ are judged as ‘strongly suspected’, and 
all other clinical signs or symptoms are with certain judgments or exact numerical 
values. 
Table 4-4: One Simulated Patient with Acute Upper GI Bleed 
Disease Clinical signs and symptoms 
strongly suspected oesophageal varices; 
pulse is 131 bpm; 
SBP is 90 mm Hg; 
postural SBP drop is 20 mm Hg; 
currently is on anticoagulants; 
no major co-morbidity; 
no stigmata of liver disease; 
no fresh red blood in vomit; 
76 years old; 
upper GI 
bleed 
urea is 8. 
Note that the same patient’s data has been used in the published paper of Kong et al. 
(2009) for illustration of inference with BRB. 
Inference with the simulated patient’s data and constructed knowledge base is 
described in the following Section. 
4.5. Inference with Knowledge Base 
4.5.1. Inference with Traditional Rule Base 
There are two methods of inference often used in traditional rule-based CDSSs, 
namely forward and backward chaining (Shortliffe and Perreault, 1990). In the study, 
forward chaining is used for reasoning with the traditional rule base as described in 
Table 4-2. Forward chaining is a top-down method which takes facts as they become 
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available and attempts to draw conclusions (from satisfied conditions in rules) which 
lead to actions being executed. 
Inference with the traditional rule-based system using forward chaining involves 
assigning values to attributes, evaluating conditions, and checking to see if all of the 
conditions in a rule are satisfied. A general algorithm for forward chaining method 
can be described as in Figure 4-1. 
 
Figure 4-1: A General Algorithm for Forward Chaining in Rule-Based System 
In the traditional rule-based system as investigated in the study, all rules are chained 
according to the real work flow shown in the practice guideline. To acquire inputs, the 
system would provide a chain of enquiries regarding clinical signs and symptoms 
which are necessary for specific diagnosis. For example, enquiries for clinical risk 
assessment in diagnosis of acute upper GI bleed may include: 
1) Are there known or suspected oesophageal varices? 
2) Is pulse > 130 bpm? 
3) Is SBP < 90 mm Hg? 
4) Is postural SBP drop > 20 mm Hg? 
5) On NSAIs/anticoagulants or not? 
6) Is there major co-morbidity (eg cardiac or renal impairment)? 
7) Is there a stigmata of liver disease? 
Input value 
Assign value to 
attribute 
Evaluate conditions 
in rules 
Fire satisfied  
rules 
Generate output
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8) Is there witnessed acute fresh red blood in vomit? 
9) Is the patient over 75 years old? 
10)  Is the patient’s urea > 8? 
Only answers Y and N are provided as options for system users to choose for all 
enquiries like those listed above in traditional rule-based system. 
If we need to assess the simulated patient’s clinical risk using the traditional rule base 
as described in Table 4-2, our work will be based on the general algorithm as 
described in Figure 4-1. Firstly, the matching between the clinical data and antecedent 
attributes of the traditional rule base can be described as (F1 is Y)^(F2 is Y)^(F3 is 
N)^(F4 is N)^(F5 is Y)^(F6 is N)^(F7 is N)^(F8 is N)^(F9 is Y)^(F10 is N). Secondly 
only condition of Rule 1 and Rule 2 in Table 4-2 are satisfied by the data. As a result, 
the inferred clinical risk of the patient generated by the traditional rule-based CDSS is 
H. 
4.5.2. Inference with BRB 
Inference with BRB using the ER approach also involves assigning values to 
attributes, evaluating conditions and checking to see if all of the conditions in a rule 
are satisfied. However, inference with BRB using the ER approach is different from 
inference with traditional rule base using forward chaining in many aspects. Firstly, 
value assignments in the ER approach are different from forward chaining due to an 
input transformation process. In a rule base, each antecedent attribute has a set of 
referential values, and individual referential value is used in different rule as an 
element of antecedent (Yang et al., 2006). Specifically, the kth rule in a traditional 
‘IF-THEN’ rule base can be described as k
k
T
kk
k DAAAR k   THEN IF ,^^^: 21 L , where 
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( )kki TiA ,,1 L=  is a referential value of the ith antecedent attribute iA  in the kth rule, 
kT  is the number of the antecedent attributes used in the kth rule, and kD  is the 
consequent in the kth rule. In traditional rule-based systems, input data is usually with 
certainty, and it can be matched directly with antecedents of rules in the system. 
While in belief rule-based systems, input clinical data can be with uncertainty, and the 
relationship between an input and each referential value in the antecedents of a rule 
needs to be determined before an inference process can start (Yang et al., 2006). This 
process is to transform an input into a distribution on referential values of one 
antecedent attribute using belief degrees. Secondly, the condition evaluation process 
is different. In the ER approach, since inputs can be transformed to distributed 
referential values as described above, conditions of more than one rule may be 
satisfied by one input patient’s data in parallel to different degrees. While in forward 
chaining, there is only an activated rule or a chain of rules activated in sequence by an 
input patient’s data. Thirdly, conclusions are derived by an aggregation process. 
Using the ER approach, the conclusions generated by all the activated rules need to be 
aggregated to generate an overall conclusion. While in forward chaining, there is no 
rule aggregation or combination process.  
Section 4.5.2.1 to 4.5.2.4 will provide a detailed description of the inference process 
carried out by the belief rule-based CDSS for the simulated patient. 
4.5.2.1. Input Transformation 
In the BRB outlined in Table 4-3, {Y, N} is used as a set of referential values for all 
clinical symptoms. The distributed values transformed from original clinical data of 
the simulated patient described in Table 4-4 in Section 4.4 are as follows: F1: {(Y, 
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0.8), (N, 0.2)}, F2: {(Y, 0.67), (N, 0.33)}, F3: {(Y, 0.5), (N, 0.5)}, F4: {(Y, 0.5), (N, 
0.5)}, F5: {(Y, 1), (N, 0)},F6: {(Y, 0), (N, 1)}, F7: {(Y, 0), (N, 1)}, F8: {(Y, 0), (N, 
1)}, F9: {(Y, 0.6), (N, 0.4)}, and F10: {(Y, 0.5), (N, 0.5)}. In the clinical data 
transformation process, a rule based transformation method (Yang, 2001) is adopted 
for transforming both qualitative and quantitative input data. Here are the details of 
the transformation. 
z Qualitative Input Transformation 
As for the qualitative input information regarding F1, F5, F6, F7 and F8, ‘Y’ and ‘N’ 
are the set of referential values for all these clinical symptoms. For F1, {known, 
strongly suspected, maybe, suspected with a low degree, no} are used as its input 
options, and transformation rules should be set between the input options and the 
referential values of {Y, N}. According to an expert clinician’s advice, the following 
transformation rules are used for F1 related inputs transformation: ‘known’ means 
100% ‘Y’, ‘strongly suspected’ means 80% ‘Y’ and 20% ‘N’, ‘maybe’ means 50% 
‘Y’ and 50% ‘N’, ‘suspected with a low degree’ means 20% ‘Y’ and 80% ‘N’, and 
‘no’ means 100% ‘N’. In real life application, the options set for acquiring original 
information about qualitative clinical symptoms should be set depending on the 
domain experts’ knowledge and experiences. There is no need to establish 
transformation rules for clinical symptoms of F5, F6, F7 and F8, because the referential 
values ‘Y’ and ‘N’ are options for acquiring original input. Based on the clinical data 
as described in Table 4-4, the transformed values for F1, F5, F6, F7 and F8 are F1: {(Y, 
0.8), (N, 0.2)}, F5: {(Y, 1), (N, 0)},F6: {(Y, 0), (N, 1)}, F7: {(Y, 0), (N, 1)}, and F8: 
{(Y, 0), (N, 1)}. 
z Quantitative Input Transformation  
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As for quantitative input data regarding F2, F3, F4, F9 and F10, their inputs are 
numerical values, and ‘Y’ and ‘N’ are also used as referential values for these 
symptoms. Moreover, each quantitative clinical symptom is associated with two types 
of threshold values defined by domain experts including an upper limit value and a 
lower limit value. Transformation rules for these quantitative clinical symptoms 
should include that (a) if the input is larger than the upper range value, the input can 
be transformed to 100% ‘Y’ or ‘N’; (b) if the input is lower than the lower range value, 
the input can be transformed to 100% ‘N’ or ‘Y’; and (c) if the input falls into the 
range between the lower and the upper limit values, the input can be transformed to 
{(Y, =Yα  %valueinput 100* valuerangelower  valuerangeupper 
 valuerangelower  
−
− ), (N, =Nα  1- Yα )} or  {(N, =Nα  
%valueinput 100*
 valuerangelower  valuerangeupper 
 valuerangelower  
−
− ), (Y, =Yα  1- Nα )}, where αY stands for the 
belief degree to which the input value can be transformed to ‘Y’ and αN  stands for the 
belief degree to which the input value can be transformed to ‘N’. 
The reason for us to adopt a saturated linear utility change process as discussed above 
rather than a step utility change process in transforming original input numerical value 
of each quantitative clinical symptom is that the transformed inputs can make the 
inference in the system better imitate human decision making in a real scenario. Take 
F2 for example, if the input value of F2 is larger than (>) 130 bpm, then the patient 
will be at high risk according to the original rules as shown in Table 4-1. However, it 
is unknown what will be the judgment if the input value is exactly 130 bpm. In a real 
clinical risk assessment of patients with upper GI bleed, a clinician would make his 
assessment about a patient with pulse of 130 bpm based on his experience and other 
observations instead of using 130 as the only standard to make a judgment. To solve 
this problem in the belief rule-based CDSS, a value area of (127, 133) is used as an 
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interval to define a gradual change area in risk assessment for patient’s pulse. 
Therefore, the input value for enquiry about F2 equal to or higher than (≥) 133 bpm 
will be transformed to F2: {(Y, 1), (N, 0)} and the input value for enquiry about F2 
equal to or lower than (≤) 127 bpm will be transformed to F2: {(Y, 0), (N, 1)}. If the 
input value lies in the range of (127, 133), it will be transformed to F2: {(Y, 
αY=
( )
( ) ( ) %
valueinput 100*
 valuerangelower 127 valuerangeupper 133
 valuerangelower 127 
−
− ), (N, αN = 1-αY)}. Similar 
transformation will be implemented in input information for enquiries about F3, F4, F9 
and F10  and the linear change area is (85, 95) for F3, (15, 25) for F4, (70, 80) for F9 and 
(5, 11) for F10. 
Based on the clinical data described in Table 4-4, the transformed values for F2, F3, F4, 
F9 and F10 are F2: {(Y, αY= )67.0100*
 value)]rangelower (127 value)range [133(upper
 value)]rangelower (127) (131[ =−
− %valueinput , 
(N, αN=1-αY=0.33)}, Fu3: {(N, αN =(90-85)/(95-85)*100%=0.5), (Y, αY=1-αY =0.5)}, 
Fu4: {(Y, αY=(20-15)/(25-15)*100%=0.5), (N, αN=1-αY=0.5)}, Fu9: {(Y, αY=(76-
70)/(80-70)*100%=0.6), (N, αN=1-αY=0.4)}, and Fu10: {(Y, αY=(8-5)/(11-
5)*100%=0.5), (N, αN=1-αY =0.5)}. 
4.5.2.2. Rules’ Activation Weights Calculation  
After the value assignment for antecedent symptoms, the next step should be to 
calculate the activation weight for each packet antecedent in the rule base. Using 
( ) ( )LkkikT
i
k
ik  , ,1
1
K==∏
=
δ
αα  as described in equation (3-4), the combined matching 
degrees of the input patient’s data to each rule’s packet antecedent are calculated as 
follows: α1=0.8, α2=0.67, α3=0.5, α4=0.5, α5=0.0165, α6=0, α7=0, α8=0, α9=0.0099, 
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α10=0.0083, and α11=0, and the activation weights ( )11,,1 K=kkω  for all rules are 
generated using ),,1(
1
LkL
j
jj
kk
k L== ∑
=
αθ
αθω as described in equation (3-4) as follows: 
ω1=0.3194, ω2=0.2675, ω3=0.1996, ω4=0.1996, ω5=0.0066, ω6=0, ω7=0, ω8=0, 
ω9=0.004, ω10=0.0031 and ω11=0.  
4.5.2.3. Belief Degrees Update  
What follows rules’ activation weights calculation is to update belief degrees in the 
possible consequents of the activated rules in the BRB as shown in Table 4-3. 
According to the activation weights ( )11,,1 K=kkω  for each rule in the BRB as 
calculated in above Section, Rules 1, 2, 3, 4, 5, 9 and 10 are activated to different 
degrees by the simulated patient’s data. After updating of belief degrees in 
consequents using equation (3-5) based on the transformed input values described in 
Section 4.5.2.1, it can be found that the updated belief degrees in possible consequents 
of the rules in the BRB remain original values because all the transformed inputs are 
complete. Here, a complete input means that if the input Uk is transformed to the 
original distributed referential values with belief degrees as described in equation (3-
3), ( )ikJj ij JjTii ,,1;,,11 LL ==∑ = α  should be 1. Take F1 for example, the sum of αY 
(0.8) and αN (0.2) of F1 transformed from the simulated input is 1, which means that 
the input to the antecedent symptom F1 is complete. If inputs related to all antecedent 
attributes are completes, the packet input will be a complete one and the belief 
degrees in the consequents of the BRB will not be affected by the inputs and remain 
as the original values given by domain experts. 
4.5.2.4. Rules Aggregation via ER 
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Finally, IDS (Xu and Yang, 2005), a Microsoft Windows-based multiple criteria 
assessment system which implements the ER approach, is used as a tool to aggregate 
all the activated rules. First, we need to model the belief rule-based clinical risk 
assessment in the ER framework by taking each patient’s illness as an alternative to 
be assessed, taking clinical risk as the top attribute for the assessment of the patient’s 
illness, and taking each activated rule’s packet antecedent as a basic attribute for the 
assessment of the top attribute. In this model, each rule’s activation weight acts like a 
basic attribute’s weight, and each possible consequent of the BRB acts like each 
individual evaluation grade set for the basic attribute. Accordingly, belief degrees in 
possible consequents in the activated rules act like belief degrees to possible 
evaluation grades. The model framed in IDS together with the inputs of the activated 
rules’ activation weights are shown in Figure 4-2, in which the clinical risk 
assessment model of the simulated patient is shown in the upper left side and the 
dialog box in IDS for acquiring each activated rule’s weight is shown in the lower 
right side where each activated rule is treated as a basic attribute in the model. A 
dialog box in IDS for acquiring belief degrees in the possible consequents of each 
activated rule for the clinical risk assessment model is shown in Figure 4-3. 
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Figure 4-2: Clinical Risk Assessment Model in IDS 
 
Figure 4-3: IDS Dialog for Acquiring Belief Degrees in Consequents 
After the modelling work, we can run IDS to generate assessments, and a final clinical 
risk assessment for the simulated patient with upper GI bleed can be visually shown in 
Figure 4-4, which shows that the patient’s clinical risk is assessed to be {(H, 0.9935), 
(M, 0.0065), (L, 0)}. If the severity score of H risk is set to 1, the severity score of M 
risk to 0.5, and the severity score of L risk to 0, the overall severity score of the 
simulated patient generated by the ER approach is 0.9968, and this score can be used 
to tell the severity difference between the patient’s illness and other patients’ which 
are also caused by upper GI bleed. 
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Figure 4-4: Clinical Risk Assessment for Simulated Patient with Upper GI Bleed 
4.6. Feasibility Analysis 
4.6.1. Advantages of Belief Rule-Based CDSS Compared To 
Traditional Rule-Based CDSS 
After detailed presentation of inference with traditional rule base using forward 
chaining and inference with BRB using the ER approach for clinical risk assessment 
of the simulated patient with acute upper GI bleed, a comparison of assessment results 
for the simulated patient can be made between traditional rule-based and belief rule-
based systems, and it is shown in Table 4-5. 
Table 4-5: A Comparison between Traditional Rule-based and Belief Rule-based 
Clinical Risk Assessment  
Clinical Risk Assessment Result 
Traditional Rule-based System Belief Rule-based System 
H {(H, 0.9935), (M, 0.0065), (L, 0)} 
It can be seen from the comparison that the conclusion reasoned from belief rule-
based system are consistent with though not exactly the same as what is inferred from 
traditional rule-based system. For the simulated patient, his/her clinical risk 
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assessment result generated by the traditional rule-based system is ‘H’, while {(H, 
0.9935), (M, 0.0065), (L, 0)} is the result reasoned from the belief rule-based system. 
The reason is that although there is no uncertainty represented in the belief rules as 
described in Table 4-3 in Section 4.3.2, a belief rule-based system can capture 
uncertainties in clinical signs and symptoms for the simulated patient, but traditional 
rule-based systems which have not taken uncertainties into consideration in system 
design and implementation can only reason with clinical signs and clinical symptoms 
with 100% certainty.  
Based on the above observation, we can draw a conclusion that if there are uncertain 
or incomplete input data regarding patients’ clinical signs and symptoms, the result 
generated by belief rule-based system with distributed belief degrees attached to 
different diagnoses is more informative than the one inferred from traditional rule-
based system with one certain diagnosis. Meanwhile, if all clinical signs and 
symptoms can be described with 100% certainty, and there is no uncertainty in 
clinical rules as well, the diagnosis conclusion derived from these clinical symptoms 
should also be without any uncertainty. In such situations, belief rules reduce to 
traditional rules.  
Note that clinical domain knowledge for the diagnosis of different diseases may 
contain different types and degrees of uncertainties, and real life clinical data are 
actually more complicated than the simulated patient’s since information about a 
patient’s clinical signs and symptoms may include ignorance of some symptoms, 
vagueness or incomplete linguistic description, inexperienced judgements and so on. 
In such situations, we prefer to using BRB to model uncertain clinical domain 
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knowledge, and using the ER approach for inference to cope with uncertainties in 
both clinical rules and clinical data. 
Moreover, if two patients are with the same diseases and both are assessed to be at H 
risk, a very important question in ED would arise as to who should be treated first, 
which is an important issue in emergency triage system (Mackway-Jones et al., 2005). 
In the belief rule-based system, a recommendation can be made based on the 
calculated overall severity scores or severity intervals of the inferred assessments for 
different patients. For example, if patients P1 and P2 are diagnosed by the system 
simultaneously, and P1 is assessed to be at {(H, 0.8), (M, 0.2), (L, 0)} risk and P2 is 
assessed to be at definitely H risk. If the severity score of H risk is set to 1, the 
severity score of M risk 0.5, and the severity score of L 0.25, as a result, the overall 
severity score of patients P1 is 0.9 and P2’s is 1. If the order of treatment in ED is 
based on patients’ severity ranking, P2 should be recommended to be treated earlier 
than P1 by the belief rule-based system. However, for the traditional rule-based 
system, it is difficult to give such a recommendation based on the inferred result. 
In consequence, compared to traditional rules in developing a CDSS, RIMER has the 
following advantages for developing a CDSS. Firstly, belief rules can provide a 
flexible framework to capture uncertainties in both clinical sings and symptoms and 
clinical domain knowledge. Secondly, inference with belief rules using ER can 
generate a more informative conclusion which is a combined one. Thirdly, if 
necessary, the distributed diagnosis recommendations can be used to rank patients’ 
severity. Actually, a traditional rule-based system is a special case of a belief rule 
based system. 
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4.6.2. Further Discussions of the Feasibility 
From the comparison study conducted above between a belief rule-based CDSS and a 
traditional rule-based CDSS, we can draw a conclusion that it is logically feasible to 
model clinical domain knowledge using BRB and to employ the ER approach for 
clinical inference. Further analysis of the technical feasibility of employing RIMER 
for developing a computerised intelligent CDSS is discussed as follows. 
From a technical perspective, developing a computerised system requires that there 
should be appropriate computing technologies that can help to implement the system 
design. As for a computerised belief rule-based CDSS, it needs to consist of at least 
four fundamental components, namely user interfaces, database, knowledge base, and 
inference engine. Interfaces are used to acquire inputs, present intermediate or final 
conclusions and provide necessary explanations. Database is used to store and manage 
input information, transformed input values and kinds of reasoned results. Knowledge 
base consists of belief rules extracted from domain knowledge. Inference engine is 
built with the ER aggregation algorithm.  
In the study, the integrated development environment (IDE) available for developing 
the CDSS is Microsoft Visual Studio .NET 2003 (Beres, 2003). With the aid of IDE, 
we can not only design web-based system architecture, but also design and develop 
each system component easily with its visual designers and a range of programming 
languages. Firstly, friendly web-based interfaces can be easily designed and 
developed by ASP.NET technology. Secondly, a database built by different types of 
Data-Base Management Systems (DBMSs) such as Microsoft Access, Microsoft SQL 
Server, Oracle and so on can be easily connected to the core programs developed in 
the IDE through ADO.NET technology. Thirdly in terms of the knowledge base, we 
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can use a unique method to store and manipulate the BRB in a relational database, and 
it can help reduce the complexity of developing a rule compiler. Fourthly the 
inference engine can be implemented by programming with languages such as Visual 
Basic .NET, Visual C++ .NET, Visual C# .NET and so on that are seamlessly 
integrated in the IDE. 
To conclude, it is feasible to employ the RIMER methodology to develop a 
computerised intelligent CDSS. 
4.7. Summary 
This chapter describes how to employ the new belief rule inference methodology -
RIMER for developing a CDSS, together with a comparison study of belief rules and 
traditional rules in reasoning out the clinical risk result of a simulated patient with 
upper GI bleeding. From the comparison study, the following conclusions can be 
drawn. Firstly, a belief rule-based CDSS can handle different uncertainties in both 
clinical domain knowledge and clinical data. Secondly, a belief rule-based CDSS can 
provide a distributed diagnostic recommendation which is more informative than a 
traditional rule-based CDSS that do not take uncertainties into consideration. Thirdly, 
if necessary, a severity score or severity interval can be calculated to rank the 
seriousness of patients’ illness in a belief rule-based CDSS.  In conclusion, it is 
feasible to employ RIMER for developing a computerised intelligent CDSS. The 
design and development of an online intelligent belief rule-based group CDSS is 
presented in the next chapter. 
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Chapter 5  
Design and Development of  
An Online Belief Rule-based Group CDSS Prototype 
 
5.1. Introduction 
The preliminary feasibility study presented in Chapter 4 proves that it is feasible to 
develop a computerised intelligent belief rule-based CDSS. What follows the 
feasibility study is an implementation of an intelligent belief rule-based CDSS. This 
chapter describes the design and development of the belief rule-based CDSS 
prototype.  
A new CDSS framework which integrates automatic knowledge learning functionality 
and online group decision supporting functionality into knowledge-based CDSS has 
been proposed and employed in the prototype design and development. The 
developed CDSS prototype helps to bridge the research gaps in the CDSSs literature 
as described in Chapter 2. Main system features of the prototype CDSS are discussed 
as follows. Firstly, the prototype has two special functions, namely representation of 
uncertain clinical domain knowledge using belief rules, and inference with belief rule 
base (BRB) using the evidential reasoning (ER) approach. The functions enable the 
prototype to handle uncertainties existing in both clinical signs and symptoms, and 
clinical domain knowledge. Secondly, apart from providing individual diagnosis 
support, a group discussion platform and an ER-based group preferences aggregation 
mechanism are developed for supporting group clinical decision making. Thirdly, a 
BRB training module is developed and integrated into the prototype, and it enables 
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the system to automatically update clinical rules in the BRB by learning through 
clinical cases accumulated in clinical practice. Fourthly, the user interfaces 
implemented in the prototype are based on clinical guidelines, and the guideline-based 
information flow can help the system to be integrated in clinical work flow easily, 
while it can also facilitate system users adhering to clinical guidelines. Fifthly, the 
BRB is uniquely structured and stored in a relational database in the prototype. 
Manipulating BRB through a relational database facilitates not only the interaction 
between knowledge base and other core system components, but also the sharing of 
clinical domain knowledge between the prototype CDSS and other clinical application 
systems. 
The methodology used for developing the CDSS prototype is prototyping as discussed 
in Chapter 3. Accordingly, we developed the system in an iterative way. Initially, we 
developed and presented a preliminary prototype CDSS to experts in MRI based on 
our system analysis elicited from first several meetings with expert clinicians in MRI. 
Then we improved the prototype iteratively based on the system users – expert 
clinicians’ feedback of the prototype.  
The system development environment is Visual Studio 2003 .NET (Beres, 2003) on 
platform Windows XP Professional. The programming languages include C#, 
ASP.NET (Liberty and Hurwitz, 2002), and MATLAB 
(http://www.mathworks.com/products/matlab/). The Data-Base Management System 
(DBMS) used for design and development of back-end relational database is SQL 
Server 2000 (Waymire and Sawtell, 2000).  
The chapter is organised as follows. Section 5.2 introduces the system structure, 
where system architecture design and system component design are discussed 
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respectively in Section 5.2.1 and Section 5.2.2. Section 5.3 presents detailed design 
and development of core system components, where inference engine is discussed in 
Section 5.3.1, group decision supporting module in Section 5.3.2, training module in 
Section 5.3.3, web-based user interfaces in Section 5.3.4, database in Section 5.3.5, 
and knowledge base is discussed in Section 5.3.6. Conclusions about the prototype 
system are provided in Section 5.4. Finally Section 5.5 summarises the chapter. 
5.2. System Structure 
5.2.1. Architecture Design 
World Wide Web (WWW) technologies (Berners-Lee et al., 1994) have transformed 
the design, development, implementation and deployment of decision support systems 
(DSSs), and great progress has been made in web-based DSSs in the past decade 
(Bhargava et al., 2007). Taking advantages of web technologies, a web-based DSS 
can link multiple decision makers who might be separated in space or time for online 
group discussion or meeting, and can deliver the suggestions or recommendations 
generated from the system to a much broader audience of decision makers who is 
geographically separated (Bhargava et al., 2007). As to web-based DSSs in clinical 
area, web-based CDSSs have advantages in providing easy accessibility for clinicians 
in geographically different places and easy dissemination of clinical domain 
knowledge and patients’ clinical data among different clinical application systems. In 
the research, through regular meetings with expert clinicians in MRI, we know that 
frontier clinicians have a strong need of an online intelligent CDSS which can help 
them to act in accordance with practice guidelines in their daily clinical work flow. 
Motivated by the above facts, we adopt a web-based three-layer client-server 
architecture (Sommerville, 2007) in the prototype design. 
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In a client-server architecture, an application is modelled as a set of services that are 
provided by servers and used by a set of clients (Orfali and Harkey, 1998). In this 
architecture, clients need to be aware of the servers that are available but usually do 
not know the existence of other clients, and clients and servers are separate processes. 
In design of client-server systems, logical structure of the application that is being 
developed should be reflected in the system architecture (Sommerville, 2007).  
Usually, an application can be structured into three layers: the presentation layer 
which is concerned with presenting information to the user and with all user 
interaction; the application processing layer which is concerned with implementing 
the logic of the application; and the data management layer which is concerned with 
all database operations. Figure 5.1 illustrates these three layers. 
 
Figure 5.1: Application Layers (Sommerville, 2007) 
In the three-layer client-server architecture, the presentation layer, the application 
processing layer and the data management layer are logically separate processes that 
execute on different processors (Sommerville, 2007). Generally, the three-layer client-
server architecture is composed of three logical parts: system user’s own computer 
with a web browser that can display system’s user interfaces is the presentation layer; 
a web server for providing all services related to the application being developed is 
the application processing layer; and a back-end database for providing data 
Presentation Layer
Application Processing Layer
Data Management Layer
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management services is the data layer (Sommerville, 2007). The three-layer 
architecture can be illustrated in Figure 5-2. 
 
Figure 5-2: Three-Layer Architecture 
The prototype CDSS is designed on the basis of the three-layer architecture. In the 
prototype, system users can access the system through web-based user interfaces, 
application logic of the system reside in the middle layer which is usually 
implemented in a web server, and data access technologies such as ADO.NET 
(Hamilton and MacDonald, 2003) can be used by system components located in the 
web server layer to communicate with the data management layer, which is usually 
implemented by a back-end database server directly.  
5.2.2. Component Design 
As for the system components implemented in the three-layer architecture, there 
should be generally at least four system components in a web-based CDSS based on 
the general structure of knowledge-based CDSSs as shown in Figure 2-1 of Chapter 2. 
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They include friendly web-based user interfaces, inference engine, knowledge base, 
and database. Both inputs and outputs of the system can be stored in the database.  
To address the research gaps identified from the CDSS literature discussed in Chapter 
2, the target belief rule-based CDSS should possess at least three capabilities. The first 
one is the capability of representing and reasoning with uncertain clinical domain 
knowledge and clinical data. The second one is the capability of providing group 
decision support. The third one is training or fine-tuning BRB by learning through 
accumulated clinical cases.  
Thus, a new CDSS framework which integrates automatic knowledge learning 
functionality and online group decision supporting functionality into knowledge-
based CDSS is proposed and employed for the prototype design and development. In 
the new knowledge-based CDSS framework, core components of the prototype 
system should include inference engine, group decision supporting module, 
knowledge base training module, database, knowledge base, and web-based user 
interfaces.  
z Inference engine is for matching the system users’ clinical inputs with clinical 
rules in the knowledge base to generate automatic diagnostic recommendations.  
z Group decision supporting module provides two important system functionalities. 
The first one is providing a discussion forum for group clinicians from 
geographically different places to hold online clinical group discussions and offer 
individual diagnosis preferences. The second one is providing an ER based 
diagnosis preferences aggregation mechanism to combine group diagnosis 
preferences.  
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z Knowledge base training module is for training BRB by optimizing the knowledge 
representing parameters of the BRB through accumulated clinical cases.  
z Database is used for storage and retrieval of system’s input data, some 
intermediate data, and system output data.  
z Knowledge base is for maintaining all clinical rules used in the system, and it is 
modelled as BRB in the prototype. Specifically, BRB is uniquely designed to be 
stored and manipulated in the back-end relational database in the prototype.  
z Finally, friendly web-based user interfaces are for acquiring system users’ inputs 
and displaying the system’s outputs. 
The following Figure 5-3 illustrates the actual implementation of the above mentioned 
core system components in the prototype. 
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Figure 5-3: Core System Components Implemented in Three-Layer Web 
Architecture 
The system structure as shown in Figure 5-3 has three characteristics. Firstly, thanks 
to advanced computing technologies, both inference engine and training module can 
be developed independently of system environment or application domain, so that 
they can be portable and adaptable to various application areas and different system 
development or running environments. Secondly, domain specific knowledge 
modelled as BRB is structured and stored in back-end relational database, which is the 
same as or separate from the database used for various system data and patients’ data 
storage. Thanks to mature technologies of today’s relational DBMS in data analysis 
and communication with main systems developed with different programming 
languages, structuring clinical domain BRB in a relational database can facilitate the 
sharing of domain knowledge, and the interactions between the knowledge base and 
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other system components including inference engine, training module, and group 
decision supporting module. Thirdly, the core algorithm of inference engine and 
group decision supporting module is the evidential reasoning (ER) approach, therefore 
the computerised ER model which is implemented in inference engine can be reused 
by the group decision supporting module for group diagnosis preferences aggregation.  
The design and development of above discussed core system components in the 
prototype are presented in the following Section. 
5.3. System Components 
In this Section, we discuss components implemented in web server layer one by one 
first, and then we discuss components implemented in the client layer and back-end 
layer. 
5.3.1. Inference Engine 
The purpose of inference engine in a knowledge-based CDSS is trying to generate a 
reasonable clinical decision or recommendation by matching system’s input data with 
domain specific knowledge modelled in the knowledge base. As such, an inference 
process is an interaction between system’s inputs and the knowledge base, and the 
interaction way is determined by the employed inference algorithm. 
The inference engine in the belief rule-based CDSS prototype is implemented using 
the recursive ER algorithm as described in the RIMER methodology (Yang et al., 
2006). The ER based inference engine is actually a non-linear function between a set 
of parameters and another set of parameters. The former set of parameters include all 
belief rules’ activation weights and consequent belief degrees in one BRB, where rule 
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activation weights are determined by rule weights, antecedent attribute weights, and 
matching degrees between system’s inputs and rules’ antecedents. The latter set of 
parameters are generated by the non-linear function provided by the ER algorithm, 
and they represent final belief degrees associated to all possible consequents in the 
BRB after combining all belief rules activated by the system inputs. The recursive ER 
algorithm implemented in the inference engine can be described by the flowchart in 
Figure 5-4. 
 
Figure 5-4: The Recursive ER Algorithm (Yang et al., 2006) 
Yes
No 
(Go to the next
activated rule) 
Start
Read (1) rules’ activation weights set; and 
(2) updated consequent belief degrees set 
determined by system inputs. 
Calculate (1) belief degrees to the consequent set after combining current
rule and previous activated rules; and (2) remaining degree of belief
unassigned to any consequent after combining current rule and previous
activated rules.  
About the non-linear function used here for aggregating current rule and
previous rules, readers can refer to Appendix B. 
Have all activated rules 
been considered? 
Normalize the final combined belief
degrees to the consequent set.  
End
Calculate (1) belief degrees to the consequent set inferred from the first
activated rule; and (2) remaining degree of belief unassigned to any
consequent inferred from the first activated rule. For the calculation of
these belief degrees, readers can refer to Appendix B. 
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There are two other fundamental sub-components that were developed in parallel in 
the implementation of the inference engine, apart from the core computerised ER 
algorithm as described in Figure 5-4. The first sub-component of the inference engine 
is input transformation sub-component, and the second one is rule matching sub-
component.  
z Input transformation sub-component 
As for the input transformation sub-component, the BRB uses sets of referential 
values to describe antecedent clinical signs and symptoms in its clinical rules, and the 
input clinical data about one clinical sign or symptom is a value in qualitative or 
quantitative or a mixed nature. So there is a demand for transforming the input clinical 
data to sets of referential values with belief degrees so that the transformed data can 
be used by the inference engine to do matching with clinical rules in the BRB. 
Accordingly, the purpose of the input transformation sub-component is to transform 
qualitative or quantitative or mixed clinical inputs to a set of data that can well 
represent uncertainties and can be used by the inference engine to do inference with 
the BRB. The techniques used for the input clinical data transformation are rule-based 
and can be found in Yang (2001). The details of input transformation have been 
described in Section 4.5.2.1 of Chapter 4. 
z Rule matching sub-component 
In terms of the rule matching sub-component, its purpose is to tell the inference 
engine which rules in the BRB are activated and to what degrees by doing matching 
between transformed input clinical data and belief rules in the BRB. As can be seen 
from the ER algorithm outlined in Figure 5-4, if we want to make the core inference 
algorithm portable and sharable for different kinds of domain application with 
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different input data and different BRB, we will need to separate it from calculating 
rules’ activation weights and updated consequent belief degrees, so that it can be 
freely called by the inference engine independent of clinical domain BRB and input 
clinical data. For this purpose, the rule matching sub-component is designed and 
developed to complete the following tasks. Firstly, do matching recognition between 
the transformed system inputs and clinical rules in the BRB. Secondly, calculate 
activation weights for all rules using equation (3-4) and updated consequent belief 
degrees using equation (3-5) as described in Chapter 3 based on system inputs. Finally, 
feed the rule activation weights and updated consequent belief degrees into the core 
inference algorithm. When the computerised inference algorithm get the data from the 
rule matching sub-component, all activated rules will be aggregated by the ER 
algorithm and a combined belief degree set assigned to the consequent set can be 
automatically generated. 
The sub-component structure of the inference engine implemented in the prototype is 
sketched in Figure 5-5, where the core ER algorithm is implemented as dynamic link 
library (DLL) by programming with Visual Basic .NET, and the other two sub-
components are implemented by programming with C#. The input to the inference 
engine is clinical data about a patient, and the output of the inference engine is an 
inferred diagnosis recommendation for the patient based on the input clinical data and 
the embedded BRB in the system. 
 
Figure 5-5: Sub-Component Structure of Inference Engine 
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5.3.2. Group Decision Supporting Module 
The group decision supporting module in the prototype is designed to serve two aims.  
z One is for providing an online discussion forum for group clinicians or 
consultants to offer different diagnosis opinions and shape individual diagnosis 
preferences.  
z The other one is for aggregating all group consultants’ diagnosis preferences via 
ER to arrive at a group combined diagnosis recommendation for target patient.  
Moreover, to facilitate online group consultants’ discussion, both the domain 
knowledge stored inside the system and those Internet-based domain knowledge 
resources are designed to be integrated seamlessly with the group module. Thus the 
group consultation participators can have access to the domain specific clinical rules 
stored in the system together with the Internet-based resources such as 
(http://www.bestbets.org/) which can aid the consultation. Details of the implemented 
group module are presented as follows. 
The way that the group decision supporting module works is similar to the real life 
group consultation in clinical practice. In real life clinical group consultation, there is 
usually a group facilitator who helps to invite other consultants to participate in the 
group consultation and facilitates the whole group discussion process, while the group 
facilitator should have knowledge about all participated group consultants’ expertise 
in advance.  
Therefore we designed two types of system user roles in the prototype system, namely 
group facilitator and consultant, which can login to the group decision supporting 
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module and use the functionalities that the module provides. What follows are 
discussion about the above mentioned two system user roles.  
z Group facilitator role 
The group facilitator role is for initializing and facilitating an online group 
consultation. The system user acting as a group facilitator should inform participated 
consultants of key information about target patient before the group consultation, so 
that a participated consultant can use the key information to identify target 
consultation group. The main user rights assigned to the group facilitator role include:  
(a) inviting group consultants to participate in the group consultation;  
(b) having access to target patient’s data and various domain knowledge resources;  
(c) facilitating the group consultation;  
(d) assigning weights to participated consultants based on their expertise;   
(e) calling the ER-based aggregation mechanism to combine all consultants’ 
diagnosis  preferences.  
z Consultant role 
The consultant role is for participating in a specific group consultation and providing 
individual diagnosis preference for target patient. The main user rights assigned to the 
consultant role include:  
(a) joining the online group consultation about one specific patient;  
(b) having access to target patient’s data and various domain knowledge resources;   
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(c) providing individual diagnosis preference.  
The working flow of each user role acting in an online group consultation supported 
by the group module is illustrated in Figure 5-6.  
 
Figure 5-6: Working Flow in Online Group Clinical Consultation 
The group decision supporting module based on the ER approach has two main 
characteristics. First, the ER based group aggregation mechanism can be implemented 
using the ER DLL that is already developed in the inference engine as discussed in 
Section 5.3.1. Reusing the ER DLL helps to reduce the complexity in developing the 
group module, and the ER based group diagnosis preferences aggregation mechanism 
can be integrated with the discussion forum seamlessly by the DLL technology. 
Secondly, the capability of the group decision supporting module to be linked directly 
to target patient’s data, the BRB, and Internet resources enables group consultants to 
easily access target patient’s data and various domain knowledge in the consultation 
process to shape their diagnosis preferences. 
Login the module as 
Group Facilitator 
Role of Group 
Facilitator 
Initialize and facilitate a 
group consultation 
End the group consultation &  
Call the group aggregation mechanism 
(ER DLL) 
Arrive at a final combined 
diagnosis recommendation
Role of 
Consultant 
Login the module as 
Consultant 
Participate in the target group consultation 
&  
Provide individual diagnosis preference 
 136
The discussion platform implemented in the group module is implemented by 
programming with ASP.NET and C#. The web-based user interfaces of the group 
module can guide system users, who act as different user roles, to different work 
flows in the process of holding an online group consultation and arriving at a final 
aggregated diagnosis recommendation. 
5.3.3. Training Module  
Assuming there is a BRB containing L belief rules, T antecedent attributes, and N 
possible consequents, the parameters of the BRB including rule weights 
( )Lkk ,,1 L=θ , antecedent attribute weights ( )Tii ,,1 L=δ , and consequent belief 
degrees ( )LkNjjk ,,1;,,1 LL ==β  can be originally given by domain experts or 
generated randomly by systems. However, it is difficult to accurately determine rule 
weights, antecedent attribute weights, and consequent belief degrees entirely 
subjectively or randomly (Yang et al., 2007). As such, there is a need to fine-tune or 
train belief rules originally constructed in a belief rule-based system by accumulated 
historical data. The training module implemented in the prototype CDSS serves the 
purpose of training the BRB by learning through accumulated clinical cases. 
The core of the training module is a BRB optimization model. We used MATLAB to 
develop and implement the BRB training model. Assume there are M set of training 
samples, the mechanism of the training model can be described by Figure 5-7. 
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Figure 5-7: Mechanism of BRB Training Model 
As described in Figure 5-7, core tasks of the BRB training model include (a) 
constructing objective function; (b) setting constraints for the training parameters; and 
(c) calling fmincon to search for optimizational parameter set.  
In the training module implementation, the training parameter set and constraints for 
those parameters can be flexibly set by system administrators as required. 
Apart from the core training model developed in MATLAB environment, a parameter 
transferring sub-component is developed and implemented in Visual Studio 
2003 .NET environment. Its functions include: (1) retrieving training data and initial 
values of the training parameter set from the back-end database; (2) feeding the initial 
values of training parameters into the training model; (3) getting the trained 
parameters from the training model; and (4) putting the trained parameters set into the 
back-end database.  
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The implemented sub-component structure of the training module is described in 
Figure 5-8, where the BRB training model is developed and implemented in 
MATLAB and packaged as component object model (COM) that can be integrated 
with the parameter transferring sub-component developed in Visual Studio 2003 .NET 
seamlessly. 
 
Figure 5-8: Sub-Component Structure of Training Module 
The training module is integrated into the prototype CDSS seamlessly and can 
provide batch-mode automatic BRB training. However, before the prototype CDSS 
can be put into clinical use, we need to find out the most suitable training parameter 
set for the training module so that it can bring the most significant performance 
improvement to the system. Thus, in the later system validation discussed in Chapter 
6, we need to compare the performances of the training model with different training 
parameter sets and identify the most suitable training parameter set for the training 
module. 
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5.3.4. User Interfaces 
The component implemented in the prototype which concerns the interaction between 
users and the system is web-based user interfaces.  
As identified by CDSSs researchers Sittig et al. (2008), the human-computer interface 
is one of top challenges in computerised clinical decision support. Human/computer 
interface is the main point of contact between the user and the computer system, 
therefore the interface should unobtrusively, but effectively, remind clinicians of 
things they have truly overlooked and put key pieces of data and knowledge 
seamlessly into the context of the work flow or clinical decision making process, so 
that the right clinical decisions can be made in the first place (Berner and Moss, 2005).  
Clinical guidelines, as a format of clinical domain knowledge, are increasingly used to 
improve the quality of care by supporting clinical decision making in recent years. 
Guideline-based CDSSs have the potential to provide recommendations aimed at each 
specific patient (Peleg et al., 2003), while conventional text-based guideline can only 
present population-based recommendations which are aimed at a population with a 
specific disease. Studies (Grimshaw and Russell, 1993, Johnston et al., 1994, Lobach 
and Hammond, 1994, Tierney et al., 1995) have shown that computer-based CDSSs 
can improve clinicians’ compliance with clinical guidelines and patient outcomes  
when developed to provide patient-specific assistances in decision making and 
integrated with clinical work flow. Development of guideline-based CDSSs has thus 
been proposed as a strategy to promote the implementation of guidelines (Field and 
Lohr, 1992, McDonald and Overhage, 1994). 
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Thus, in the design of user interfaces for the prototype CDSS, we consider two factors. 
Firstly, in terms of interfaces for individual diagnosis, the information flow embedded 
in the user interfaces should be the same as the related clinical guideline that 
clinicians use daily in their practice, so that the CDSS can help clinicians to adhere to 
the guideline. Secondly, the prototype CDSS should have the capability of being 
integrated into the clinical work flow seamlessly, so that a right clinical decision can 
be made in the right place at the right time. By using the prototyping methodology to 
develop the CDSS prototype, we developed and improved the user interfaces 
iteratively based on frontier clinicians’ feedback about the prototype.  
In the following, the information flow of all the user interfaces implemented in the 
system will be discussed, and for illustration, the user interfaces for individual 
diagnosis will be described using diagnosis of upper Gastrointestinal (GI) bleed as an 
example. 
z Information flow of user interfaces 
The information flow of the implemented user interfaces can be sketched in Figure 5-
9 based on the system’s main functionalities, which include individual diagnosis, 
group consultation, and automatic knowledge updating. 
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Figure 5-9: User Interface Information Flow Diagram 
Note that there are different flows in the user interfaces as shown in Figure 5-9 due to 
different functionalities that the system can provide. The system users should specify 
their roles when they login to the system so as to navigate through different 
information flow. The system user roles include: (1) clinician for individual diagnosis; 
(2) clinicians for group consultation including group facilitator and consultant; and (3) 
clinician for updating clinical rules in the BRB. For illustration, user interfaces for 
individual diagnosis are described as follows.  
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Interfaces for individual diagnosis of one disease were designed based on the 
guideline to facilitate system users to adhere to clinical guidelines. Take diagnosis of 
upper GI bleed as an example, main user interfaces for diagnosis and treatment of 
upper GI bleed can be illustrated as in Figure 5-10. 
As can be seen from the interfaces in Figure 5-10, a clinical work flow for diagnosis 
and management of patients with upper GI bleed in ED is provided in the main 
diagnosis interface as shown in Figure 5-10(B) after a clinician logs into the system 
through the login interface as shown in Figure 5-10(A). There are several links in the 
main diagnosis interface linking to different web forms for acquiring different types 
of patients’ data. For example, ‘Please input patient’s personal information here’ in 
the main diagnosis interface is linked to the web form as shown by Figure 5-10(C) for 
acquiring a patient’s personal data. Moreover, the interface can guide the clinician to 
go back to the main diagnosis interface when necessary data has been input. Then the 
clinician can proceed to the next diagnosis or treatment step as indicated by the 
clinical work flow in the main interface. The interface in Figure 5-10(D) is for 
acquiring a patient’s necessary clinical data for risk assessment, and from the interface, 
the inference engine can be triggered automatically to do inference with the input 
clinical data, and then another interface as shown by Figure 5-10(E) for showing the 
inferred result of the patient can be displayed automatically. Note that all these 
interfaces designed for acquiring patients’ data or displaying inferred results have 
‘Back’ links which can guide clinicians back to the main diagnosis interface and to 
proceed to the next step. 
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(A)        (B)        (C) 
 
                                 
(D)          (E) 
Figure 5-10: Main User Interfaces for Individual Diagnosis of Upper GI Bleed 
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About the user interfaces designed for group consultation and knowledge updating in 
the system, readers can refer to a brief user manual in Appendix A. 
Thus far we have presented all core system components implemented in the web 
server layer and client layer. All these components can not work independently from 
data layer, which is used to store and manage patients’ clinical data, system data, and 
clinical domain knowledge used in the prototype CDSS. What follows is a discussion 
about the database and the knowledge base implemented in the back-end relational 
Data-Base Management System (DBMS). 
5.3.5. Database 
Generally, there are three phases to the database development process, namely logical 
design, physical implementation, and application development (Hernandez, 2003).  
Logical design involves determining and defining the structure of the database, which 
includes tables and their fields, primary and foreign keys of tables, table relationships, 
and so on. Physical implementation involves using proper DBMS software to 
implement the database structure we created in logical design phase. Application 
development involves creating an application that allows system users to interact with 
the data stored in the database. 
As the main application programs developed in the prototype CDSS have been 
discussed from Section 5.3.1 to Section 5.3.4, we will briefly describe logical design 
and physical implementation of the database in this Section. 
z Logical design 
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In designing the database, we used the database design method introduced by 
Hernandez (2003). Using the design method, there are seven steps involved in 
designing the database, namely (1) identify purpose of the database; (2) analyze the 
data used in clinical environment, and identify Subjects that the database needs to 
keep track of for supporting clinical decision making and Characteristics of those 
subjects; (3) create the data structures, and this step involves establishing tables based 
on identified subjects and associating each table with fields that represent 
characteristics of the table’s subject; (4) determine table relationships; (5) define rules 
to set constraints to the data stored in the database; (6) establish views to facilitate 
manipulation of data stored in the database; and (7) review data integrity of the 
designed database structure.  
For clarification, here we give a brief discussion of terms used in this Section, and the 
term definition is based on Hernandez (2003). Subjects represent objects such as 
persons, places, or events that occur at a given point in time. Characteristics represent 
details of one subject. Take the subject of patient as an example, the patient’s first 
name, last name, age, gender and so on are characteristics of one patient. Tables are 
the chief structures in a relational database, and each table represents a single, specific 
subject. Fields are the structures that actually store data in the database and a field 
represents a characteristic of the subject represented by the table to which it belongs. 
A relationship exists between two tables if we can in some way associate the records 
of the first table with those of the second. Here a record represents a unique instance 
of the subject of a table. A view is a virtual table composed of fields from one or more 
tables in the database. 
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In the following discussion, we will not show details of the whole logical design 
process, we will however briefly discuss first the purpose of the database, and then the 
subjects together with their characteristics that we identified by analyzing data 
requirement for the prototype CDSS, and finally the tables we created for the database 
according to those identified subjects and characteristics. 
(1) Purpose of the database 
The purpose of back-end database in a CDSS is for the maintenance of various data 
used by or generated from system components reside in the server layer or client layer 
as shown in Figure 5-3. For example, inference engine needs patients’ clinical data 
and clinical rules in the BRB for reasoning about a patient’s clinical risk level or 
disease status, while group decision supporting module needs not only patients’ data, 
but also group consultants’ data to help a group facilitator organise a group 
consultation.    
(2) Identified subjects and characteristics 
To identify subjects and their characteristics that the database need to keep track of, 
we need to analyze the data requirement for the prototype CDSS first.  
As for knowledge modelled as BRB in the system, logical design and physical 
implementation of BRB in a relational database will be discussed in Section 5.3.6. In 
this Section, we focus on discussion about other data used by or generated from the 
system. 
Besides domain knowledge modelled as BRB, other necessary data used by or 
generated from the prototype can be classified into three categories: (a) patients’ data, 
(b) doctors’ data, and (c) data generated from group consultation which includes 
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group discussion content, group consultants’ individual diagnosis preferences, and 
group combined diagnosis suggestion for one patient. 
(i) Subjects and characteristics in patients’ data 
As for a patient’s data stored in the prototype, it should contain (a) the patient’s key 
personal data, (b) the patient’s clinical data including his/her clinical signs or 
symptoms, (c) the clinical guideline used by doctors for his/her diagnosis, and (d) 
system generated diagnosis recommendation about the patient’s disease.  
We first identified “Patient” as one subject, and its characteristics include (1) key 
personal information; (2) clinical data; (3) clinical guideline used for his/her diagnosis; 
and (4) diagnosis recommendation generated by the system or the doctor. We then 
further identified subjects from these characteristics which have their own 
characteristics. Thus we treat characteristics of the subject “Patient” including 
“Clinical sign or symptom”, “Clinical guideline”, and “Diagnosis recommendation” 
as subjects. Furthermore, we take “Severity level” which is a characteristic of 
“Clinical sign or symptom” and “Diagnosis recommendation” as a separated subject. 
Identified subjects and characteristics from patients’ data can be listed as in Table 5-1.   
Table 5-1: Identified Subjects and Characteristics from Patients’ Data  
Subjects  Characteristics  
Patient (1) Key personal information including Medical Record No. 
(MRN), last name, first name, gender, age, etc. 
(2) Clinical data including his/her clinical signs or symptoms
(3) Clinical guideline used for his/her diagnosis 
(4) Diagnosis recommendation generated by the system 
Clinical sign or symptom Name, severity level 
Clinical guideline Name  
Diagnosis 
recommendation 
Name, severity level 
Severity level Name, associated clinical sign/symptom or diagnosis 
recommendation 
 148
(ii) Subjects and characteristics in doctors’ data 
In terms of one doctor’s data stored in the system, firstly, the doctor should be a 
system user of the system with username and password; secondly, the doctor should 
have his/her user role for each login; and thirdly, the doctor should have his/her 
expertise domain stored in the system.  
We first identified “System user” as one subject, and its characteristics include (1) 
user name; (2) password; (3) first name; (4) last name; (5) associated user roles; and 
(6) expertise domains. Since characteristics of “Associated user roles” and “Expertise 
domains” have their own attributes, we then take these two characteristics as separate 
subjects. 
Identified subjects and characteristics from doctors’ data can be listed as in Table 5-2. 
Table 5-2: Identified Subjects and Characteristics from Doctors’ Data 
Subjects  Characteristics 
System user (1) User name 
(2) Password 
(3) First name 
(4) Last name 
(5) Expertise domains 
(6) Associated user roles 
User role  Name, user right 
Doctor expertise (1) Associated doctor 
(2) Expertise name 
(3) Rank order compared to the doctor’s other expertises  
(iii) Subjects and characteristics in data generated from group consultation 
As for data generated from a group consultation, it is mainly include (a) discussion 
content and individual diagnosis preferences provided by group consultants; and (b) 
group combined diagnosis suggestion for the target patient.  
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Identified subjects and characteristics from group consultation data can be listed as in 
Table 5-3, where the subjects of “Group consultant”, “Group discussion content”, 
“Individual diagnosis preference”, and “Combined diagnosis preference” are 
characteristics of subject “Facilitated consultation group”. The characteristic of 
“Belief degree provided by the consultant” associated to the subject “Individual 
diagnosis preference” represents the belief degree assigned by one consultant to 
his/her diagnosis preference. For the role of this belief degree played in the group 
preferences aggregation process, readers can refer to Section 3.2.2 for how to use the 
evidential reasoning (ER) approach to aggregate group diagnosis preferences with 
belief degrees. The characteristic of “Aggregated belief degree” associated to the 
subject “Combined diagnosis preference” represents the belief degree assigned to the 
final diagnosis preference after aggregating all group consultants’ diagnosis 
preferences.   
Table 5-3: Identified Subjects and Characteristics from Group Consultation 
Data 
Subjects  Characteristics 
Facilitated consultation 
group 
(1) Group facilitator 
(2) Group consultants 
(3) Consulted patient 
(4) Group discussion content 
(5) Individual diagnosis preferences provided by group 
consultants 
(6) Aggregated diagnosis preference  
Group consultant Name, weight 
Group discussion content (1) Associated consultation group  
(2) Associated consultant 
(3) Discussion content 
Individual diagnosis 
preference 
(1) Associated consultation group 
(2) Associated consultant 
(3) Diagnosis preference 
(4) Belief degree provided by the associated consultant 
Combined diagnosis 
preference 
(1) Associated consultation group 
(2) Aggregated diagnosis preference 
(3) Aggregated belief degree 
(3) Created tables 
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After identifying subjects and characteristics from data used by or generated form the 
system, we designed tables to represent those identified subjects.  
(i) Tables for patients’ data 
In designing tables to represent subjects in patients’ data, we used table PATIENTS to 
represent subject “Patient” with key personal information, table DIAGNOSISITEMS to 
represent subjects of “Clinical sign or symptom” and “Diagnosis recommendation”, 
table DISEASEDIAGNOSISGUIDELINES to represent subject “Clinical guideline”. To 
make distinction among records of “Clinical sign or symptom” and “Diagnosis 
recommendation” or other types of clinical data, we used table 
DIAGNOSISITEMCATEGORIES to represent categories of clinical data.  
To represent severity level related to one patient’s clinical sign or symptom or 
diagnosis recommendation, we used table DIAGNOSISITEMEVALUATIONGRADES to 
represent severity level which is used to describe clinical signs or symptoms, clinical 
risk or disease. For table linkage, we used table 
PATIENTDISEASEDIAGNOSISGUIDELINES to link tables of PATIENTS and 
DISEASEDIAGNOSISGUIDELINES, and we used table PATIENTDIAGNOSISITEMS to 
link tables of PATIENTS and DIAGNOSISITEMS.  
In a BRB, different severity levels associated to one antecedent clinical sign or 
symptom may be used as a set of referential values for it. Thus to capture matching 
degree of a doctor’s judgement about one patient’s clinical sign or symptom to 
different severity levels associated to the clinical sign or symptom, we used field 
DIAGNOSISITEMBELIEFDEGREE associated to table PATIENTDIAGNOSISITEMS to capture 
these matching degrees. If severity levels are not applicable to one clinical sign or 
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symptom, the field of DIAGNOSISITEMBELIEFDEGREE in table PATIENTDIAGNOSISITEMS 
can be used to capture one doctor’s belief degree in his/her judgement about the 
clinical sign or symptom. 
To represent belief degrees in the system’s recommended clinical diagnosis as 
described in equation (3-6) of Chapter 3, the field of DIAGNOSISITEMBELIEFDEGREE in table 
PATIENTDIAGNOSISITEMS can also be used to capture these belief degrees. 
The created tables together with their fields for representing patients’ data can be 
listed as in Table 5-4.  
Note that due to space restrictions, in the following discussion, we can not show all of 
the fields for a created table, we will however show the fields that are most 
representative of characteristics belonging to the subject that the table represents.   
Table 5-4: Tables for Representing Patients’ Data 
Tables  Fields 
Patients PatientID, PatientFirstName, PatientMiddleName, 
PatientLastName, PatientGender, PatientAge 
DiagnosisItemCategories  DiagnosisItemCategoryName, 
DiagnosisItemCategoryID, 
DiagnosisItemCategoryDescription 
DiagnosisItems DiagnosisItemCategoryID, DiagnosisItemName, 
DiagnosisItemID, DiagnosisItemDescription  
DiagnosisItemEvaluationGrades DiagnosisItemID, 
DiagnosisItemEvaluationGradeName, 
DiagnosisItemEvaluationGradeID, 
DiagnosisItemEvaluationGradeDescription 
DiseaseDiagnosisGuidelines DiseaseDiagnosisGuidelineName, 
DiseaseDiagnosisGuidelineID, 
DiseaseDiagnosisGuidelineDescription 
PatientDiagnosisItems PatientID, DiagnosisItemID, 
PatientDiagnosisItemID, 
DiagnosisItemEvaluationGradeID, 
DiagnosisItemBeliefDegree 
PatientDiseaseDiagnosisGuidelines PatientID, DiseaseDiagnosisGuidelineID, 
PatientDiseaseDiagnosisGuidelineID 
(ii) Tables for doctors’ and group consultation data 
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Based on the identified subjects from doctors’ and group consultation data, we used 
table USERS to represent subject “System users” and “Group consultant”, table ROLES 
to represent subject “User role”, table DOCTOREXPERTISES to represent subject 
“Doctor expertise”, table  FACILITATEDGROUPS to represent subject “Facilitated 
consultation group”, table GROUPDISCUSSIONS to represent subject “Group 
discussion content”, table  GROUPCONSULTANTDIAGNOSES to represent subject 
“Individual diagnosis preference”, and table GROUPFINALDIAGNOSES to represent 
subject “Combined diagnosis preference”. 
Since the characteristic “Weight” of subject “Group consultant” is assigned by a 
group facilitator before he/she calls the group preferences aggregation tool to combine 
all group consultants’ diagnosis preferences, we can not design table USERS with the 
field WEIGHT. However, we used table GROUPCONSULTANTWEIGHTS to represent the 
weights of group consultants in one consultation group, and this table has 
relationships with tables of USERS and FACILITATEDGROUPS.  
For table linkage, we used table USERROLES to link table USERS and ROLES.  
The created tables together with their fields for representing system users’ and group 
consultation data can be listed as in Table 5-5. The field of BELIEFDEGREE associated to 
table GROUPCONSULTANTDIAGNOSES is for representing belief degree in one 
consultant’s judgement about one patient’s clinical status, and the field 
DIAGNOSISITEMBELIEFDEGREE associated to table GROUPFINALDIAGNOSES is for 
representing belief degree in one diagnosis preference after aggregating all group 
consultants’ diagnosis preferences.  
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Table 5-5: Table for Representing Data about System Users and Group 
Consultation 
Tables  Fields 
Users UserID, FirstName, LastName, UserName, 
UserPassword 
Roles  RoleID, RoleDescription  
UserRoles UserID, RoleID 
DoctorExpertises DoctorID(UserID), DiagnosisItemID, ExpertiseOrder 
FacilitatedGroups GroupID, GroupDesc, FacilitatorID(UserID), 
PatientID 
GroupDiscussions GroupDiscussionID, GroupID, 
ConsulatntID(UserID), DiscussionContent 
GroupConsultantDiagnoses GroupID, ConsultantID(UserID), 
DiagnosisItemEvaluationGradeID, BeliefDegree 
GroupFinalDiagnoses GroupID, DiagnosisItemEvaluationGradeID, 
DiagnosisItemBeliefDegree 
GroupConsultantWeights GroupID, ConsultantID(UserID), ConsultantWeight 
 Note that we used different field names for the field of USERID in different tables. For 
example, in table DOCTOREXPERTISES, we used field DOCTORID to represent the 
characteristic of “Associated doctor”, while DOCTORID is actually the field USERID used 
in table USERS for identifying different user records stored in the database. We added 
USERID in parentheses to the field which functions the same but with different name in 
different table as shown in Table 5-5. 
z Physical implementation 
For physical implementation of the designed tables as described above, we choose 
Microsoft SQL Server 2000 as the DBMS software. For illustration, the diagrams 
drawn by SQL Server 2000 for those implemented tables can be shown in Figure 5-11 
and Figure 5-12. 
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Figure 5-11: Diagram of Tables Representing Patients’ Data 
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Figure 5-12: Diagram of Tables Representing System Users and Group 
Consultation Data 
Now the logical design and physical implementation of relational models for various 
data except BRB used in the prototype have been discussed. The following Section 
5.3.6 will present brief logical design and physical implementation of BRB in a 
relational database. 
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5.3.6. Knowledge Base 
The knowledge base constructed in the prototype CDSS is based on belief rules. 
Traditionally, a knowledge base in a rule-based system is constructed separately from 
the back-end database which is used for storing system inputs and outputs. For 
example, some logic programming language such as Prolog (Ivan, 2001) can be 
applied specifically for rule representation and processing in a rule-based system, and 
in such a system, knowledge base is implemented as a part of the main program of the 
system and is separated from the fact data. EXtensible Markup Language (XML) has 
been recently proposed as a carrier for business rule representation, interchange, and 
reasoning in Web-based applications because of its easy readability and platform 
independent attributes (HTTP://RULEML.ORG/). 
However, none of the above existent rule base implementation methods is ideal for 
belief rule-based systems. As to using a specific logic programming language, it will 
add complexity to system development if we use a specific logic programming 
language to represent and manipulate belief rules, because the existent logic 
programming languages can neither well represent belief rules nor provide ER based 
inference for those rules. As to XML technology,  it has advantages in representing 
business rules because XML can provide a declarative format of rules which can be 
read by both rule users and computers, but XML is not a widely used technology for 
rule representation and inference though it has been recommended as a standard for 
data storage for more than one decade. Compared to relational database, firstly, XML 
syntax is too verbose for rule owners to design, and different rule owner may have 
different XML design; secondly, XML-based rules will add complexity to system 
developers to develop an inference engine to process XML-based rules since there is 
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no existent standard XML processor to do XML documents processing for 
applications. Readers can refer to (http://www.w3.org/XML/) for details of XML.   
In the research, we propose to store and manage BRB by relational database. We will 
discuss the knowledge base from perspectives of logical design and physical 
implementation. 
z Logical design  
To design a relational model for a BRB containing L belief rules as described by 
equation (3-2) in Chapter 3, as usual, we analyzed BRB first to identify necessary 
subjects and characteristics that the knowledge base needs to keep track of, and then 
based on the identified subjects and characteristics, we designed table structures. 
(i) Subjects and characteristics identified from BRB 
Based on the description of a belief rule Rk as described by equation (3-2) in Chapter 
3, the relationship between BRB, belief rule, rule antecedent, and rule consequent can 
be illustrated with Figure 5-13. For details of the symbols used in the figure, readers 
can refer to Section 3.2.1 of Chapter 3. 
 
Figure 5-13: Relationship between BRB, Belief Rule, Rule Antecedent, and Rule 
Consequent 
Contains Contains
Contains
Belief rules (with rule weight ( )Lkk ,,1 L=θ )
Rule antecedent  
(with antecedent attribute referential value
& weight ( )LkTi kki ,,1; , ,1 KK ==δ ) 
Rule consequent  
(with consequent attribute referential value 
& belief degree ( )LkNjjk ,,1; , ,1 KK ==β )
BRB (with domain name)
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Usually the knowledge representation parameters in a BRB would change after 
training. The trained set of knowledge representation parameters should be stored in 
the system for domain experts’ check and approval. Furthermore, to keep track of the 
training history, we need to store the trained knowledge representation parameters 
after each training round in the database.  
The subjects and characteristics that can be identified from a BRB and its training are 
shown in Table 5-6, where subjects of “Belief rule” and “Training rounds” are 
characteristics of subject “BRB”, subjects of “Rule antecedent” and “Rule 
consequent” are characteristics of subject “Belief rule”, and subjects of “Trained rule 
weights”, “Trained antecedent weights”, and “Trained belief degrees” are seen as 
characteristics of subject “Training round”.  
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Table 5-6: Identified Subjects and Characteristics from a BRB and Training 
Subjects Characteristics 
BRB (1) Domain name 
(2) Order in the inference process 
(3) Belief rules 
(4) Training rounds 
Belief rule (1) Associated BRB  
(2) Rule number 
(3) Rule weight 
(4) Rule antecedents 
(5) Rule consequents 
Rule antecedent (1) Associated belief rule  
(2) Antecedent attribute referential value 
(3) Attribute weight 
Rule consequent (1) Associated belief rule  
(2) Consequent attribute referential value 
(3) Belief degree 
Training round (1) Associated BRB  
(2) Trained rule weights  
(3) Trained antecedent weights 
(4) Trained consequent belief degrees 
Trained rule weights (1) Associated training round 
(2) Associated rule 
(3) Trained rule weight 
Trained antecedent 
weights 
(1) Associated training round 
(2) Associated BRB 
(3) Associated antecedent 
(4) Trained antecedent weight 
Trained belief degrees (1) Associated training round 
(2) Associated rule 
(3) Associated consequent 
(4) Trained belief degree 
(ii) Created tables 
Based on the identified subjects and characteristics shown in Table 5-6, we designed 
tables as shown in Table 5-7. As the antecedent attribute in one clinical rule is one 
clinical sign or symptom and the consequent attribute in the clinical rule is a disease 
or clinical risk, tables RULEANTECEDENTS and RULECONSEQUENTS are designed to 
have relationships to tables of RULES and DIAGNOSISITEMEVALUATIONGRADES, 
where the table DIAGNOSISITEMEVALUATIONGRADES is for representing severity 
level of one clinical sign or symptom or one disease as discussed in above database 
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design. For the table of RULEBASEANTECEDENTS, it is designed to have relationship 
to tables of RULEBASES and DIAGNOSISITEMS, where table DIAGNOSISITEMS is for 
representing clinical sign or symptom or disease status.  
Table 5-7: Tables for Representing BRB 
Tables Fields 
Rulebases DiseaseDiagnosisGuidelineID, RulebaseID, 
RulebaseDesc, OrderID  
Rules RulebaseID, RuleID, RuleWeight 
RuleAntecedents RuleID, DiagnosisItemEvaluationGradeID  
RuleConsequents RuleID, DiagnosisItemEvaluationGradeID, 
ConsequentBeliefDegree 
RulebaseAntecedents RulebaseID, DiagnosisItemID, 
AntecedentAttributeWeight 
TrainingRounds TrainingRoundID, RulebaseID, TrainingRoundDesc 
TrainedRuleWeights TrainingRoundID, RuleID, TrainedRuleWeight 
TrainedAntecedentWeights TrainingRoundID, RulebaseID, DiagnosisItemID; 
TrainedAntecedentWeight 
TrainedBeliefDegrees TrainingRoundID, RuleID, 
DiagnosisItemEvaluationGradeID, TrainedBeliefDegree
z  Physical implementation  
We use diagram drawn by Microsoft SQL Server 2000 about designed tables for 
representing BRB and its training to illustrate physical implementation, and the 
diagram is shown in Figure 5-14. 
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Figure 5-14: Diagram of Tables for Representing BRB 
Structuring and storing BRB in relational database can meet the needs of a belief rule-
based system. Firstly, it supports dynamics of BRB. The BRB structure is a dynamic 
one which may change after training with accumulated data. By storing BRB and its 
training results in relational database as discussed above, changes of BRB can be 
recorded in the database as well. As a result, the prototype can have a dynamic BRB 
which can change with different training sample. Secondly, based on the mature 
relational database technology, the domain specific knowledge, which is modelled by 
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BRB and stored in relational database, can be freely retrieved, updated, and shared by 
various computerised clinical systems independent of their platform. Thirdly but not 
the least importantly, storing BRB in relational database ease the interaction between 
knowledge base and other core system components thanks to mature database 
technology. 
5.4. Discussions 
The system development is really a time-consuming and demanding process.  During 
prototype development, we have demonstrated developed system regularly to expert 
clinicians in MRI. Based on experts’ prompt feedback, we improved the prototype 
until we obtained the current one which is introduced in this chapter. Experts in MRI 
gave positive judgements about the system, and they have strong interests in applying 
a mature system in their clinical practice. The prototype seems to possess six main 
system features. 
(1) Web-based system architecture enables the system to be accessed online from 
geographically different places, which makes the system have convenient 
accessibility. 
(2) Guideline-based user interface information flow design enables the system to be 
integrated into clinical work flow relatively easily, and the system can help to 
improve clinicians’ compliance with clinical guidelines.  
(3) Modelling domain specific knowledge with BRB and inference with BRB using 
the ER approach enables the system to represent and reason with clinical domain 
knowledge under uncertainties in an informative and accurate way. 
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(4) Group clinical decision supporting module helps the system to provide not only a 
group discussion platform for experts to hold group meetings, discussions or 
consultations, but also a ER-based group aggregation mechanism via which a 
consultant group can arrive at a combined group diagnosis recommendation. 
(5) Updating BRB automatically by learning through accumulated clinical cases 
enables the system to be adaptive to clinical practice, and this functionality helps 
the system to provide evidence-based clinical decision support. 
(6) Structuring and storing BRB in relational database helps to keep the dynamic 
nature of BRB, facilitates the interactions between knowledge base and other 
system components, and makes the sharing of domain knowledge between 
different clinical systems free of technology barriers. 
To conclude, the developed prototype CDSS proves that it is feasible and viable to 
develop a CDSS based on the RIMER methodology, and it helps to bridge the 
research gaps in the CDSS literature as identified in Chapter 2.  
5.5. Summary 
Detailed design, development, and implementation of the belief rule-based CDSS is 
described in this chapter. In the system development, three-layer system architecture 
is employed in system design, and core system components implemented in the 
system include: inference engine, group decision supporting module, knowledge base 
training module, web-based user interfaces, database, and knowledge base, where 
web-based user interfaces reside in the client layer, inference engine, group decision 
supporting module, and knowledge base training module reside in web server layer, 
database and knowledge base are implemented in the back-end layer. We 
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implemented web-based user interfaces using ASP.NET, implemented inference 
engine and group decision supporting module using C#, implemented knowledge base 
training module using MATLAB, and implemented knowledge base and database 
using Microsoft SQL Server 2000. The developed CDSS has the following three main 
system functionalities: (1) representing and reasoning with uncertain clinical domain 
knowledge, (2) offering group clinical decision support, and (3) providing automatic 
clinical belief rules updating. In addition, it has the following system features: firstly, 
its three layer system architecture makes it can be accessed easily through Internet or 
Intranet; secondly, the clinical guideline-based user interfaces can help clinicians 
comply with clinical guidelines; and thirdly, the knowledge base implemented using 
relational database can help dissemination and sharing of clinical domain knowledge 
free of barrier due to mature database technologies. Validation of the developed 
prototype system is discussed in the following chapter. 
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Chapter 6  
Validation of the Online Intelligent CDSS Prototype 
 
6.1. Introduction 
Following the chapter of system design and development, validation of the prototype 
CDSS is discussed in this chapter. The purpose of system validation is to validate two 
key features of the system. One is the capability of handling clinical uncertainties and 
providing reliable diagnosis recommendations. The other one is the system can 
provide better diagnostic performance via learning from accumulated clinical data. 
Thus two core components of the system form the focus of the system validation. One 
is the inference engine, which is responsible for generating diagnosis 
recommendations by matching input clinical data with clinical rules in the knowledge 
base. The other is the training module, which is responsible for training or fine-tuning 
the knowledge base by learning from accumulated clinical data.  
For the validation design, we choose CCP as the target clinical area, and the main 
purpose of the system is set as to aid doctors in ED to assess clinical risks of patients 
with CCP. Ideally, in the CDSS validation, we should use real patients’ clinical data 
to train BRB and to test the system’s diagnostic performance. However, we failed to 
get the ethical approval of using such data due to the strict data protection regulations 
in the UK, although our research collaborators in MRI have indeed managed to collect 
two sets of patients’ data in CCP. Instead, we used a simulated dataset of 1000 
patients with CCP to validate the developed prototype. The made-up dataset is 
provided by Dr Richard Body in MRI. All the variables in the dataset including 
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clinical signs and symptoms and clinical risk status have similar positive response 
rates to reality.  
Initial ‘IF-THEN’ clinical rules for risk assessment of CCP are provided by our 
research collaborators in MRI, and the rules are their recent research outcome (Body, 
2009). Based on the initial rules, we constructed belief rule base (BRB) for system 
validation. In inference engine validation, we compared the diagnostic performance of 
the system with a doctor’s in assessing clinical risks of those 1000 patients. In training 
module validation, we split the simulated data into two sets: one set for training the 
system, and the other set for testing the trained system’s diagnostic performance, and 
to avoid a trained system to overfit the training data, we tried five rounds of BRB 
training with different sets of training parameters to seek a set of training parameters 
that is most suitable for the clinical data.  
Three conclusions can be drawn from the system validation study. Firstly, the system 
built with belief rule-based inference methodology can well handle clinical 
uncertainties and can provide reliable diagnosis recommendations. Secondly, the 
system’s diagnostic performance can be improved after BRB training, and the most 
suitable training parameters for the BRB training model contains antecedent attribute 
weights and belief degrees. 
We used receiver operating characteristics (ROC) curve (Metz, 1978, Park et al., 2004) 
which will be discussed in Section 6.4 to analyze the diagnostic performance of the 
system before and after each BRB training in the validation, and all ROC curves were 
plotted by SPSS v 17.0 software (http://www.spss.com/). We used StAR (Vergara et 
al., 2008, http://protein.bio.puc.cl/cardex/servers/roc/home.php), which is a specific 
software developed for statistical analysis of ROC curves, to compare the area under 
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the curve (AUC) of different ROC curves. For details of using AUC to compare ROC 
curves, readers can refer to (DeLong et al., 1988, Mei-Ling Ting and Bernard, 2001). 
For application of ROC curve analysis in diagnostic tests, readers can refer to (Body, 
2009). 
This chapter is structured as follows. Domain BRB employed for the validation is 
described in Section 6.2. Simulated dataset used in the validation is discussed in 
Section 6.3. A brief introduction to the ROC curve analysis is provided in Section 6.4. 
Inference engine validation and training module validation are presented in Section 
6.5 and Section 6.6 respectively. Finally, conclusions of the chapter are summarised 
in Section 6.7.   
6.2. Domain Knowledge Base 
CCP is probably the most frequent serious presentation to ED in the UK. At MRI, 
some 3% of new attendances are covered by the label of CCP (Central Manchester 
and Manchester Children's University Hospitals NHS Trust, 2003a). Possible CCP 
can be viewed as a continuum, ranging from total global acute myocardial infarction 
(AMI) to simple short lived angina. Within this spectrum lie the acute coronary 
syndromes with critical cardiac ischaemia and minimal myocardial damage 
(Mackway-Jones, 2001). 
In all these disorders, the risk of death is highest before admission to hospital, with 
mortality rates of up to 20% (Junghans and Timmis, 2006). Risk remains high after 
admission to hospital, and although mortality rates have fallen greatly in recent years, 
up to 7% of patients die before discharge, and risk continues to be high for six months 
after the ischaemic event (Carruthers et al., 2005).  
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To minimise the risk of patients with CCP, it is crucial for clinicians in ED to identify 
patients at high risk early on and treating them with appropriate level of care and 
medical therapy (Junghans and Timmis, 2006).  
Motivated by the above consideration, we chose CCP as target clinical area for system 
validation, and the purpose of the system was set to provide support for assessing 
clinical risks of patients with CCP. One of our collaborators, Dr. Richard Body in 
MRI, has spent years in investigating more accurate and advanced rules for 
identifying clinical risk of CCP. A set of advanced clinical risk assessment rules as 
shown in Figure 6-1 are taken from his research (Body, 2009), and the knowledge 
base constructed for system validation is based on these rules.  In Figure 6-1, STEMI 
stands for ‘ST segment Elevation Myocardial Infarction’, ECG stands for 
‘electrocardiography’, and EVaMACS represents ‘Early Vascular Markers of Acute 
Coronary Syndromes’ and its score can be calculated from results of different clinical 
tests including Heart type Fatty Acid Binding Protein (H-FABP), Troponin I (TnI), 
and ECG as displayed at the left bottom of Figure 6-1. 
If we use traditional ‘IF-THEN’ format to represent those rules shown in Figure 6-1, 
seven ‘IF-THEN’ rules shown in Table 6-1 can be transformed from Figure 6-1.   
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Figure 6-1: Rules for Assessing Clinical Risk of CCP  (Body, 2009) 
Table 6-1: Traditional ‘IF-THEN’ Rules Transformed from Figure 6-1 
No. Antecedent Consequent 
1 IF ECG shows STEMI THEN Very High Risk 
2 IF ECG shows no STEMI, AND EVaMACS Score is >2THEN Very High Risk 
3 IF ECG shows no STEMI, AND EVaMACS Score is 
between 1 and 2 
THEN  High Risk 
4 IF ECG shows no STEMI, AND EVaMACS Score 
equals 0, AND the patient has Worsening angina or 
diabetes 
THEN High Risk 
5 IF ECG shows no STEMI, AND EVaMACS Score 
equals 0, AND the patient has no Worsening angina or 
diabetes, AND the patient is smoking 
THEN Low Risk 
6 IF ECG shows no STEMI, AND EVaMACS Score 
equals 0, AND the patient has no Worsening angina or 
diabetes, AND the patient is not smoking, AND the 
patient’s sex is Male and the patient ages >=40 years 
THEN Low Risk 
7 IF ECG shows no STEMI, AND EVaMACS Score 
equals 0, AND the patient has no Worsening angina or 
diabetes, AND the patient is not smoking, AND the 
patient’s sex is Female or the patient ages <40 years 
THEN No Risk 
1-2 
>2 
No STEMI 
STEMI 
No
ECG 
EVaMACS 
Score 
0 Worsening angina
OR diabetes? No 
Smoker? 
No 
Male sex 
AND age>=40 
years? 
Very High Risk High Risk Low Risk No Risk
Yes
Yes
Yes
The EVaMACS score: 
H-FABP>58ng/ml  =2 
TnI>0.055ng/ml  =1 
Acute ischaemic ECG features =2 
 
Score>2 – Very high risk 
Score 1-2 – High risk 
Score 0 – Proceed to next question 
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From rules as shown in Figure 6-1 and Table 6-1, we can find that ECG status, 
EVaMACS score, having worsening angina/diabetes or not, smoking status, sex and 
age all are factors that can affect clinical risk level of a patient with CCP. According 
to these rules, doctors would stop asking further questions or prescribing more tests 
for a patient if they think they have obtained enough clinical evidence and can make a 
final decision about the patient’s risk status. For example, doctors in ED would judge 
a CCP patient to be at ‘Very High’ clinical risk if the patient’s ECG shows STEMI, 
and the doctor would not consider other factors such as EVaMACS score, smoking 
status, or diabetes status. However, in clinical practice, a careful doctor usually would 
like to seek all possible clinical data to make conclusion about a patient’s risk status 
due to inescapable uncertainties in clinical decision making.  
Specifically, uncertainties occurring in the process of risk assessment of CCP may 
arise from the following sources. Firstly, doctors may have incomplete or vague 
knowledge in shaping clinical rules for risk assessment. For example, based on 
clinical experience, some doctors may provide such a rule as “IF a patient’s ECG is 
strongly suggestive of STEMI, THEN the patient has a high probability of ‘Very High’ 
risk”. Here, ‘strongly suggestive’ is not a clear cut description of doctors’ judgements 
about one patient’s ECG. Secondly, doctors may not be 100% sure of their 
judgements about patients’ clinical symptoms or clinical tests. For example, doctors 
sometimes can not be 100% sure if a patient’s ECG is consistent with STEMI, and 
they may use “maybe” to describe their judgement about the patient’s ECG status. 
Taking these clinical uncertainties into consideration, we choose to use BRB to model 
clinical domain knowledge.  
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In our research, doctors did not provide us rules with uncertainties. Traditional rules 
as described in Table 6-1 for assessing clinical risk of CCP without uncertainty are 
what we have for system validation. We then extended the initial seven traditional 
‘IF-THEN’ rules using a belief structure, and accordingly, a set of 48 belief rules can 
be created as in Table 6-2, where A1, A2, A3, A4 and A5 represent ‘ECG status’, 
‘EvaMACS Score’, ‘worsening angina or diabetes’, ‘smoking’, and ‘male sex and age 
larger than 40’ respectively. Validation of inference engine and training module of 
the system is based on this BRB. 
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Table 6-2: BRB for Assessing Clinical Risk of CCP 
Antecedent Consequent No. 
A1 A2 A3 A4 A5 Clinical Risk 
1 STEMI >2 Yes Yes Yes {(Very High, 1),(High 0),(Low, 0),(No, 0)}
2 STEMI >2 Yes Yes No {(Very High, 1),(High 0),(Low, 0),(No, 0)}
3 STEMI >2 Yes No Yes {(Very High, 1),(High 0),(Low, 0),(No, 0)}
4 STEMI >2 Yes No No {(Very High, 1),(High 0),(Low, 0),(No, 0)}
5 STEMI >2 No Yes Yes {(Very High, 1),(High 0),(Low, 0),(No, 0)}
6 STEMI >2 No Yes No {(Very High, 1),(High 0),(Low, 0),(No, 0)}
7 STEMI >2 No No Yes {(Very High, 1),(High 0),(Low, 0),(No, 0)}
8 STEMI >2 No No No {(Very High, 1),(High 0),(Low, 0),(No, 0)}
9 STEMI [1 2] Yes Yes Yes {(Very High, 1),(High 0),(Low, 0),(No, 0)}
10 STEMI [1 2] Yes Yes No {(Very High, 1),(High 0),(Low, 0),(No, 0)}
11 STEMI [1 2] Yes No Yes {(Very High, 1),(High 0),(Low, 0),(No, 0)}
12 STEMI [1 2] Yes No No {(Very High, 1),(High 0),(Low, 0),(No, 0)}
13 STEMI [1 2] No Yes Yes {(Very High, 1),(High 0),(Low, 0),(No, 0)}
14 STEMI [1 2] No Yes No {(Very High, 1),(High 0),(Low, 0),(No, 0)}
15 STEMI [1 2] No No Yes {(Very High, 1),(High 0),(Low, 0),(No, 0)}
16 STEMI [1 2] No No No {(Very High, 1),(High 0),(Low, 0),(No, 0)}
17 STEMI 0 Yes Yes Yes {(Very High, 1),(High 0),(Low, 0),(No, 0)}
18 STEMI 0 Yes Yes No {(Very High, 1),(High 0),(Low, 0),(No, 0)}
19 STEMI 0 Yes No Yes {(Very High, 1),(High 0),(Low, 0),(No, 0)}
20 STEMI 0 Yes No No {(Very High, 1),(High 0),(Low, 0),(No, 0)}
21 STEMI 0 No Yes Yes {(Very High, 1),(High 0),(Low, 0),(No, 0)}
22 STEMI 0 No Yes No {(Very High, 1),(High 0),(Low, 0),(No, 0)}
23 STEMI 0 No No Yes {(Very High, 1),(High 0),(Low, 0),(No, 0)}
24 STEMI 0 No No No {(Very High, 1),(High 0),(Low, 0),(No, 0)}
25 No >2 Yes Yes Yes {(Very High, 1),(High 0),(Low, 0),(No, 0)}
26 No >2 Yes Yes No {(Very High, 1),(High 0),(Low, 0),(No, 0)}
27 No >2 Yes No Yes {(Very High, 1),(High 0),(Low, 0),(No, 0)}
28 No >2 Yes No No {(Very High, 1),(High 0),(Low, 0),(No, 0)}
29 No >2 No Yes Yes {(Very High, 1),(High 0),(Low, 0),(No, 0)}
30 No >2 No Yes No {(Very High, 1),(High 0),(Low, 0),(No, 0)}
31 No >2 No No Yes {(Very High, 1),(High 0),(Low, 0),(No, 0)}
32 No >2 No No No {(Very High, 1),(High 0),(Low, 0),(No, 0)}
33 No [1 2] Yes Yes Yes {(Very High, 0),(High 1),(Low, 0),(No, 0)}
34 No [1 2] Yes Yes No {(Very High, 0),(High 1),(Low, 0),(No, 0)}
35 No [1 2] Yes No Yes {(Very High, 0),(High 1),(Low, 0),(No, 0)}
36 No [1 2] Yes No No {(Very High, 0),(High 1),(Low, 0),(No, 0)}
37 No [1 2] No Yes Yes {(Very High, 0),(High 1),(Low, 0),(No, 0)}
38 No [1 2] No Yes No {(Very High, 0),(High 1),(Low, 0),(No, 0)}
39 No [1 2] No No Yes {(Very High, 0),(High 1),(Low, 0),(No, 0)}
40 No [1 2] No No No {(Very High, 0),(High 1),(Low, 0),(No, 0)}
41 No 0 Yes Yes Yes {(Very High, 0),(High 1),(Low, 0),(No, 0)}
42 No 0 Yes Yes No {(Very High, 0),(High 1),(Low, 0),(No, 0)}
43 No 0 Yes No Yes {(Very High, 0),(High 1),(Low, 0),(No, 0)}
44 No 0 Yes No No {(Very High, 0),(High 1),(Low, 0),(No, 0)}
45 No 0 No Yes Yes {(Very High, 0),(High 0),(Low, 1),(No, 0)}
46 No 0 No Yes No {(Very High, 0),(High 0),(Low, 1),(No, 0)}
47 No 0 No No Yes {(Very High, 0),(High 0),(Low, 1),(No, 0)}
48 No 0 No No No {(Very High, 0),(High 0),(Low, 0),(No, 1)}
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6.3. Simulated Dataset 
The simulated dataset used for system validation is provided by our research 
collaborator, Dr Richard Body, working in MRI. In the dataset, independent variables, 
which contribute to clinical risk status of patients with CCP, include clinical signs or 
symptoms, demographics, and clinical test results of simulated patients, namely 
‘ECG’, ‘Worsening_Angina’, ‘Diabetes’, ‘Smoking’, ‘Sex’, ‘Age’, and 
‘EvaMACS_Score’. Dependent variable in the dataset is ‘Outcome’ which is used for 
recording the outcome of the simulated patients. Here, the outcome was the composite 
of AMI or the occurrence of adverse events within six months, where adverse events 
were defined as death (all-cause), AMI or the need for urgent coronary 
revascularisation (Body, 2009). 
In the dataset, two numerical values including 1 and 0 are used to record outcome of 
simulated patients, where 1 represents that the patient had AMI or he/she died, had 
AMI or needed urgent coronary revascularisation within six months, and 0 represents 
that the patient had no real clinical risk. As for the values used to record ‘ECG’, 
subjective judgements including ‘definitely yes’, ‘strongly suggestive’, ‘maybe’, ‘a 
little like’, and ‘absolutely no’ are used to simulate patients’ ECG status which is 
diagnosed as with STEMI under uncertainties, and in the dataset, Dr Richard Body 
has transformed these subjective judgements into degrees of belief in STEMI. 
Specifically, for variable ‘ECG’, 1 represents ‘definitely yes with STEMI’, 0.8 
represents ‘strongly suggestive of STEMI’, 0.5 represents ‘maybe STEMI’, 0.2 
represents ‘a little like STEMI’, and 0 represents ‘absolutely no STEMI’. For other 
variables including ‘Worsening_Angina’, ‘Diabetes’, and ‘Smoking’, value of 1 
represents ‘yes’ while value of 0 represents ‘no’. For variable ‘Sex’, 1 represents male 
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and 0 represents female. Table 6-3 displays five example patients’ data extracted from 
the simulated dataset. 
Table 6-3: Example Patients’ Data in the Simulated Dataset 
No. Outcome ECG 
Worsening 
Angina 
Diabetes Smoking Sex Age 
EVaMACS
_Score 
1 0 0.2 0 0 0 0 87 0 
2 1 1.0 0 0 0 0 81 1 
3 1 0.8 0 0 1 0 80 1 
4 0 0.0 0 0 0 0 39 0 
5 1 0.5 1 0 0 1 61 1 
The dataset has two features that are important for the research. Firstly, the dataset is 
close to reality. All of the variables including clinical signs or symptoms, 
demographics, clinical test results and outcome in the dataset have similar positive 
response rates to reality. For example, in clinical practice, around 20% of patients 
with CCP attended in ED are with STEMI, and among them, some are definitely with 
STEMI, some are strongly suggestive of STEMI, while some others show a little sign 
of STEMI. The probabilities of the various STEMI situations are reflected in the 
simulated data. Secondly, the dataset reflects uncertainties in clinical decision making. 
In the simulated dataset, doctors’ judgement of a patient’s ECG can be ‘definitely yes 
with STEMI’, ‘strongly suggestive of STEMI’, ‘maybe STEMI’, ‘a little like STEMI’, 
and ‘absolutely no STEMI’.  
Note that there are some conflicting cases in the dataset.  For example, for the Rule 13 
in the BRB as described in Table 6-2, if one patient’s clinical data match this rule’s 
conditions, the patient should be at ‘Very High’ clinical risk. While in the simulated 
dataset, there are 35 cases that are consistent with the rule, however there are two 
other cases having no real clinical risk in spite that their ECGs show ‘strongly 
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suggestive’ of STEMI and their other clinical data exactly match other conditions of 
the rule. The latter 2 cases conflict with the former 35 cases. 
To enforce our confidence of using the simulated dataset for the system validation, we 
presented all conflicting data to two more sophisticated expert clinicians in CCP in 
MRI to seek their advice for handling these conflicting cases in the system validation. 
Based on their knowledge and clinical experience, the two experts believed that this 
type of medical errors could happen everyday due to uncertainties, and they suggested 
us including all conflicting data in the validation. Thus we tried to include all 
conflicted cases in the simulated dataset for both the inference engine and the training 
module validation. 
6.4. Brief Introduction to Receiver Operating Characteristic 
(ROC) Curve Analysis  
In the prototype validation, a necessary procedure is to compare the diagnostic 
performance of the system with a doctor’s. Moreover, to validate the implemented 
training module as described in Section 5.3.3 of Chapter 5, we need to compare the 
diagnostic performance of the system before and after BRB training. As such, a 
question would arise as how to evaluate the diagnostic performance of different tests.  
Usually, in diagnostic research, there are several ways for evaluating performance or 
accuracy of a diagnostic test such as overall diagnostic accuracy, diagnostic odds 
ratios, and ROC curve (Body, 2009), where the overall diagnostic accuracy and 
diagnostic odds have their drawbacks and will be briefly discussed together with ROC 
curve in Section 6.4.1. As identified by Body (2009), the ROC curve has its advantage 
in demonstrating diagnostic performances as it can be used to summarise the accuracy 
 176
of an investigation with a single number by calculating the area under the curve 
(AUC). In the literature, the ROC curve has been widely used in evaluating the 
performance of diagnostic tests or some other classifiers, and the AUC has also been 
widely used for comparing performance of different diagnostic tests and machine 
learning algorithms (Metz, 1978) (Body, 2009) (Bradley, 1997, Jin and Ling, 2005). 
Taking the above into consideration, we opted to use the ROC curve to measure 
diagnostic performance of all tests in the validation.  
In this Section, a brief introduction to the ROC curve and the AUC is presented in 
Section 6.4.1 and Section 6.4.2 respectively, followed by a brief discussion about 
comparison of the AUC for different ROC curves in Section 6.4.3.  
6.4.1. ROC Curve 
Before introducing the ROC curve, we will briefly discuss some other measures for 
evaluating diagnostic performance of a test first. In measuring a diagnostic test, a 
decision matrix as described in Table 6-4 can be created to evaluate the diagnostic 
performance of the test, where Positive means having a specific disease while 
Negative means having no the disease.  
Table 6-4: Decision Matrix for a Diagnostic Test (Body, 2009) 
True Condition Status  
Test Result Positive (+) number Negative (-) number 
 
Total 
Positive (+) 
True Positive 
(TP) a 
False Positive 
(FP) b a + b 
Negative (-) False Negative 
(FN) c 
True Negative 
(TN) d c + d 
Total a + c b + d  
The overall diagnostic accuracy of the diagnostic test is determined as the proportion 
of cases in which the results of the diagnostic test and the reality are the same: 
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The diagnostic odds ratio is defined as the odds of a positive test result in patients 
with disease, relative to the odds of a positive test result in patients without disease: 
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Both of above described measures have their disadvantages in evaluating diagnostic 
performance of a test. For example, if the prevalence of disease in the test population 
is very low, any investigation that returns predominantly negative results will tend to 
have a high overall diagnostic accuracy. For details, readers can refer to (Body, 2009). 
A better way to assess the diagnostic test performance is to use sensitivity or True 
Positive Rate (TPR), and specificity or True Negative Rate (TNR) (Body, 2009). 
Sensitivity is determined by the proportions of patients with the disease who were 
correctly identified by the diagnostic test. Specificity is determined by the proportion 
of negatives which are correctly identified. These statistics can be calculated as 
follows: 
db
dySpecificit
ca
aySensitivit
+=
+=
  
  
 
The sensitivity and specificity of a diagnostic test can tell us about the ability of the 
test to discriminate between healthy and diseased patients.  Moreover, these values are 
independent of the disease prevalence.  
When the results of a diagnostic test fall into two obviously defined categories, such 
as either the presence or absence of a disease, then the test has only a pair of 
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sensitivity and specificity values using the sensitivity and specificity calculations as 
discussed above. However, in many diagnostic situations, making a decision in a 
binary mode is both difficult and impractical. For example, Some diagnostic test 
results may be ordinal (for example a risk score with possible values being whole 
numbers ranging from 0 to 5) or continuous (for example a blood test, where possible 
values can be anything within the detectable range of the instruments, including 
decimals).  In order to calculate sensitivity and specificity for ordinal and continuous 
data, the values must first be dichotomised.  To do this we must select an appropriate 
threshold value as a diagnostic cut-off.  Values above this cut-off would be considered 
‘positive’ and values below it considered ‘negative’.  As a result, a single pair of 
sensitivity and specificity values is insufficient to describe the full range of diagnostic 
performance of a test  (Metz, 1978). In such situations, the ROC curve can be used for 
evaluation of the diagnostic performance of an investigation (Body, 2009). Details of 
the ROC curve are briefly discussed as follows. 
The ROC curve, which is defined as a plot of test sensitivity or TPR as the y 
coordinate versus its 1-specificity or false positive rate (FPR), which is determined by 
the proportion of negatives which are wrongly identified, as the x coordinate, is an 
effective method of evaluating the performance of diagnostic tests which have ordinal 
or continuous results (Body, 2009). Each point on the graph represents a pair of 
sensitivity and 1-specificity based on a different diagnostic cut-off value.  
Take a fictional diagnostic test for example, there are 20 patients involved in the test. 
These patients have different clinical risk status in reality and they have been judged 
by doctors with different risk scores ranging from 1 to 5. The detailed data are 
presented in Table 6-5, where value 1 in Real Status column means that the patient is 
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at high clinical risk, while 0 means no clinical risk. To measure the performance of 
the fictional diagnostic test, a ROC curve as represented by blue line in Figure 6-2 can 
be generated by SPSS, and all cut-off values used to shape the curve by SPSS is 
shown in Table 6-6 which is cut from SPSS, where pairs of specificity and 1-
specificity values which correspond to each cut-off value are displayed as well. Take 
the cut-off value of 2.5 for example, based on this cut-off, the calculated sensitivity of 
the fictional diagnostic test is 0.9167, and 1-specificity of the test is 0.1250.  
Table 6-5: A Fictional Diagnostic Test Data  
No. Risk Score Real Status No. Risk Score Real Status 
1 1 0 11 1 0 
2 2 0 12 2 0 
3 3 1 13 3 0 
4 4 1 14 4 1 
5 5 1 15 5 1 
6 1 0 16 1 0 
7 2 1 17 2 0 
8 3 1 18 3 1 
9 4 1 19 4 1 
10 5 1 20 5 1 
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Figure 6-2: ROC Curve Demonstrating the Performance of a Fictional 
Diagnostic Test 
Table 6-6:  Coordinates of the Curve (Cut from SPSS)  
Diagnostic Cut-off Sensitivity 1-Specificity 
0.0000 1.0000 1.0000 
1.5000 1.0000 0.5000 
2.5000 0.9167 0.1250 
3.5000 0.6667 0.0000 
4.5000 0.3333 0.0000 
6.0000 0.0000 0.0000 
A perfect diagnostic test would have 100% sensitivity and specificity and the ROC 
curve would therefore intersect the top left hand corner of the graph.  If a diagnostic 
test has no ability to differentiate between healthy and diseased patients, the ROC 
curve will take the form of a straight line intersecting the bottom left and top right 
diagonals  which is called ‘chance diagonal’, and it is represented by the green line in 
Figure 6-2. 
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6.4.2. Area under the Curve (AUC): a Measure of Overall 
Diagnostic Performance 
An advantage of the ROC curve is that it can be used to summarise the accuracy of a 
diagnostic test with a single number by calculating the size of the area under the curve 
(AUC) (Body, 2009). The AUC can take any value between 0 and 1, since both the x 
and y axes have values ranging from 0 to 1 and size of the square between (0, 0) and 
(1, 1) is 1. The closer AUC is to 1, the better the overall diagnostic performance of the 
test. A test with an AUC value of 1 is one that is perfectly accurate, while a test with 
an AUC value of 0 is one that is perfectly inaccurate. The practical lower limit for the 
AUC of a diagnostic test is 0.5. Because if we were to rely on pure chance to 
distinguish those subjects with a particular disease against those without a particular 
disease, the resulting ROC curve would fall along this diagonal line, which is referred 
to as the chance diagonal as shown in Figure 6-2, and the line segment from (0, 0) to 
(1, 1) has an area with size of 0.5. 
In the fictional example of clinical risk assessment as discussed in Section 6.4.1, the 
AUC is estimated to be 0.9583 by SPSS, which suggests that the diagnostic 
performance of the fictional test is very good as the AUC is very close to 1.   
Note that a ROC curve and its AUC can be generated by different methods, namely 
parametric and non-parametric approaches. If we use parametric to estimate a ROC 
curve or the AUC, we need to make assumption about the distribution of the 
diagnostic test’s results, and very often bi-normal distribution is assumed (Skalska 
and Freylich, 2006). While we do not have to do any assumption about the test results 
if we use non-parametric approach to plot ROC curve or estimate the AUC. In the 
research, we chose non-parametric approach to do ROC analysis, and the ROC 
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analysis conducted in this thesis is also based on non-parametric approach. For details 
of parametric and non-parametric approaches for conducting ROC analysis, readers 
can refer to (Metz, 1978, Hanley, 1988, Zou et al., 1997, DeLong et al., 1988, Mei-
Ling Ting and Bernard, 2001). 
6.4.3. Comparing the AUC: Comparing Overall Diagnostic 
Performance 
The overall diagnostic performance of different tests can be compared by comparing 
AUC of different ROC curves, as AUC is a measure of the overall performance of a 
diagnostic test. The bigger its AUC is, the better the overall performance of the 
diagnostic test will have. For example, we can easily find that diagnostic test B0 has 
better performance than A0 from Figure 6-3, as the AUC in test A0 is 0.9583 and the 
AUC in test B0 is 0.9844. 
 
Figure 6-3: Two ROC Curves with Different Values of the AUC (A0-0.9583; B0-
0.9844) 
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Furthermore, to test the statistical significance of the difference between the areas 
under different ROC curves, some specific software have been developed by 
researchers for AUC comparison. Frequently mentioned software for AUC 
comparison in the literature include MedCalc (http://www.medcalc.be/), ROCKIT 
(http://www-radiology.uchicago.edu/krl/KRL_ROC/software_index6.htm), and StAR 
(http://protein.bio.puc.cl/cardex/servers/roc/home.php). In the research, we chose 
StAR to do AUC comparison as StAR is online software which can be accessed freely 
and can meet our requirements for comparison of paired data. StAR is designed for 
the ROC analysis of paired data and the core of the software is a non-parametric test 
for the difference of the AUC that accounts for the correlation of the ROC curves. 
Here, paired data are data generated from those diagnostic tests in which each case in 
the studied sample has been tested (Metz et al., 1998). 
Generally, we call the difference between the diagnostic performances of two tests 
that are summarized by AUC statistically significant if there is enough evidence 
showing that the difference does not occur by chance. When we use statistical 
software to compare two groups of paired data, we can get a p-value from the 
comparison, where p-value is a measure of probability that a difference between two 
groups of data happened by chance. In statistics, the highest acceptable p-value, at 
which we can still say that a difference between two groups does not happen by 
chance, is called significance level or α level (Aczel and Sounderpandian, 2005, 
Wright, 1997). The difference between two groups of data can be described as 
statistically significant when a p-value is less than the set significance level, and as 
non-significant when a p-value is above the significance level. Conventionally, 
significance level is set to be 0.05 (Wright, 1997). The lower the p-value, the more 
likely it is that the difference between groups of data does not occur by chance. 
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In the following discussion, we will use p-values generated by StAR in comparing 
AUC of ROC curves to measure the statistical significance of differences between 
different diagnostic performances. 
6.5. Inference Engine Validation 
6.5.1. Method 
Validation of the inference engine was basically composed of three main steps. The 
first one was to produce a doctor’s assessment for risks of the simulated 1000 patients 
and to calculate the doctor’s overall diagnostic performance. To facilitate the process 
of acquiring the doctor’s assessment for those 1000 patients’ clinical risk status, we 
produced risk assessment results for the 1000 patients first based on the initial rules as 
shown in Figure 6-1, and then we invited one of our collaborators in MRI to verify the 
judgements. The second step included using the simulated patients’ clinical data as 
inputs to the system and triggering the system to assess clinical risk of the patients, 
and then calculating the system’s overall diagnostic performance. The third step was 
to compare the system’s diagnostic performance with the doctor’s and draw 
conclusions about the reliability of the prototype system. The ROC analysis as 
discussed in Section 6.4 was used to analyze the diagnostic performances of the 
system and the doctor. 
As noted in Section 6.4.1, the ROC curve analysis can effectively measure 
performances of diagnostic tests having ordinal or continuous results. While in our 
research, according to the evidential reasoning (ER) approach and the BRB described 
in Table 6-2, the system’s inferred result for each patient should be a belief 
distribution among four risk levels, namely ‘Very High’, ‘High’, ‘Low’, and ‘No’. 
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Thus we need to transform the inferred diagnosis result, which is distributed in 
different risk levels, into a value that suits the ROC analysis.  
As proposed by Yang and Xu (2002), if necessary, an overall utility value can be 
estimated from an assessment of both qualitative and quantitative characteristics. 
Similar to transforming assessments of alternatives under decision into overall utility 
values, the diagnosis recommendations about patients’ risk status provided by the 
system or the doctor can be transformed into overall severity scores, as mentioned in 
Section 4.6.1 of Chapter 4. As the overall severity score is numerical and continuous 
in the range from 0 to 1, ROC curves can be constructed from overall severity scores 
to demonstrate diagnostic performances of different tests. Therefore in our research, 
we used the overall severity scores estimated from risk assessment results that are 
either generated from the system or provided by the doctor to compare diagnostic 
performances.  
To estimate the overall severity score from risk assessment result of each patient, we 
need to estimate severity scores of those four different risk levels as described in 
Figure 6-1 first.  
With advices from an expert clinician, we assigned a severity score of 1 to ‘Very 
High’, 0.67 to ‘High’, 0.33 to ‘Low’, and 0 to ‘No’. For example, we can estimate a 
patient’s overall severity score as 0.9668 if the risk result generated by the system for 
the patient is {(Very High, 0.94), (High, 0.04), (Low, 0), (No, 0)}. Therefore, every 
patient in the simulated dataset can be given an overall severity score automatically by 
the system or manually based on the risk assessment result produced by one doctor, 
and we can then use the overall severity scores of those 1000 simulated patients 
generated in different situations to do the ROC analysis.  
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6.5.2. Results 
In inference engine validation, we obtained two sets of overall severity scores of the 
simulated 1000 patients. One set was automatically generated by the system and the 
other set was manually produced based on a doctor’s judgements. 
In using the ROC curve to analyze diagnostic performances of the system and the 
doctor, we used the recorded outcome of those 1000 patients as benchmark, and we 
obtained the following two ROC curves as shown in Figure 6-4, which represent the 
diagnostic performances of the system and the doctor’s. The ROC curve as 
represented by the blue line in Figure 6-4 is plotted from the severity score set 
generated by the system, and the AUC is 0.7921 (95% confidence intervals 0.7586 – 
0.8257). The ROC curve as represented by the green line in Figure 6-4 is plotted from 
the severity score set manually produced based on the doctor’s judgements, and its 
AUC is 0.7525 (95% confidence intervals 0.7177 – 0.7873). Here we required SPSS 
to give a 95% confidence interval estimate together with a single AUC value estimate, 
where the 95% confidence interval can tell us that the value of the parameter in 
estimation can lie within the estimated interval with 95% certainty (Aczel and 
Sounderpandian, 2005).  
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Figure 6-4: ROC Curves Demonstrating the Diagnostic Performances of the 
System and One Doctor 
From the two ROC curves as displayed in Figure 6-4, we can see that the AUC 
representing diagnostic performance of the system is larger than the AUC 
representing performance of the doctor. To test whether the difference of 
performances between the system’s and the doctor’s is caused by chance or not, we 
then used StAR to compare the AUC of these two ROC curves and got a p-value less 
than 0.0001.  
The results show that under clinical uncertainties, the diagnostic performance of the 
CDSS prototype implemented using the RIMER methodology is better than manual 
judgement produced by a doctor, and the performance difference is statistically 
significant with a perfect p-value less than 0.0001.  
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6.6. Training Module Validation 
6.6.1. Method 
The kernel model of the training module integrated in the system is the BRB 
optimization model as described in Section 3.2.3 of Chapter 3 and Section 5.3.3 of 
Chapter 5. In the validation, we need to validate that the diagnostic performance of 
the system can be improved after BRB training with accumulated clinical cases. Thus 
we should test performance of the system after BRB training using a dataset which is 
independent and not included in the training dataset. 
There is no a general rule on how to choose the training examples and the test 
examples size (Hastie et al., 2001). Conventionally, in machine learning applications, 
to measure performance of the training system, we can split all available data in half, 
while one half goes to the training set for system training and the other half goes to 
the test set for performance measurement after training (Seufert and O'Brien, 2007, 
Liu et al., 2005, Agarwal et al., 2010, Yang et al., 2007). About the method we used 
to draw training data and test data in the training module validation, we will discuss it 
in next Section 6.6.1.1. 
As described in Section 5.3.3 of Chapter 5, knowledge representation parameters 
including rule weights ( )Lkk ,,1 L=θ , antecedent attribute weights ( )Tii ,,1 L=δ , 
and consequent belief degrees ( )NjLkkj ,,1;,,1 LL ==β are main training 
parameters for the training module. In our training module design and development as 
described in Section 5.3.3 of Chapter 5, we employed the training model proposed by 
Yang et al. (2007) which is based on numerical system outputs, .thus we need to 
transform the distributed inferred results ( )( )NjD jj ,,1, L=β  generated from the 
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prototype for one patient into a numerical value that can denote the patient’s severity 
status. Here, based on the utility concept ( )( )NjD j ,,1 L=µ  proposed by Yang and 
Xu (2002), as described in Section 6.5.1, different severity scores can be assigned to 
the four consequent risk levels of the BRB in Table 6-2, and thus an overall severity 
score can be generated by the system based on the inferred distributed result for one 
patient. In such situations, the severity scores of the four consequent risk levels in the 
BRB can also be trained by the training data. Here, ( )NjD j ,,1 L=  is the 
consequents of the BRB, and ( )Njj ,,1 L=β  is the inferred belief degree from the 
prototype associated to the jth consequent. L is the number of rules in the BRB, and it 
equals 48 in our system; T is the number of antecedent attributes used in the BRB, and 
it equals 5; N is the number of consequents in the BRB, and it equals 4 in the 
prototype. For details of the BRB, readers can refer to Table 6-2 in Section 6.2.     
However, in machine learning, a common issue is overfitting. A trained model is 
thought to overfit training data if there is some alternative trained model, such that the 
former model fits the training data better than the alternative one, but the alternative 
one performs better than the former over a test dataset which is independent of the 
training data (Mitchell, 1997). Overfitting is especially likely to happen when we give 
the training algorithm a very rich searching space for the parameters of the model 
being trained and thus enable the model being trained to overfit the training data 
(Mitchell, 1997).  
In the context of BRB training, we may get a trained BRB which can overfit the 
training data if we give the training model too many parameters that can vary during 
the training process.  
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To avoid overfitting in BRB training, we tried five different sets of training 
parameters for the training module. In the following discussion, we will use R1, R2, R3, 
R4, and R5 to represent the BRB training with different parameters, where  
R1: training with rule weights ( )48,,1 L=kkθ , antecedent attribute weights 
( )5,,1 L=iiδ , consequent belief degrees ( )4,,1;48,,1 LL == jkkjβ , and severity 
scores of the four different risk levels ( )( )4,,1 L=jD jµ ;  
R2: training with rule weights ( )48,,1 L=kkθ , antecedent attribute weights 
( )5,,1 L=iiδ , and consequent belief degrees ( )4,,1;48,,1 LL == jkkjβ ;  
R3: training with antecedent attribute weights ( )5,,1 L=iiδ  and consequent belief 
degrees ( )4,,1;48,,1 LL == jkkjβ ;  
R4: training with rule weights ( )48,,1 L=kkθ  and consequent belief degrees 
( )4,,1;48,,1 LL == jkkjβ ;  
R5: training with belief degrees ( )4,,1;48,,1 LL == jkkjβ .  
There are actually some other combinations of the parameters for BRB training, the 
reasons for us to try above five combinations are as follows. The main purpose for the 
training is to find a BRB model that can better represent domain knowledge in 
assessing clinical risk of CCP, though we set all knowledge representation parameters 
of the BRB and severity scores of consequent risk levels as training parameters in the 
first training round R1, we took severity scores of the four risk levels out of training in 
round R2 as too many training parameters may cause the trained system overfit the 
training data. As it is really hard for domain clinicians to give exact belief degrees to 
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different consequent severity levels in those 48 rules as shown in Table 6-2, we took 
consequent belief degrees as core parameters that need to be fine-tuned by training 
data. Thus after training round R2 where all knowledge representation parameters 
were taken as training parameters, we tried to combine consequent belief degrees with 
antecedent attribute weights and rule weights respectively as training parameters in 
training rounds R3 and R4, and finally in training round R5, we tried to put only 
consequent belied degrees as training parameters to avoid overfitting. 
Taking above mentioned into consideration, we designed the training module 
validation as follows.  
Firstly, we drew representative training examples and test examples from the 
simulated 1000 cases.  
Secondly, we trained the system by simulated cases in the training set with above 
mentioned five different set of training parameters, and we set the same initial values 
for the training parameters of each training round.  
Thirdly, we test the performance of the system before and after different BRB training 
over simulated cases in the test set. 
Fourthly, we analyzed the system’s diagnostic performance using ROC curves as 
described in Section 6.4.  
Finally, based on the system performance analysis results, we drew conclusions about 
the training module. 
Further details regarding how to split the simulated cases into training set and test set 
and how to set initial values and constraints for training parameters will be discussed 
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in the following Sections 6.6.1.1 and 6.6.1.2. 
6.6.1.1. Training Set and Test Set 
First and foremost, we need to draw training examples and test examples from those 
simulated 1000 clinical cases. Usually, in supervised machine learning as described in 
Section 3.2.3 of Chapter 3, training set can be drawn from available data randomly 
(Dale et al., 2010, Tong and Koller, 2001). In choose training examples, an important 
attribute of training examples is how well it represents the distribution of test 
examples over which performance of the trained system be measured, and generally, 
learning is most reliable when the training examples follow a similar distribution to 
that of the future test examples (Mitchell, 1997, Freund et al., 1997).  
In the context of BRB model training and validation, to ensure the reliability of BRB 
training, we need to draw similar data into both training set and test set. As in BRB 
training, it is not uncommon that the following two situations about the training would 
happen. Firstly, in some cases, parameters related to some clinical rules can be trained 
from the training data, but there are no cases in the test set that can activate the trained 
rules in testing performance of the trained system, and then it would affect the 
performance evaluation of the training module since not all trained rules have made 
contributions in the test of system performance after training. Secondly, in some other 
cases, parameters related to some clinical rules can not be trained by the training data 
due to lack of training examples in these regions where BRB was designed to operate, 
but there are cases in the test set that can activate the untrained rules in system 
performance testing after training, and then it would also affect performance 
evaluation of the training module as untrained rules would lead to irrational 
conclusions if they were initially assigned randomly or without care (Yang et al., 
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2007). Take Rule 1 in Table 6-2 for example, if knowledge representation parameters 
related to Rule 1 can be trained from the training data, then in the test set, there should 
be some patients’ data fall in the region that Rule 1 was designed to operate so that the 
trained Rule 1 can play its role in system performance test after BRB training, and 
thus the performance of the training module can be rationally evaluated. 
To draw representative data into training set and test set for training and validating all 
rules in the BRB model, we analyzed the matching status between all simulated cases 
and clinical rules in the BRB first, and then we randomly split matched cases of each 
rule probably into half (if there are enough cases for both training and test), while 
probably one half goes to training set and the other half for test set. The details are as 
follows. 
z Analyzing matching status between simulated cases and clinical rules in the 
BRB 
In analyzing the matching status between simulated patients and clinical rules, we 
checked the matching status between each simulated patient’s clinical data except 
recorded outcome and one specific rule’s antecedents. Here, the degree of matching 
between one simulated patient’s data and one clinical rule need not be with 100% 
certainty, because inference with BRB as described in Section 4.5.2 of Chapter 4 and 
Section 5.3.1 of Chapter 5 can consider different matching degrees between input data 
and one rule’s packet antecedent.  
In the simulated dataset as described in Section 6.3, we have uncertain judgements 
about patients’ ECG status: ‘definitely yes with STEMI’, ‘strongly suggestive of 
STEMI’, ‘maybe STEMI’, ‘a little like STEMI’, and ‘absolutely no STEMI’. Thus for 
some clinical cases, they may be consistent with two different clinical rules’ 
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antecedents to different degrees because of the uncertain ECG judgements. In 
calculating the number of matched cases to one clinical rule in the BRB, we 
considered all cases whose matching degrees to the rule are larger than 0. The number 
of all matched clinical cases to each clinical rule in the BRB as described in Table 6-2 
is reported in Table 6-7.  
Table 6-7: Number of Matched Clinical Cases to Each Clinical Rule in the BRB 
Rule No. Number of Matched Cases Rule No. Number of Matched 
C1 2 25 0 
2 1 26 0 
3 2 27 1 
4 2 28 2 
5 0 29 2 
6 1 30 0 
7 1 31 0 
8 1 32 1 
9 42 33 34 
10 16 34 18 
11 58 35 64 
12 37 36 45 
13 35 37 49 
14 13 38 39 
15 36 39 87 
16 40 40 97 
17 4 41 16 
18 3 42 14 
19 15 43 38 
20 10 44 31 
21 8 45 59 
22 8 46 59 
23 13 47 132 
24 18 48 128 
z Splitting simulated cases into training set and test set 
From Table 6-7, we can find that the number of matched cases to rules numbering 
from 1 to 8 and from 25 to 32 is 0 or 1 or 2, which means there are no enough cases 
falling in the regions where these rules were designed to operate for both training and 
testing these rules. Specifically, for Rule 5, Rule 25, Rule 26, Rule 30, and Rule 31, 
there is no matched case in the dataset, and thus it is impossible to use the dataset to 
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train these rules. For Rule 2, Rule 6, Rule 7, Rule 8, Rule 27 and Rule 32, there is 
only one clinical case matched to each of these rule’s antecedents, and this means if 
we put the matched case in the training set, there would be no case in the test set to 
activate the rule after training. For Rule 1, Rule 3, Rule 4, Rule 28, and Rule 29, there 
are two cases in the dataset that match each rule’s antecedents, and the only option for 
us to do both training and testing for these rules is to put one case in the training set 
and put the other case in the test set. However, if two clinical cases matched to one 
clinical rule have extremely different recorded outcomes, it will negatively affect the 
reliability of the training module if we put one case in the training set and put the 
other case in the test set.  
Taking above into consideration, we put aside the 12 cases in the simulated dataset 
that are matched to rules numbering from 1 to 4, from 6 to 8, from 27 to 29, and Rule 
32 as shown in Table 6-7, and randomly split the remaining 988 cases, with one half 
for training and the other half for test. During the data splitting, we tried to make that 
probably half of matched cases to each rule goes for training and the other half goes 
for test. We did so to ensure that each rule that has been trained in the training process 
can make contribution to system performance test after training. 
As a result, rules numbering from 1 to 8 and rules numbering from 25 to 32 have not 
be trained in the training process or tested in the test process, and the final diagnostic 
performance analyses were based on clinical cases that match rules numbering from 9 
to 24 and rules numbering from 33 to 48 in the BRB as illustrated in Table 6-7.  
6.6.1.2. Initialization of the Training Model 
z Initial values of the training parameters 
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For BRB training, a necessary task is to set initial values and constraints for the 
training parameters. We set the initial values of the training parameters for each BRB 
training round of R1, R2, R3, R4, and R5 as follows. 
(1) Severity scores of four risk levels ( )( )4,,1 L=jD jµ : ( )Very High) (1Dµ  = 1, 
( ) High)(2Dµ  = 0.67, ( )Low) (3Dµ  = 0.33, and ( ) No) (4Dµ = 0; 
(2) Rule weights ( )48,,1 L=kkθ : ( )48,,1 L=kkθ  = 1; 
(3) Antecedent attribute weights ( )5,,1 L=iiδ : ( )5,,1 L=iiδ  = 1;  
(4) Consequent belief degrees ( )4,,1;48,,1 LL == jkkjβ : we set the initial 
values of the consequent belief degrees in the BRB based on the statistical calculation 
of the training dataset. For example, for Rule 11 in the BRB in Table 6-2, there are 9 
cases in the training dataset that match the rule’s antecedents with 100% certainty, 
and the recorded outcome of those 9 cases show that 8 of them were at ‘Very High’ 
clinical risk while 1 case had ‘No’ clinical risk. Thus we set the initial values of 
consequent belief degrees in Rule 11 as {(Very High, 8/9=0.8889), (High 0), (Low, 0), 
(No, 0.1111)}. Here, with advice from experts, we assigned ‘Very High’ clinical risk 
to patients with outcome of 1 and ‘No’ clinical risk to patients with outcome of 0 in 
the simulated dataset.  
The initial values of severity scores of four risk levels, antecedent attribute weights, 
rule weights, and consequent belief degrees will be displayed together with 
corresponding trained values after different BRB training rounds in Table 6-8, Table 
6-9, Table 6-10, and Table 6-11 respectively in Section 6.6.2.1. Readers can refer to 
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the beginning part of Section 6.6.1 for details about the training parameters used in 
training rounds R1, R2, R3, R4, and R5.   
z Constraints of the training parameters 
In terms of the constraints for training parameters, we set constraints for training 
parameters as follows.  
(1) Severity scores of four risk levels ( )( )4,,1 L=jD jµ : ( )( ) 04,,11 ≥=≥ LjD jµ , 
and ( )Very High) (1Dµ  ≥ ( ) High)(2Dµ  ≥ ( )Low) (3Dµ  ≥ ( )No) (4Dµ ; 
(2) Rule weights ( )48,,1 L=kkθ : ( ) 01.048,,11 ≥=≥ Lkkθ , here we set the 
lower bound of rule weight to be 0.01, because we want to keep each rule’s weight to 
be larger than 0 after training to ensure that each simulated patient in the test set could 
be diagnosed with trained rules in the BRB. For example, if there is a patient in the 
test set whose data is 100% matched to one clinical rule, the patient would not be 
diagnosed by the system in the performance test process if the clinical rule’s weight is 
trained to be 0, which means the rule is of no importance in diagnosis. To avoid such 
situations, we set 0.01 as a lower bound to rule weight, and 0.01 can represent low 
importance of the rule while the rule with trained weight 0.01 can still be activated in 
the performance test process. We have tried other similar values as low bounds of rule 
weight, and it actually makes no difference to the system’s performance after training 
if it is set to be other similar small values. 
(3) Antecedent attribute weights ( )5,,1 L=iiδ : 1 ≥ 1δ (ECG status) ≥ 0.5, and 
1≥ ( )5,4,3,2=iiδ ≥  0, here we set the weight of the ECG status between 0.5 and 1, 
because we know the ECG status is a very important risk factor in daily clinical risk 
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assessment of CCP, and this constraint can help to make the importance of ECG 
status not be less than half of other antecedent attributes’ importance in diagnosis 
process. 
(4) Consequent belief degrees ( )4,,1;48,,1 LL == jkkjβ : 
1≥ ( )4,,1;48,,1 LL == jkkjβ ≥  0, and ( ) 048,,11 4 1 ≥=≥ ∑ = Lkj kjβ .  
What follows is discussion about the results generated from the training module 
validation.  
6.6.2. Results 
In this Section, the comparison of BRB model in the system before and after training 
is discussed in Section 6.6.2.1. Comparison of the system’s performance on test set 
before and after BRB training with different training parameters is discussed in 
Section 6.6.2.2.  
6.6.2.1. Comparison of the BRB before and after Training 
In the BRB training process, with the same training data set, different training 
parameters brought different changes to the BRB model in the system. As described 
in Section 6.6.1, R1, R2, R3, R4, and R5 are used to represent BRB training with 
different parameters, and we will use these five symbols in the following discussion. 
 The severity scores of the four consequent risk levels were trained once in training R1, 
and the comparison of the severity scores before and after training R1 is shown in 
Table 6-8.  
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For the BRB model, values of the antecedent attribute weights, rule weights, and 
consequent belief degrees before and after each training round are shown in Table 6-9, 
Table 6-10 and Table 6-11 respectively. In Table 6-8, Table 6-9, Table 6-10 and Table 
6-11, values in column ‘Initial’ represent the initial values of associated parameters 
before training. Values in columns ‘R1’, ‘R2’, ‘R3’, ‘R4’ and ‘R5’ represent the trained 
values of associated parameters after training R1, R2, R3, R4 and R5 respectively.  
Table 6-8: Severity Scores of Consequent Risk Levels Before and After Training 
R1  
Severity Score  Risk Level 
Initial  R1 
Very High 1.0000 1.0000 
High 0.6700 0.5977 
Low 0.3300 0.4006 
No 0.0000 0.0038 
Table 6-9: Antecedent Attribute Weights Before and After Training R1, R2, and 
R3 
Attribute Weight Antecedent Attribute 
Initial R1 R2 R3 
A1 1 0.5 0.5 0.5
A2 1 1 1 1
A3 1 1 1 1
A4 1 1 1 1
A5 1 1 1 1
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Table 6-10: Rule Weights Before and After Training R1, R2, and R4 
Rule Weight Rule Weight 
No. 
Initial R1 R2 R4 
No.
Initial R1 R2 R4 
1 1 1.0000 1.0000 1.0000 25 1 1.0000 1.0000 1.0000
2 1 1.0000 1.0000 1.0000 26 1 1.0000 1.0000 1.0000
3 1 1.0000 1.0000 1.0000 27 1 1.0000 1.0000 1.0000
4 1 1.0000 1.0000 1.0000 28 1 1.0000 1.0000 1.0000
5 1 1.0000 1.0000 1.0000 29 1 1.0000 1.0000 1.0000
6 1 1.0000 1.0000 1.0000 30 1 1.0000 1.0000 1.0000
7 1 1.0000 1.0000 1.0000 31 1 1.0000 1.0000 1.0000
8 1 1.0000 1.0000 1.0000 32 1 1.0000 1.0000 1.0000
9 1 1.0000 1.0000 1.0000 33 1 0.5829 0.6754 0.7614
10 1 1.0000 1.0000 1.0000 34 1 0.8170 0.8258 0.6635
11 1 0.4153 0.4097 0.2498 35 1 0.9472 0.9396 0.9886
12 1 0.0100 0.0100 0.0100 36 1 1.0000 1.0000 0.9997
13 1 0.9986 0.9973 0.9992 37 1 0.0386 0.0119 0.0175
14 1 0.7337 0.7586 0.5464 38 1 1.0000 1.0000 0.9999
15 1 0.0100 0.0100 0.0100 39 1 0.9998 0.9995 0.9988
16 1 0.7860 0.8113 0.9173 40 1 0.9765 0.9981 0.6959
17 1 1.0000 1.0000 1.0000 41 1 0.8759 0.8887 0.8321
18 1 1.0000 1.0000 1.0000 42 1 0.0343 0.0778 0.0100
19 1 0.8134 0.7930 1.0000 43 1 1.0000 0.9999 0.9514
20 1 0.8789 0.8662 1.0000 44 1 0.9999 0.9982 0.9031
21 1 0.7496 0.7264 0.9666 45 1 1.0000 1.0000 1.0000
22 1 0.7571 0.7316 1.0000 46 1 1.0000 1.0000 0.9893
23 1 0.6853 0.6488 0.9857 47 1 1.0000 0.9994 0.9994
24 1 0.6206 0.5783 0.9969 48 1 0.9983 0.9893 0.9567
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Table 6-11: Consequent Belief Degrees Before and After Training R1, R2, R3, R4, and R5  
Consequent Belief Degree 
Very High Clinical Risk High Clinical Risk Low Clinical Risk No Clinical Risk No. 
Initial R1 R2 R3 R4 R5 Initial R1 R2 R3 R4 R5 Initial R1 R2 R3 R4 R5 Initial R1 R2 R3 R4 R5 
1 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 
2 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 
3 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 
4 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 
5 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 
6 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 
7 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 
8 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 
9 1.0000 0.9496 0.9566 0.9771 0.9367 0.9444 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0029 0.0000 0.0034 0.0000 0.0000 0.0504 0.0405 0.0229 0.0599 0.0556 
10 1.0000 0.8402 0.8393 0.8637 0.7488 0.7603 0.0000 0.0107 0.0091 0.0055 0.0516 0.0121 0.0000 0.0000 0.0012 0.0000 0.0137 0.0314 0.0000 0.1491 0.1504 0.1309 0.1859 0.1961 
11 0.8889 0.8732 0.8745 0.7762 0.8731 0.7566 0.0000 0.0010 0.0149 0.0000 0.0178 0.0000 0.0000 0.0266 0.0396 0.0000 0.0127 0.0000 0.1111 0.0991 0.0709 0.2238 0.0964 0.2434 
12 1.0000 0.9550 0.8969 0.5010 0.9092 0.4126 0.0000 0.0450 0.1031 0.0000 0.0696 0.0001 0.0000 0.0000 0.0000 0.0000 0.0013 0.0000 0.0000 0.0000 0.0000 0.4990 0.0200 0.5873 
13 1.0000 0.8242 0.8322 0.9765 0.8161 0.9183 0.0000 0.0059 0.0076 0.0000 0.0022 0.0000 0.0000 0.0280 0.0092 0.0117 0.0471 0.0002 0.0000 0.1419 0.1511 0.0117 0.1345 0.0815 
14 1.0000 0.9945 0.9891 0.9238 0.9945 0.8731 0.0000 0.0055 0.0069 0.0000 0.0007 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0040 0.0762 0.0048 0.1269 
15 1.0000 0.9879 0.9850 0.6819 0.9985 0.6274 0.0000 0.0029 0.0073 0.0000 0.0015 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0092 0.0077 0.3181 0.0000 0.3726 
16 1.0000 0.8258 0.8282 0.7665 0.6706 0.7095 0.0000 0.0011 0.0008 0.0000 0.0224 0.0000 0.0000 0.0000 0.0000 0.0000 0.0070 0.0000 0.0000 0.1731 0.1710 0.2335 0.3000 0.2905 
17 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 
18 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 
19 1.0000 0.8877 0.8742 0.7538 1.0000 1.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0001 0.0000 0.0000 0.0000 0.0000 0.1123 0.1257 0.2462 0.0000 0.0000 
20 1.0000 0.9218 0.9133 0.8344 1.0000 1.0000 0.0000 0.0000 0.0001 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0782 0.0866 0.1656 0.0000 0.0000 
21 1.0000 0.8488 0.8328 0.6815 0.9799 0.9826 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0001 0.0000 0.0000 0.0000 0.1512 0.1672 0.3185 0.0201 0.0173 
22 1.0000 0.8744 0.8578 0.7144 1.0000 1.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.1256 0.1422 0.2856 0.0000 0.0000 
23 1.0000 0.8470 0.8192 0.6224 0.9927 0.9928 0.0000 0.0000 0.0002 0.0000 0.0001 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0001 0.0000 0.1530 0.1806 0.3776 0.0071 0.0071 
24 1.0000 0.8417 0.8139 0.5564 0.9985 1.0000 0.0000 0.0002 0.0018 0.0000 0.0015 0.0000 0.0000 0.0004 0.0000 0.0020 0.0000 0.0000 0.0000 0.1577 0.1843 0.4417 0.0000 0.0000 
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Table 6-11 (Cont. ): Consequent Belief Degrees Before and After Training R1, R2, R3, R4, and R5  
Consequent Belief Degree 
Very High Clinical Risk High Clinical Risk Low Clinical Risk No Clinical Risk No. 
Initial R1 R2 R3 R4 R5 Initial R1 R2 R3 R4 R5 Initial R1 R2 R3 R4 R5 Initial R1 R2 R3 R4 R5 
25 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 
26 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 
27 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 
28 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 
29 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 
30 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 
31 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 
32 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 
33 0.2857 0.3250 0.3465 0.3877 0.4252 0.4453 0.0000 0.0000 0.0000 0.0000 0.0000 0.0001 0.0000 0.0020 0.0036 0.0000 0.0166 0.0012 0.7143 0.6730 0.6499 0.6123 0.5583 0.5534 
34 0.0000 0.1221 0.1287 0.1680 0.1735 0.2659 0.0000 0.0000 0.0000 0.0000 0.0004 0.0000 0.0000 0.0030 0.0003 0.0000 0.0259 0.0012 1.0000 0.8749 0.8710 0.8320 0.8001 0.7328 
35 0.3077 0.1150 0.0968 0.0000 0.1042 0.0000 0.0000 0.2191 0.2280 0.3237 0.2215 0.3487 0.0000 0.0367 0.0259 0.0061 0.0743 0.0044 0.6923 0.6292 0.6492 0.6702 0.6000 0.6469 
36 0.1667 0.0676 0.0819 0.0000 0.0674 0.1133 0.0000 0.1196 0.1132 0.1907 0.1195 0.1126 0.0000 0.0813 0.0773 0.0331 0.1142 0.0007 0.8333 0.7314 0.7276 0.7762 0.6989 0.7735 
37 0.2143 0.1899 0.1844 0.3329 0.1955 0.3911 0.0000 0.0200 0.0229 0.0000 0.0184 0.0000 0.0000 0.0169 0.0553 0.0000 0.0281 0.0000 0.7857 0.7732 0.7374 0.6671 0.7580 0.6089 
38 0.3333 0.1307 0.1454 0.1021 0.1594 0.1281 0.0000 0.0307 0.0072 0.0523 0.0171 0.0458 0.0000 0.0276 0.0420 0.0446 0.0339 0.0287 0.6667 0.8110 0.8054 0.8010 0.7896 0.7974 
39 0.1667 0.0538 0.0555 0.0000 0.0727 0.0314 0.0000 0.1897 0.1795 0.2134 0.1494 0.1810 0.0000 0.0358 0.0161 0.0031 0.0286 0.0131 0.8333 0.7206 0.7488 0.7836 0.7493 0.7744 
40 0.0323 0.0358 0.0290 0.0000 0.0323 0.0520 0.0000 0.0000 0.0114 0.0369 0.0039 0.0000 0.0000 0.0000 0.0021 0.0209 0.0083 0.0001 0.9677 0.9642 0.9575 0.9422 0.9555 0.9479 
41 0.4000 0.3983 0.4188 0.4277 0.4531 0.4676 0.0000 0.0385 0.0015 0.0000 0.0012 0.0000 0.0000 0.0001 0.0006 0.0000 0.0041 0.0018 0.6000 0.5631 0.5790 0.5723 0.5416 0.5306 
42 0.1667 0.1438 0.1499 0.3153 0.1774 0.3581 0.0000 0.0162 0.0100 0.0000 0.0001 0.0000 0.0000 0.0014 0.0057 0.0000 0.0179 0.0000 0.8333 0.8385 0.8344 0.6847 0.8046 0.6419 
43 0.1818 0.1123 0.1127 0.0663 0.1893 0.1915 0.0000 0.0857 0.0877 0.1478 0.0000 0.0000 0.0000 0.0136 0.0169 0.0335 0.0000 0.0000 0.8182 0.7884 0.7827 0.7524 0.8107 0.8085 
44 0.2000 0.1552 0.1468 0.1254 0.2150 0.2197 0.0000 0.0440 0.0658 0.0976 0.0008 0.0000 0.0000 0.0173 0.0109 0.0231 0.0000 0.0000 0.8000 0.7835 0.7765 0.7539 0.7843 0.7803 
45 0.1923 0.1178 0.1139 0.0565 0.1773 0.1759 0.0000 0.0981 0.0970 0.1705 0.0206 0.0173 0.0000 0.0237 0.0239 0.0381 0.0045 0.0047 0.8077 0.7604 0.7652 0.7349 0.7977 0.8021 
46 0.1200 0.0480 0.0381 0.0000 0.1201 0.1211 0.0000 0.0988 0.1049 0.1707 0.0001 0.0000 0.0000 0.0227 0.0244 0.0346 0.0005 0.0000 0.8800 0.8305 0.8327 0.7946 0.8793 0.8789 
47 0.1017 0.0445 0.0021 0.0010 0.0771 0.0917 0.0000 0.0456 0.1351 0.1348 0.0336 0.0091 0.0000 0.0623 0.0318 0.0260 0.0094 0.0051 0.8983 0.8476 0.8309 0.8382 0.8799 0.8941 
48 0.0364 0.0161 0.0064 0.0014 0.0110 0.0352 0.0000 0.0130 0.0225 0.0482 0.0021 0.0011 0.0000 0.0251 0.0499 0.0027 0.0712 0.0013 0.9636 0.9457 0.9212 0.9477 0.9156 0.9623 
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From Table 6-10 and Table 6-11, we can see that the rule weights and belief degrees 
attached to rules numbering from 1 to 8 and numbering from 25 to 32 kept untouched 
in the training process. The reason is that as described in Section 6.6.1.1, there are no 
enough clinical cases in the simulated dataset fall in the regions that above rules were 
designed to operate, and then we put those scarce cases aside before drawing data into 
training set and test set. 
Therefore, in the following system performance test over both the test set, above rules 
that kept untouched in the training process will not make contribution, and changes of 
the system’s performance before and after BRB training over the test set are made by 
the other rules, which were trained by the training data.   
6.6.2.2. System Diagnostic Performance over Test Set 
This Section discusses changes of the system’s diagnostic performance before and 
after BRB training over simulated patients in test set. Here, BRB training was 
conducted with R1, R2, R3, R4, and R5. Based on the system generated overall severity 
scores (as discussed in Section 6.5.1) for patients in the test set before and after each 
BRB training, we employed SPSS to plot six different ROC curves as in Figure 6-5 to 
illustrate the system’s performance before and after each BRB training. In Figure 6-5, 
the source of each curve is annotated, where ScoreWithPreTrainedBRB represents 
severity scores of patients generated by the system running with a BRB model before 
any training; ScoreAfterR1 represents severity scores generated by the system running 
with a BRB model after training R1;  ScoreAfterR2 represents severity scores 
generated by the system running with a BRB model after training R2; ScoreAfterR3 
represents severity scores generated by the system running with a BRB model after 
training R3; ScoreAfterR4 represents severity scores generated by the system running 
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with a BRB model after training R4; ScoreAfterR5 represents severity scores generated 
by the system running with a BRB model after training R5. Take the blue curve in 
Figure 6-5 for example, from the annotated source of the curve in the figure, we know 
that the blue curve is based on patients’ severity scores generated by the system 
before BRB training, and the curve can be used to illustrate the system’s performance 
over the test set before BRB training. 
 
Figure 6-5: Six ROC Curves Demonstrating the Diagnostic Performance of the 
System before and after BRB Training over Test Set 
We then required SPSS to estimate corresponding AUC values together with their 
95% confidence intervals for the six ROC curves. The AUC values and their 95% 
confidence intervals estimated by SPSS are shown in Table 6-12, where each ROC 
curve is denoted by its source severity scores. 
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Table 6-12: AUC Values and 95% Confidence Intervals of the Six ROC Curves 
in Figure 6-5 
95% Confidence Interval ROC Curves 
(denoted by source scores) 
AUC 
Lower Bound Upper Bound 
ScoreWithPreTrainedBRB 0.7956 0.7464 0.8449 
ScoreAfterR1 0.8280 0.7830 0.8729 
ScoreAfterR2 0.8299 0.7860 0.8739 
ScoreAfterR3 0.8290 0.7851 0.8729 
ScoreAfterR4 0.8245 0.7791 0.8699 
ScoreAfterR5 0.8208 0.7752 0.8664 
As seen from Table 6-12, AUC of the ROC curves representing system’s diagnostic 
performance after BRB training are all larger than the AUC of the ROC curve 
representing system’s diagnostic performance before BRB training.  
Based on results as shown in Table 6-12, we can draw a conclusion that the training 
module implemented with different sets of training parameters can invariably help the 
system to improve the diagnostic performance, and training rounds R1, R2, and R3 
helped to bring better system performance than training rounds of R4 and R5 .  
However, since the difference between the AUC of ROC curves after BRB training R1, 
R2, R3, R4 and R5 is slight, we cannot tell which training has brought most significant 
performance improvement to the system. To test which BRB training can help the 
system to achieve most significant performance improvement among all conducted 
BRB training, we need to statistically analyze the statistical significance of the 
performance improvement after each BRB training round.   
Thereafter, to measure the statistical significance of the system’s diagnostic 
performance improvement, we used StAR to compare the AUC values of RUC curves 
representing system’s performance before BRB training and after each BRB training 
with different training parameters, and the AUC comparison results are shown in 
Table 6-13. 
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Table 6-13: p-values for AUC Comparison between ROC Curves before and 
after BRB Training 
 ScoreAfterR1 ScoreAfterR2 ScoreAfterR3 ScoreAfterR4 ScoreAfterR5
ScoreAfterR2 0.4530     
ScoreAfterR3 0.8863 0.8881    
ScoreAfterR4 0.4984 0.2038 0.5639   
ScoreAfterR5 0.3890 0.2326 0.0984 0.5596  
ScorePre 
TrainedBRB 
0.0323 0.0198 0.0076 0.0764 0.0836 
Based on the comparison results as shown in Table 6-13, we know that training R3 
(with p-value 0.0076) brought the most statistically significant performance 
improvement for the system though there is no significant difference between system 
performances after training rounds of R1, R2, R3, R4, and R5 . Thus we considered the 
parameter set that was used in training R3 as the most suitable training parameter set 
for the training module, and it is composed of antecedent attribute weights 
( )5,,1 L=iiδ  and consequent belief degrees ( )4,,1;48,,1 LL == jkkjβ . 
6.7. Summary 
This chapter presents a validation study of the developed CDSS prototype. The 
system validation was conducted using a set of 1000 simulated patients in CCP.  The 
BRB constructed in the system for validation is based on rules for assessing clinical 
risk of CCP provided by one of our research collaborators – Dr. Richard Body at MRI, 
and the statistical method we used for diagnostic performance evaluation is ROC 
analysis.  There are two main conclusions that can be drawn from the validation study. 
z Firstly, based on the RIMER methodology, the developed prototype CDSS can 
handle different uncertainties in both clinical domain knowledge and clinical data, 
and the system can provide reliable diagnosis recommendations. 
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z Secondly, based on the BRB optimization model implemented in the system, the 
system’s performance can be statistically significantly improved after training 
BRB with available accumulated cases. While the most suitable training 
parameters for the training module contain antecedent attribute weights and belief 
degrees. 
Based on the developed CDSS prototype and the system validation study presented in 
this chapter, we can conclude that it is feasible, viable, and reliable to use RIMER for 
implementing a CDSS.   
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Chapter 7  
Conclusions and Potential Future Research 
 
7.1. Introduction 
This chapter first summarises the whole study, pointing out what has been done in the 
study in Section 7.2. Then Section 7.3 recapitulate the whole thesis and highlights 
main findings and contributions of the research, where the main findings from 
previous chapters are discussed in Section 7.3.1 and main contributions of the 
research are discussed in Section 7.3.2. Finally, limitations of the research and 
possible future research are discussed in Section 7.4  
7.2. Summary of the Study 
Motivated by the strong need in CDSSs research for a competent CDSS, which can (a) 
represent and reason with clinical domain knowledge under uncertainties; (b) update 
knowledge base automatically based on accumulated clinical cases; and (c) provide 
online group clinical decision support, the study aimed to use a newly developed 
belief rule-base inference methodology – RIMER (Yang et al., 2006) for the design 
and development of an online intelligent group CDSS. Main research questions that 
the study tries to answer include: (a) is it feasible to employ RIMER for developing a 
CDSS? (b) how to facilitate online group clinical decision making and arrive at a 
group combined clinical recommendation for target patient in a belief rule-based 
CDSS? and (c) how to train belief rule-based CDSS and make its knowledge base be 
adaptive to clinical practice? Based on theses research questions, the measurable 
objectives of the research include: (a) investigate existent CDSSs, and identify system 
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features of existing CDSSs; (b) acquire target clinical domain knowledge; (c) 
investigate the feasibility of employing belief rule base (BRB) to model clinical 
domain knowledge and using the evidential reasoning (ER) approach to do clinical 
inference in a CDSS; (d) design and develop an online belief rule-based group CDSS 
prototype; and (e) validate the online intelligent CDSS prototype using clinical cases 
in target clinical areas. Clinical areas being investigated in the study includes upper 
Gastrointestinal (GI) bleed and CCP. Finally, a belief rule-based online group CDSS, 
which provides guideline-based individual diagnosis support, group consultation 
support, and automatic knowledge base updating via learning through accumulated 
clinical cases, was developed in the research. The prototype CDSS has been validated 
using a set of simulated clinical cases in CCP.  
The research methodology used in the study is a multiple-methodology approach. 
Modelling and prototyping are the two main research methods used for prototype 
design and development. Field study is used in the study for gaining deep 
understanding of domain knowledge and daily clinical work flow in NHS hospitals, 
and acquisition of users’ requirements of a CDSS. Statistical techniques including the 
receiver operating characteristic (ROC) curve analysis and the area under the ROC 
curve (AUC) comparison are used in the prototype validation for system performance 
analysis. 
In the research, various research gaps in the CDSSs literature that impedes 
successfully application of existent CDSSs in clinical practice were identified first. 
Then a preliminary study on the feasibility of using RIMER for developing a CDSS 
was conducted. It is followed by the design and development of a belief rule-based 
online group CDSS which can help address the identified research gaps, and finally 
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the validation of the developed prototype was conducted using a set of simulated 
patients’ data. 
The research developed an online belief rule-based group CDSS and proved that (a) it 
is feasible and viable to use RIMER for developing a CDSS; (b) the developed CDSS 
can handle uncertainties in both clinical domain knowledge and clinical data, and the 
system can provide reliable diagnosis recommendations; and (c) the BRB in the 
system can be updated automatically by learning through available cases accumulated 
in clinical practice, and the BRB training can help to improve the system’s diagnostic 
performance statistically significantly. 
In a word, all the research questions presented in Section 1.2 of Chapter 1 have been 
addressed comprehensively by the study. 
7.3. Major Conclusions 
7.3.1. Findings 
This thesis has proposed using RIMER for developing an intelligent CDSS that can 
make use of the uncertainty-handling capability of RIMER for representing and 
reasoning with clinical domain knowledge under uncertainties. A preliminary 
feasibility study proved that it is logically feasible to employ RIMER for developing a 
CDSS. In order to demonstrate the technical feasibility of the proposed belief rule-
based CDSS, an online CDSS prototype was developed using Visual Studio 
2003 .NET and MATLAB. A set of patients in CCP was simulated by an expert 
clinician in MRI for validating the developed prototype. The major findings 
addressing the research questions are outlines as follows. 
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z The developed prototype CDSS shows the feasibility and viability of using 
RIMER for developing an online intelligent CDSS. 
z Representing clinical domain knowledge with belief rules and inference with 
BRB using the ER approach enables the system to handle uncertainties in both 
clinical domain knowledge and clinical data. 
z The group decision supporting module implemented in the prototype enables 
clinicians to hold online group meetings, discussions or consultations via the 
system. The ER-based group preferences aggregation mechanism in the module 
can help to arrive at a group combined diagnosis recommendation. 
z The BRB training module implemented in the system helps the system to update 
the knowledge base automatically by learning through available accumulated 
cases, and it helps to improve the system’s performance after learning from 
accumulated cases. Therefore, the training module enables the system to be 
adaptive to clinical practice and provide an evidence-based clinical decision 
support.  
z Structuring and storing BRB in relational database facilitates the interactions 
between knowledge base and other system components. It also facilitates the 
sharing of domain specific knowledge due to the mature database technology and 
networking technology. 
z The system validation offers encouraging outcomes for the system. Firstly the 
system can provide reliable diagnosis recommendations under clinical 
uncertainties. Secondly automatic BRB training using accumulated clinical cases 
can help the system improve diagnostic performance statistically significantly.  
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7.3.2. Contributions 
The research questions pursued in this study are new, creative, and important in 
CDSSs research fields. The research is quite complex and demanding, as it is 
interdisciplinary and mainly involves (a) investigation of the existent CDSSs; (b) 
investigation of clinical domain knowledge; (c) investigation of advanced models for 
representing and reasoning with clinical domain knowledge under uncertainties, group 
preferences aggregation, and knowledge base training; (d) system design and 
development; and (e) system validation. The research deals with theoretical 
investigation, field study, software development, and system validation. It bridges the 
gaps in the CDSS literature. Major contributions of the research are listed as follows.  
(1) From the CDSS research perspective: 
z The research develops a new CDSS framework which integrates automatic 
knowledge learning functionality and online group decision supporting 
functionality into a knowledge-based CDSS. 
z The research proposes and uses relational database to uniquely store and 
manage BRB model, and this makes physical knowledge base construction 
flexible and portable. It also makes the knowledge sharing between different 
clinical systems free of technology barriers thanks to mature relational 
database technologies. 
(2) From a practical domain application perspective: 
z The research develops a target clinical domain BRB for modelling domain 
specific knowledge under uncertainty. The BRB can be used not only for 
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generating automatic diagnosis recommendations but also for clinicians’ future 
domain knowledge reference in practice. 
z  The research develops an ER based inference engine to infer with input 
uncertain clinical data and back-end uncertain domain knowledge in the BRB. 
The inference engine infers with different clinical uncertainties in a rational 
way, and can generate prioritised and informative diagnosis recommendations. 
z The research develops an ER based group clinical decision supporting module. 
The group decision support module provides not only a group diagnosis 
preferences aggregation mechanism but also a discussion forum for group 
consultants to hold online group discussions or consultations. 
z The research develops a BRB training module that can help update the 
embedded clinical rules automatically and routinely and keep the knowledge 
base being adaptive to clinical practice. 
z The research implements guideline-based user interfaces which not only 
facilitates clinicians complying with the practice guidelines, but also makes the 
integration of CDSS with clinical work flow implemented easily. 
7.4. Potential Future Research 
Although the research shows positive and encouraging results about employing 
RIMER methodology for developing a CDSS, there are limitations in the research. 
Firstly, from technical perspective, the system developed in the research is a prototype 
with preliminary functionalities, and the system has not been tested with real clinical 
scenarios. Secondly, from system validation perspective, only inference engine and 
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BRB training module were validated in the research with simulated data, the group 
decision supporting module was not validated due to lack of data. Thirdly, about the 
simulated data used in system validation, though the data is close to reality, the 
recorded outcome of patients in the dataset is a composite one, and the dataset can not 
tell exactly at which level that one patient’s clinical risk is. Fourthly, in clinical 
environment, one patient’s clinical data that are necessary for clinical risk assessment 
may not be available at the point of risk assessment, and the risk status of one patient 
may keep changing, but these two situations in clinical risk assessment have not been 
considered in the research. Finally, through the ROC curve analysis in system 
validation, we know that the system can provide reliable diagnosis recommendations 
and the system’s performance can be statistically significantly improved after BRB 
training, but it is difficult for doctors to accept the system and use it in clinical 
practice just based on current research outcomes. Then we need further research to 
convince the clinicians to accept the system in their clinical practice. 
We know that more work needs to be done to deploy the system in a real clinical 
environment. Future research on the belief rule-based online group CDSS could be 
promising in many areas. Some of them are listed as follows. 
z Apart from the uncertainty in domain knowledge and clinical data, which are 
represented as incomplete clinical rules in the system’s BRB and uncertain 
subjective judgements about patients’ clinical symptoms, there are other various 
types of uncertainties in clinical domain specific knowledge and patients’ data. 
For example, belief degrees assigned to possible consequents of one clinical rule 
may be an interval other than a numerical value. Thus the BRB model in the 
system can be further developed to embed other possible types and degrees of 
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uncertainties in domain knowledge, and the ER based inference engine can be 
extended to accommodate these uncertainties in the inference process.  
z A dynamic belief rule-based clinical inference model can be developed and 
integrated into the system for providing continuous and dynamic clinical decision 
support, considering the fact that availability of patients’ clinical data is unstable 
and the clinical status of a specific patient may keep changing in the diagnosis 
process. 
z The prototype can be tested by various real clinical scenarios, and real patients’ 
clinical data in target clinical areas can be used to train and to validate the system 
to get more convincible results about the system. 
z As for knowledge base training with accumulated clinical cases, study about more 
advanced BRB training techniques can be conducted for learning situations where 
there are no preliminary clinical rules but a large set of patients’ data is available 
in one clinical area. 
z The system can be deployed in a real clinical environment after various technical 
tests, and then the study about real clinical benefits that the system can bring to 
hospitals, doctors and patients can be conducted.  
z Research about user acceptance of the system can be conducted after the system 
is deployed in real clinical environment, considering the fact that doctors may 
still have doubts about the adoption of a CDSS in their clinical practice even if 
the system is proven to technically facilitate clinical decision making and help 
reduce medical errors. 
Many fruitful research can be conducted by using and enhancing the belief rule-based 
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online group CDSS although many challenges remain ahead. 
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Appendix A  Brief User Manual 
A1. Introduction 
This user manual briefly describes guidance on the use of the system for various 
specific purposes: support of individual diagnosis of one patient; support of group 
consultation about one patient; and support of automatic knowledge base updating. 
This brief user manual uses screenshots to guide system users to main features of the 
system.  
A2. Individual Diagnosis Support 
(1) Login as a clinician for the purpose of individual diagnosis. 
 
(2) Click on the main symptom of the patient. Note that we use upper 
gastrointestinal (GI) bleed as an example diagnosis for illustration in this 
manual. 
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(3) Click on ‘Please input patient’s personal information here’. 
 
(4) Input the patient’s personal information. 
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(5) Click ‘OK’ to go back to the main interface for diagnosis of upper GI 
bleed. 
 
(6) Click on ‘Complete PDI/050 overleaf’. 
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(7) Input your judgment about the patient. 
 
(8) Clinical decision support terminates here if the patient is not suitable for 
the guideline-driven investigation. 
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(9) Or, clinical decision support continues if the patient is suitable for the 
guideline-driven investigation. Click on ‘Complete CDU/051 overleaf’. 
 
(10) Input the patient’s clinical information for risk assessment. 
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(11) Click on ‘OK’ to check the risk assessment result for the patient. 
 
(12) Click on ‘Check it!’ to get the patient’s severity score. Input your 
judgment about the patient’s severity score. Click on ‘Link to all activated 
rules in the inference process!’ to check all rules activated in the process of 
assessing the patient’s risk. 
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(13) All activated rules are displayed.  
 
(14) Go back to the main diagnosis interface. Click on ‘Investigate IP/052 
overleaf’. Here we use clinical management of patient in ‘High risk’ for 
illustration in this manual. 
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(15) Select the clinical decision about the patient. 
 
(16) What to do next is to follow the ‘High risk’ branch in the guideline and 
manage the patient as the guideline indicated step by step. 
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A3. Group Consultation Support 
(1)  For group facilitator 
a. Login as a clinician for the purpose of group consultation. 
 
b. Click on ‘For Group Facilitator’. 
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c. Input necessary information about the patient who is the target of the 
group consultation.  
 
d. Select the purpose of the group consultation from the listbox. 
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e. Select available consultants whose expertise is in target area.  
 
f. Wait online for group consultants’ discussion and diagnosis preferences. 
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g. Facilitate the group consultation by inputting your judgment in the 
textbox. 
 
h. Click on ‘Ask the system to aggregate member consultants’ diagnoses’ 
after you have terminated the group consultation. 
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i. Assign weight to group consultants in the group consultation. 
 
j. Check the aggregated risk result for the patient. Click on ‘Edit’ to input 
final judgment for record purpose.  
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(2)  For consultant 
a. Login as a clinician to do group consultation. 
 
b. Click on ‘For Consultant’. 
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c. Input necessary information about the target patient.   
 
d. Check the recorded information about the patient.  
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e. Select your preference from the listbox about the patient’s risk level. 
Enter your judgment about the patient’s in the textbox. Click on ‘Link to 
the final group diagnosis of the patient!’ after receiving the message 
from the group facilitator for terminating the group consultation. 
 
f. Check the final aggregated risk result for the patient. 
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A4. BRB Updating Support 
(1)  Login as a clinician for the purpose of updating medical rules. 
 
(2)  Click on ‘Display All Rules Used in The System’ for displaying all medical 
rules stored in the system. Click on ‘Train Medical Rules based on Diagnosed 
Cases’ for automatically training medical rules using accumulated cases in the 
system. 
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(3)  For displaying medical rules 
a. Select the target rule base for displaying. 
 
b. Check all rules stored in the rule base. 
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(4)  For automatically updating medical rules 
a. Select target rule base for training. 
 
b. Click on ‘OK’ to train selected rule base using accumulated clinical 
cases. 
 236
 
c. Select the training parameters you want to check after the training. We 
use rule weights as an example for illustration in this manual. 
 
d. Trained rule weights are displayed. 
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Appendix B  BRB Inference Using the ER Approach in 
Recursive Format (Yang et al., 2006) 
Suppose we have a BRB that has L belief rules with N possible consequents, and rule 
activation weights ( )Lkk ,,1 L=ω  and belief degrees in consequents 
( )LkNjjk ,,1;,,1 LL ==β  of the BRB have been calculated based on observed facts. 
The ER approach in recursive format can be directly applied to inference with the 
BRB as follows. 
First, transform the degrees of belief jkβ  for all Nj ,,1 L= , Lk ,,1 L=  into basic 
probability masses using the following ER algorithm: 
Njm jkkkj ,,1,, L== βω  
∑∑
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−=−=
N
j
jkk
N
j
kjkD mm
11
,, 11 βω  
kkDm ω−= 1,  
⎟⎟⎠
⎞
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⎛ −= ∑
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N
j
jkkkDm
1
, 1~ βω  
for all Lk ,,1 L= , where kDkDkD mmm ,,, ~+=  for all Lk ,,1 L=  and 11 =∑ =Lj jω . The 
probability mass assigned to the consequent set D, which is unassigned to any 
individual consequent, is split into two parts: one caused by the relative importance of 
the kth packet antecedent Ak (or kDm , ) and the other by the incompleteness of the kth 
packet antecedent Ak (or kDm ,~ ). 
Then, aggregate all the packet antecedents of the L rules to generate the combined 
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degree of belief in each possible consequent jD  in D. Suppose )(, kIjm  is the 
combined degree of belief in jD  by aggregating the first k packet antecedents 
( )kAA ,,1 L , and )(, kIDm  is the remaining degree of belief unassigned to any 
consequent. Let 1,)1(, jIj mm =  and 1,)1(, DID mm = . Then, the overall combined degree 
of belief jβ  in  jD  is generated as: 
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Dβ  represents the remaining belief degrees unassigned to any jD . It has been proven 
that 1
1
=+∑ = DNj j ββ . The final conclusion generated by aggregating the L rules, 
which are activated by the actual input vector { }LkAA k ,,1,* L== , can be 
represented as 
( ) ( ){ }NjDAS jj ,,1;,* L== β . 
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